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Resumen
Una interaccio´n farmacolo´gica ocurre cuando los efectos de un fa´rmaco se modi-
fican por la presencia de otro. Las consecuencias pueden ser perjudiciales si la intera-
ccio´n causa un aumento de la toxicidad del fa´rmaco o la disminucio´n de su efecto,
pudiendo provocar incluso la muerte del paciente en los peores casos. Las interaccio-
nes farmacolo´gicas no so´lo suponen un grave problema para la seguridad del paciente,
sino que adema´s tambie´n conllevan un importante incremento en el gasto me´dico.
En la actualidad, el personal sanitario tiene a su disposicio´n diversas bases de datos
sobre interacciones que permiten evitar posibles interacciones a la hora de prescribir
un determinado tratamiento, sin embargo, estas bases de datos no esta´n completas.
Por este motivo, me´dicos y farmace´uticos se ven obligados a revisar una gran canti-
dad de art´ıculos cient´ıficos e informes sobre seguridad de medicamentos para estar
al d´ıa de todo lo publicado en relacio´n al tema. Desgraciadamente, el gran volumen
de informacio´n al respecto hace que estos profesionales este´n desbordados ante tal
avalancha. El desarrollo de me´todos automa´ticos que permitan recopilar, manterner
e interpretar toda esta informacio´n es crucial a la hora de conseguir una mejora real
en la deteccio´n temprana de las interacciones entre fa´rmacos. Por tanto, la ex-
traccio´n de informacio´n podr´ıa reducir el tiempo empleado por el personal me´dico
en la revisio´n de la literatura me´dica. Sin embargo, la extraccio´n de interacciones
farmacolo´gicas a partir textos biome´dicos no ha sido dirigida hasta el momento.
Motivados por estos aspectos, en esta tesis hemos realizado un estudio detallado
sobre diversas te´cnicas de extraccio´n de informacio´n aplicadas al dominio farma-
colo´gico. Basa´ndonos en este estudio, hemos propuesto dos aproximaciones distintas
para la extraccio´n de interacciones farmacolo´gicas de los textos. Nuestra primera
aproximacio´n propone un enfoque h´ıbrido, que combina ana´lisis sinta´ctico superfi-
cial y la aplicacio´n de patrones le´xicos definidos por un farmace´utico. La segunda
aproximacio´n se aborda mediante aprendizaje supervisado, concretamente, el uso de
me´todos kernels. Adema´s, se han desarrollado las siguientes tareas auxiliares: (1) el
ana´lisis de los textos utilizando la herramienta UMLS MetaMap Transfer (MMTx),
que proporciona informacio´n sinta´ctica y sema´ntica, (2) un proceso para identificar
y clasificar los nombres de fa´rmacos que ocurren en los textos, y (3) un proceso para
reconoger las expresiones anafo´ricas que se refieren a fa´rmacos. Un prototipo ha
sido desarrollado para integrar y combinar las distintas te´cnicas propuestas en esta
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tesis. Para la evaluacio´n de las dos propuestas, con la ayuda de un farmace´utico
desarrollamos y anotamos un corpus con interacciones farmacolo´gicas. El corpus
DrugDDI es una de las principales aportaciones de la tesis, ya que es el primer cor-
pus en el dominio biome´dico anotado con este tipo de informacio´n y porque creemos
que puede alentar la investigacio´n sobre extraccio´n de informacio´n en el dominio
farmacolo´gico. Los experimentos realizados demuestran que el enfoque basado en
kernels consigue mejores resultados que los reportados por el enfoque que utiliza
informacio´n sinta´ctica y patrones le´xicos. Adema´s, los kernels consiguen resultados
comparables a los obtenidos en dominios similares como son las interacciones entre
prote´ınas.
Esta tesis se ha llevado a cabo en el marco del consorcio de investigacio´n MAVIR-
CM (Mejorando el acceso y visibilidad de la informacio´n multilingu¨e en red para la
Comunidad de Madrid, www.mavir.net) dentro del Programa de Actividades de
I+D en Tecnolog´ıas 2005-2008 de la Comunidad de Madrid (S-0505/TIC-0267) as´ı
como en el proyecto de investigacio´n BRAVO: ”Bu´squeda de Respuestas Avanzada
Multimodal y Multilingu¨e” (TIN2007-67407-C03-01).
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Abstract
A drug-drug interaction occurs when one drug influences the level or activity
of another drug. The detection of drug interactions is an important research area
in patient safety since these interactions can become very dangerous and increase
health care costs. Although there are different databases supporting health care
professionals in the detection of drug interactions, this kind of resource is rarely
complete. Drug interactions are frequently reported in journals of clinical pharma-
cology, making medical literature the most effective source for the detection of drug
interactions. However, the increasing volume of the literature overwhelms health
care professionals trying to keep an up-to-date collection of all reported drug-drug
interactions. The development of automatic methods for collecting, maintaining and
interpreting this information is crucial for achieving a real improvement in their early
detection. Information Extraction (IE) techniques can provide an interesting way
of reducing the time spent by health care professionals on reviewing the literature.
Nevertheless, no approach has been carried out to extract drug-drug interactions
from biomedical texts.
In this thesis, we have conducted a detailed study on various IE techniques ap-
plied to biomedical domain. Based on this study, we have proposed two different
approximations for the extraction of drug-drug interactions from texts. The first
approximation proposes a hybrid approach, which combines shallow parsing and
pattern matching to extract relations between drugs from biomedical texts. The
second approximation is based on a supervised machine learning approach, in par-
ticular, kernel methods. In addition, we have created and annotated the first corpus,
DrugDDI, annotated with drug-drug interactions, which allow us to evaluate and
compare both approximations. To the best of our knowledge, the DrugDDI corpus
is the only available corpus annotated for drug-drug interactions and this thesis is
the first work which addresses the problem of extracting drug-drug interactions from
biomedical texts. We believe the DrugDDI corpus is an important contribution be-
cause it could encourage other research groups to research into this problem. We
have also defined three auxiliary processes to provide crucial information, which will
be used by the aforementioned approximations. These auxiliary tasks are as follows:
(1) a process for text analysis based on the UMLS MetaMap Transfer tool (MMTx)
to provide shallow syntactic and semantic information from texts, (2) a process for
III
drug name recognition and classification, and (3) a process for drug anaphora resolu-
tion. Finally, we have developed a pipeline prototype which integrates the different
auxiliary processes. The pipeline architecture allows us to easily integrate these
modules with each of the approaches proposed in this thesis: pattern-matching or
kernels. Several experiments were performed on the DrugDDI corpus. They show
that while the first approximation based on pattern matching achieves low perfor-
mance, the approach based on kernel-methods achieves a performance comparable
to those obtained by approaches which carry out a similar task such as the extraction
of protein-protein interactions.
This work has been partially supported by the Spanish research projects: MAVIR
consortium (S-0505/TIC-0267, www.mavir.net), a network of excellence funded by
the Madrid Regional Government and TIN2007-67407-C03-01 (BRAVO: Advanced
Multimodal and Multilingual Question Answering).
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Chapter 1
Introduction
1.1. Motivation
During the last years, biomedicine has witnessed a huge development. Large
amounts of experimental and computational biomedical data have been generated
along with new discoveries, which are accompanied by an exponential increase in
the number of biomedical publications describing these discoveries. The continuing
growth and diversification of the scientific literature require tremendous systematic
and automated efforts to utilize the underlying information. Pharmaceutical in-
dustry represents a clear example of the growing biomedical literature. During the
whole drug life cycle tens of thousands of documents are generated and must be
analyzed. In the near future, tools for knowledge discovery will play a pivotal role
in biomedical systems since the overwhelming amount of biomedical knowledge in
texts demands automated methods to collect, maintain and interpret them.
Patient safety has become a priority for health systems, since the Institute of
Medicine (IOM) of United States, in its Err is Human report [Kohn et al., 1999],
estimated that between 44 and 98 thousand people die in U.S hospitals each year as
the result of problems in patient safety. In recent years, several of the major health
organizations such as the World Health Organization (WHO)1, the Pan American
Health Organization (PAHO)2 and the European Environment and Health Com-
mittee (EEHC)3 have developed strategies to propose plans, actions and legislative
measures to control avoidable adverse effects in the most relevant domains of pa-
tient safety such as hospital-acquired infections, medications errors, operative and
post-operative complications, obstetrics. Some progress has been made in the area
of patient safety, however, there is still plenty of room for improvement. Although
some areas have effective safety systems, the area of drugs does not appear to have
1http://www.who.int/en/
2http://www.paho.org/
3http://www.ifeh.org/activities.eehc.html
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reached the level of development initially expected [Longo et al., 2005, Leape and
Berwick, 2005]. Among the advices given for patient safety, major health organiza-
tions recommend promoting communication of incidents.
Pharmacovigilance is formally defined by the WHO as “the science and activities
related to the detection, assessment, understanding and prevention of adverse effects
or any other drug-related problems” [WHO, 2002]. This stage is considered vital
by the pharmaceutical companies and other agencies due to the recent high profile
safety incidents. Currently, spontaneous post-marketing reporting systems are used
when adverse effects are discovered in a drug that is already on the market. Health
care professionals are responsible for recognizing and reporting those side effects.
Several published drug safety issues have shown that adverse effects of drugs may be
detected too late, when millions of patients have already been exposed to them. This
fact poses a serious problem for the patient safety, motivating a growing interest for
improving these reporting systems. A clear example of it is the EU-ADR 4 project
for the early detection of adverse drug reactions (ADR) by integrative mining of
clinical records and biomedical knowledge.
Following this emphasis, the general aim of this thesis is to improve the early
detection of drug-drug interactions (DDIs) in scientific publications, a special case of
ADRs. A DDI occurs when one drug influences the level or activity of another, for
example, raising its blood levels and possibly intensifying its side effects or decreas-
ing drug concentrations and thereby reducing its effectiveness [Stockley, 2007]. Some
DDIs can be beneficial. The pharmacoenhancing effect of ritonavir on lopinavir re-
sults in a highly potent, clinically effective antiretroviral drug with a high genetic
barrier to viral resistance [von Hentig, 2007]. However, many DDIs can be very dan-
gerous [Aronson, 2007], for example hypoglycaemia can be experienced by patients
taking clarithromycin and glibenclamide concurrently.
In Spain, the APEAS [2008] study showed that 47.8% of adverse events are
due to drugs, of which 3.5% result from drug interactions. DDIs can range in
severity, including prolonged morbidity and even death. The estimated incidence of
DDIs that have a clinical significance ranges from 3% to 20%, depending on how
many drugs are taken [Nies, 2001]. The frequency of drug interaction increases
disproportionally with the increase in the number of drugs in combination. For
example, only 5% of patients with less than six drugs manifested clinical signs of
drug interaction; while 40% of patients given 16 drugs experienced an adverse DDI
[Naguib et al., 1997]. In addition, DDIs can greatly increase health care costs. A
study revealed an increased length of stay of 3.1 days for patients who received
warfarin with potentially interacting drugs compared with a control group [Jankel
et al., 1994]. Another study [Rosholm et al., 1998] showed that 1.2% of hospital
admissions were related to DDIs.
4http://www.alert-project.org/
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DDIs are a serious problem for patient safety. However, the management of
DDIs is a critical issue due to the overwhelming amount of information available on
them [Hansten, 2003]. The introduction of new technologies in primary care and
hospitals has led to the development of electronic medical record systems, which has
opened the possibility of incorporating decision support systems to prevent drug-
drug interactions and inform on possible actions to take. However, the deployment
of these systems is not widespread yet [Rodr´ıguez-Terol et al., 2009]. The assisted
electronic prescription is only available in the 22.4% of the hospitals [Vicedo and
Conde, 2007]. In primary care, these systems do not support the management of
DDIs.
Therefore, clinicians and pharmacists must be able to manage by themselves the
richness of information available on DDIs. There is a great amount of DDI databases
[Rodr´ıguez-Terol et al., 2009]. Some of them are Bot-plus [Plus, 2008], Medinter-
act5, SEFH guide6, Medscape7, Hansten, Micromedex8, Stockley [Stockley, 2007],
Drug Interactions Facts [Tatro, 2003]. The diversity of DDI databases currently
available poses a significant problem to health care professionals when collecting
and evaluating information about a particular interaction from these databases.
Several studies [LAM et al., 2003, Edward et al., 2004] have shown that the
quality of the DDI databases is very uneven and the consistency of their content
is scarce, so it is very difficult to assign a real clinical significance to each drug
interaction. Ideally, prescribing information about a drug should list its potential
interactions, together with the following information about each interaction: its
mechanism, its relation to the doses of both drugs, its time course, the factors that
alter an individual’s susceptibility to it, its seriousness and severity, and the prob-
ability of its occurrence [Ferner and Aronson, 2006, Aronson, 2004b]. In practice,
however, this information is rarely available [Aronson, 2007]. Most DDIs are docu-
mented as anecdotal reports or as effects in small studies, in which interactions may
be missed if they are limited to a susceptible subset of the population [Aronson,
2004a]. Rodr´ıguez-Terol et al. [2009] established a set of criteria to evaluate and
compare 24 databases. The minimum quality criteria includes levels of severity and
evidence, bibliographic reference, and the description of clinical management for
each drug interaction. They concluded that only 9 databases satisfied the minimum
criteria. In particular, an increasingly important issue is the update periods of these
databases. The update period is described only in 12 of the 24 databases, from im-
mediate updates to a period of 3 years. Updates over 1 year should be inadmissible,
and even more frequent updates should be required.
5http://medinteract.net/
6www.sefh.es
7http://www.medscape.com/druginfo/druginterchecker
8http://www.micromedex.com/products/drugreax/
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On the other hand, despite the availability of these databases, a great amount
of the most current and valuable information is unstructured, written in natural
language and hidden in published articles, scientific journals, books and technical
reports. Drug interactions are bread and butter to journals of clinical pharmacology
due to the vast number of interactions that can happen [Aronson, 2007]. Each year
300,000 articles are published just within the pharmacology domain [Duda et al.,
2005]. Therefore, the medical literature is probably by far the most effective system
for detection of DDIs [Aronson, 2007].
The great amount of DDI databases and the deluge of published research have
overwhelmed most health care professionals because it is not possible to be kept
up-to-date of everything published about drug-drug interactions. Information ex-
traction (IE) from both structured and unstructured data sources can be of great
benefit in the pharmaceutical industry allowing identification and extraction of rel-
evant information and providing an interesting way of reducing the time spent by
health care professionals on reviewing the literature. In addition, the development
of tools for automatically extracting DDIs from biomedical texts is essential for
improving and updating the drug knowledge databases.
In this document, we have proposed and evaluated different IE techniques for
automatic detection of DDIs from unstructured texts. In particular, we have de-
veloped a prototype that allows to combine and compare these techniques. Our
approach divides the problem in subtasks such as recognition and classification of
pharmacological substances and the detection of interactions between them.
This work has been partially supported by the Spanish research projects: MAVIR
consortium (S-0505/TIC-0267, www.mavir.net), a network of excellence funded by
the Madrid Regional Government and TIN2007-67407-C03-01 (BRAVO: Advanced
Multimodal and Multilingual Question Answering).
1.2. Objectives
Due to the dynamic nature of biomedicine, new terms and relations between these
terms are constantly rising in the biomedical texts [Ananiadou and McNaught, 2006].
Gene or protein interactions have attracted much attention in the field of biomedical
IE and plenty of approaches have been proposed for their detection, however, the
automatic extraction of DDIs has been hardly addressed. DDIs have been only tack-
led by [Duda et al., 2005, Guo and Ramakrishnan, 2009]. Indeed, theses approaches
classified and located articles about DDIs but did not mine these interactions explic-
itly. The solutions for biomedical relation extraction range from simple statistical
methods relying on co-occurrences of genes or proteins, methods employing a deep
syntactic or semantic analysis, to machine learning tecniques. Pattern-based ap-
proaches have been widely applied but with limited success because they are not
4
able to correctly process anything other than short and straightforward sentences.
Supervised machine learning methods have shown promising results but they have
not often been applied in the biomedical domain mainly due to the shortage of gold
standard corpora for training and testing these systems. Relations that can span
several sentences are rarely tackled. Very few approaches have focused on construc-
tions such as mood, modality and negation, which can significantly alter or even
reverse the meaning of the sentence.
The development of automatic methods to produce structured information from
unstructured text sources would be extremely valuable to the biomedical community.
A structured resource would allow researches and healthcare professionals to write a
single query to retrieve all the transcription interactions of any drug. Instead of the
thousands of abstract provided by querying the unstructured corpus, the query on
the structured corpus might result in a few hundred well formed results; this would
obviously save a tremendous amount of time and energy. On the other hand, the
extraction of drug-drug interactions can also help to improve the curation process of
the drug interactions databases. Most biomedical and pharmacological knowledge
resources are manually updated by experts. This manual process is an expensive
and laborious task. Our long term goal is to enrich DDI databases by extracting
information from large text collections such as MedLine9 or EMBASE 10, so we are
trying to reduce the manual review work needed. Both are bibliographic databases
which contain millions of references to articles published in life science journals.
In total, there are 23 million biomedical and pharmacological records from both
databases.
The main objective of this thesis is to propose and evaluate information extrac-
tion techniques in biomedical documents, particularly, for automatic detection of
DDIs from unstructured texts. Our proposal divides the problem in subtasks such
as text analysis, recognition and classification of pharmacological substances, resolv-
ing drug anaphora and the detection of interactions between drugs. These tasks are
crucial to support the extraction of DDIs. The specific objectives addressed in this
thesis are listed as follows:
1. The creation of an annotated corpus of drug-drug interactions to evaluate the
results of our different experiments. To the best of our knowledge, this corpus
is the first corpus for DDIs.
2. Study the main approaches for biomedical IE.
3. The integration of several biomedical knowledge resources into a framework
to provide broad coverage for a huge amount of biomedical terms and their
relations.
9http://www.nlm.nih.gov/pubs/factsheets/medline.html
10http://www.embase.com/
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4. Evaluate the usefulness of nomenclature standards in the detection and classi-
fication of drugs. The family to which a drug belongs can be an essential clue
to automatically detect information regarding its interactions.
5. Develop a framework that allows the study and combination of the different
modules of the prototype.
6. Propose a method to resolve the anaphoric expressions involving drugs.
7. Combine the resolution of complex syntactic constructions and a set of patterns
defined by a pharmacist in order to extract DDIs.
8. Study the performance of a supervised machine learning method to detect
DDIs.
9. Compare both previous approaches and analyze the results.
1.3. Outline of thesis proposal
This section summarizes our proposal to extract DDIs from biomedical texts.
Since the major goal of this thesis is to propose and evaluate IE techniques for
automatic detection of DDIs from biomedical texts, we have developed a prototype,
which allows us to develop, combine and compare these techniques. The prototype
has a modular pipeline architecture, which consists of four main processes shown in
figure 1.1. The following subsections briefly describe each process.
1.3.1. Text Analysis
This phase is devoted to preprocess the text including the following tasks: tok-
enization, morphological analysis, PoS tagging, shallow syntactic parsing and seman-
tic annotation. In particular, the UMLS MetaMap Transfer tool (MMTx) [Aronson,
2001b] is used to syntactically and semantically analyze these texts.
In addition, the text analysis process is also used in the construction of an an-
notated corpus with DDIs. While several corpora [Bunescu et al., 2005, Ding et al.,
2002, Kim et al., 2003, Nedellec, 2005, Pyysalo et al., 2007] contain annotations of
biological relationships such as protein-protein or genetic interactions, there is no
corpus annotated with DDIs. For this reason, our first task is to build an annotated
corpus for drug-drug interaction extraction. The pharmacological database Drug-
Bank [Wishart et al., 2006, 2007a] offers a complete collection of text documents
describing DDIs, which was compiled from several resources and checked by accred-
ited pharmacists. We have used these text documents as a source of unstructured
textual information on DDIs. MMTx assists the human annotators by providing
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Figure 1.1: Architecture of the prototype
lexical, syntactic and semantic information such as sentence boundaries or UMLS
concepts. To the best of our knowledge, this corpus is the first gold standard data
available for DDI extraction. This corpus allows to evaluate the different experi-
ments. Different approximations can be rated on how close to the gold standard
their output is.
1.3.2. Drug name recognition
In this work, we do not assume that the entities are given, as it is often the case in
other relation extraction works. Instead the recognition of the drug names is solved
as a previous task. While most studies of biomedical named entity recognition have
mainly focused on genes and proteins, the drug names have not widely addressed.
Although many drug information resources are available, and can be used to recog-
nize drug names, there are several open issues such as ambiguous names, synonyms,
variations and newly published names related to the drug name recognition, which
require special attention.
This thesis proposes a hybrid method which combines information obtained by
the MMTx program and nomenclature rules recommended by the WHO Interna-
tional Nonproprietary Names (INN) Programme[Drugs and Policy, 2006] to identify
and classify drug names. Thus, a module called DrugNer has been developed to
identify and classify drug names.
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1.3.3. Anaphora resolution
Extracting DDIs from text should take into account the resolution of pronominal
and nominal references to entities since interactions are often specified through these
references. IE at the sentence level has a limited effect because there are frequent
references to previous entities in the discourse, a phenomenon known as ’anaphora’.
DDI Extraction is a difficult task whose complexity increases when one or both
drugs involved in an interaction are expressed with an anaphoric expression. We have
developed two different approaches to address the problem of co-referring expressions
in pharmacological literature. In addition, a corpus is developed in order to analyze
the phenomena and evaluate both approaches. The first approach is based on a
scoring method similar to other works in the biomedical domain [Castano et al.,
2002, Lin et al., 2004, Kim and Park, 2004a]. It uses a combination of the domain-
specific syntax and semantic information provided by MMTx with generic heuristics.
Our second approach uses a set of linguistic rules inspired by Centering Theory Grosz
et al. [1995] and constraints satisfaction over the analysis provided by the biomedical
syntactic parser MMTx.
1.3.4. Extraction of Drug-Drug Interactions (DDIs)
In this thesis, we propose two approximations for the extraction of drug-drug
interactions from biomedical texts. The first approximation is a hybrid approach
which combines shallow parsing and pattern matching to extract relations between
drugs from biomedical texts. Our second approximation is based on the kernel
methods presented by Giuliano et al. [2006].
We should note that most of the existing approaches for relation extraction usu-
ally assume that the argument entities of the relation occur in the the same sentence
[Sarawagi, 2007]. We also assume the scope of the interaction is the sentence, that
is, interactions which span several sentences are not addressed by neither of our
approximations.
1.4. Document Structure
As it was pointed out in the previous section, this thesis proposes two different
approximations for the automatic extraction of DDIs from texts. In addition, we
also propose a set of complementary techniques to deal with the following tasks:
text analysis, drug name recognition and drug anaphora resolution.
The layout of the thesis is split into two main parts. The first one carries out
the description of the complementary techniques and the process of construction of
an annotated corpus with drug-drug interactions. Thus, each chapter focuses on a
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particular technique, reviewing the main approaches to this task and describing our
particular proposal.
Chapter 2 reviews the methodologies evaluation for Information Extraction in
the biomedical domain and the most commonly used measures for evaluating the
performance of these systems.
Chapter 3 reviews the main biomedical corpora used in relation extraction task,
and describes the process of construction and annotation of the first annotated
corpus of drug-drug interactions, the DrugDDI corpus.
Chapter 4 introduces the main approaches to biomedical named entity recogni-
tion. Then we propose a method for drug name recognition and classification.
Chapter 5 reviews the main methods for anaphora resolution in the biomedical
domain and proposes two different approaches for drug anaphora resolution.
The second part begins with a detailed review of the main approaches to rela-
tion extraction in biomedical domain, continues describing the two approximations
proposed in this thesis and finishes with some conclusions and future work.
Chapter 6 discusses the state of art in biomedical relation extraction. The prob-
lem is analyzed from the perspective of the type of approach. In this chapter,
different strategies as well as architectures are described.
A hybrid approach that combines shallow parsing and pattern matching to ex-
tract relations between drugs from biomedical texts is presented in chapter 7.
Chapter 8 presents the second approach to the extraction of DDIs, a kernel-based
method. We describe the experimental approach followed in this work and compare
the performance of both approaches addressed in this thesis.
Finally, Chapter 9 highlights the main conclusions of the work and proposes the
future work as a direction for further related research.
9
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Chapter 2
Evaluation of Biomedical
Information Extraction Systems
This chapter reviews the main methodologies for IE in the biomedical domain,
as well as the most commonly used measures for evaluating the performance of
information extraction systems.
The goal of biomedical IE systems is to help biomedical researchers to extract
knowledge from the biomedical literature and facilitate new discovery in a more
efficient manner. However, such systems are still research prototypes. This is due
mainly to the lack of systematic and rigorous evaluation.
2.1. Methodologies
System-oriented and user-oriented paradigms are the main evaluation approaches.
While the system-oriented evaluation focuses on the system and/or its components,
the user-oriented evaluation focuses on how the system faces to the real world.
Most research in biomedical IE is still devoted to the development of specific
functions or algorithms and consequently researchers have chosen to focus on the
evaluation of specific components of systems, such as named entity recognition or
detection of relationships instead of in a complete system such as medical question
answering application. However, until recently, it has not been possible to compare
different approaches, because the various groups involved were addressing different
problems and often using private datasets. In the absence of shared datasets and
standardized evaluation measures, it was no possible to compare them. In the last
years, several workshops on biomedical text processing and text mining for biology
have been held. These workshops have made it possible for different approaches
can be compared with each other through the introduction of common evaluation
frameworks, shared resources, and standardized metrics. This allowed the research
community to assess what techniques do and do not work, and to demonstrate the
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progress being made in these fields. Some of the challenge evaluations to date for
biomedical IE are listed below:
Knowledge Discovery and Data Mining (KDD) Challenge Cup 2002 [Yeh et al.,
2002] focused on constructing models to assist genome annotators by automat-
ically extracting information from scientific articles.
TREC Genomics Track [Hersh et al., 2005]: Document retrieval and classifi-
cation tasks for genomics.
Critical Assessment of Information Extraction in Biology (BioCreAtIvE)
[Hirschman et al., 2005, Krallinger et al., 2009] focuses on two tasks: gene
mention identification and normalization and extraction of protein-protein in-
teractions (PPI) from text.
DTMBIO [Song et al., 2009] and BioNLP [Demner-Fushman et al., 2008]: Both
workshops cover a wide range of topics from most areas of natural language
processing and from both the clinical and the genomics domains.
However, these assessments are still very limited in discerning the larger role of
IE as a tool for real-world biomedical researchers. Thereby, it would be desirable
to undertake user-oriented evaluations to determine the most effective use of these
systems for their intended audience.
2.2. Evaluation Measures
It is critical to select clear, reproducible, and easily understood evaluation met-
rics. To introduce the metrics, it is necessary to define a structure known as a
confusion matrix or contingency table. The confusion matrix has four categories:
True Positives (TP) are examples correctly labeled as positives.
False Positives (FP) refer to negative examples incorrectly labeled as positive.
True negatives (TN) correspond to negatives correctly labeled as negative.
False negatives (FN) refer to positive examples incorrectly labeled as negative.
actual positive actual negative
predicted positive TP FP
predicted negative FN TN
Table 2.1: Confusion Matrix
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True positives and false negatives, as well as false positives and true negatives
are mutually related to. We define N+ as the total number of positive examples,
and N− as the total number of negative examples. Thus, it is clear that TP and FN
are the complementary labels for N+, and similarly TN and FP for N−. TP and
FP are the only two of the four numbers TP, FP, TN, FN that are independent.
N+ = TP + FN (2.1)
N− = TN + FP (2.2)
The following list defines various metrics based on the confusion matrix:
The True Positive Rate (TPR) measures the fraction of positive examples that
are correctly labeled. TPR has also been referred to as sensitivity or recall.
This score is usually used for evaluating the performance of medical tests.
TPR = Sensitivity = Recall =
TP
TP + FN
=
TP
N+
(2.3)
The False Positive Rate (FPR) measures the fraction of negative examples
that are misclassified as positive.
FPR =
FP
TN + FP
=
FP
N−
(2.4)
True Negative Rate (TNR) as measures the fraction of negative examples that
are correctly labeled. TNR has also been referred to as specificity. In medical
applications, FPR is replaced with TNR.
TNR = Specificity =
TN
TN + FP
=
TN
N−
(2.5)
False Negative Rate (FNR) as measures the fraction of positive examples that
are misclassified as negative.
FNR =
FN
FN + TP
=
FN
N+
(2.6)
Then, it is clear that:
TPR + FNR = 1 (2.7)
FPR + TNR = 1 (2.8)
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To evaluate the performance of an IE system, normally recall and precision values
are measured. Recall has been previously defined (equation 2.3). Precision is the
proportion of detected examples that are actually positive examples:
Precision =
TP
TP + FP
(2.9)
An ideal information extracting system should fulfill FN = 0, FP = 0. Precision
and recall stand in opposition to one another. As precision goes up, recall usually
goes down (and vice versa). F-measure is defined by the harmonic (weighted) aver-
age of precision and recall where the parameter beta indicates a relative weight of
precision with respect to the recall. With β = 1, the balanced F-score (F1) is ob-
tained in which recall and precision are evenly weighted; when β = 2 (F2), an overall
performance but giving more importance to precision (twice as much as recall) is
achieved.
F (β) =
(1 + β2)PR
β2P +R
(2.10)
2.3. Unsolved issued in evaluation process
If the promise of IE techniques to enhance biomedical research is to be met,
better evaluation is essential. This will not only help the field better determine
what approaches work best, but also provide insight into how systems can enhance
the work of their intended users.
Different researchers not only use different collections, but also use those that do
exist in different ways. A number of researchers have developed their own collections
for use by their own research systems. For example, the systems Textpresso [Muller
et al., 2004b] and MedScan [Novichkova et al., 2003], have their own test collections
that have been used only for their evaluation. Similarly, the well-known Abgene
tagger [Tanabe and Wilbur, 2002] has a test collection that has not been re-used by
other research groups. A major problem with collections that cannot be shared is
that the results of reported findings cannot be replicated or improved upon.
Therefore, an important challenge is the development of the gold standard for
evaluation systems. A gold standard dataset or corpus is one whose annotation
has been checked and corrected. This is typically carried out in order to evaluate
automatic annotation systems. Different programs can be rated on how close to the
gold standard their output is. However, the development of this gold standard is still
under way, far from maturity, which requires more concerted efforts. The experience
in the newswire domain shows that the construction of evaluation benchmarks in
the face of common challenges contribute greatly to the rapid development of IE.
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Efforts will be required to focus on linking the knowledge in the databases with
text sources available. In the future, biomedical IE might provide new approaches
for relation discovery that exploit efficiently indirect relationships derived from bib-
liographic analysis of entities contained in biological databases. In addition, the
developers of IE systems need to improve the test collections for system-oriented
evaluation and undertake user-oriented evaluations to determine how systems will
be most effective in real world settings.
The main objective of this thesis is to propose and evaluate information ex-
traction techniques in biomedical documents for automatic extraction of DDIs from
biomedical texts. Our proposal divides the problem in tasks such as text anal-
ysis, recognizing and classification of pharmacological substances, resolving drug
anaphora and the detection of interactions between drugs. For this reason, the eval-
uation methodology followed in this thesis, will focus on those specific tasks rather
than on the user needs. In particular, we use the standard metrics precision, recall
and f-measure for the evaluation.
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Chapter 3
DrugDDI: an annotated corpus for
Drug-Drug Interaction Extraction
An annotated corpus is a collection of texts that have been tagged with linguistic
information (part-of-speech tags, syntactic structure, co-references, etc) or domain
knowledge information (named entities and relations). Annotated corpora are valu-
able resources as they provide the gold standard data for the systematic automatic
evaluation of the NLP techniques. During the last decade, there has been a surge of
interest in using NLP techniques to retrieving and extracting information from the
biomedical texts. Thus, there is an increased demand for building corpora annotated
with biomedical entities and relations.
The goals of this chapter are: (1) to review the biomedical corpora used by
NLP techniques for the relation extraction, and (2) to describe the process of con-
struction and annotation of the first annotated corpus of drug-drug interactions, the
DrugDDI corpus. Section 3.1 concludes while several corpora contain annotations
of biological relationships such as protein-protein or genetic interactions, there is no
corpus annotated with DDIs. Therefore, one of the main objectives of the thesis is
to provide an annotated corpus for DDI extraction. The creation of the DrugDDI
corpus is described in the section 3.2
3.1. Biomedical corpora for relation extraction
During the last years, several biomedical corpora have been developed for evalu-
ating the performance of NLP techniques. Text collections such as Ohsumed [Hersh
and Bhupatiraju, 2003], TREC Genomics track data sets [Hersh and Bhupatiraju,
2003, Hersh et al., 2004], or the evaluation dataset for the Protein interaction ar-
ticle subtask [Krallinger and Valencia, 2007] of the second BioCreative challenge,
are very useful for the information retrieval research. Several biomedical annotated
corpora are available for named entity recognition. Some of these corpora are Ge-
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nia [Ohta et al., 2002, Kim et al., 2003], Yapex [Franzen et al., 2002], GENETAG
[Tanabe et al., 2005] and MedStract [Pustejovsky et al., 2002b]. They have been
annotated with semantic classes relevant to the molecular biology domain such as
gene, protein, or cell, among others. MedStract is also annotated for anaphora res-
olution. The size of these corpora is relatively small, not exceeding 2,000 abstracts.
A detailed comparative analysis of the above corpora can be found in [Cohen et al.,
2005]. Currently, the CALBC project1 [Rebholz-Schuhmann et al., 2009] (Collabo-
rative Annotation of a Large Biomedical Corpus) aims to build a large annotated
corpus made up of 150,000 Medline abstracts by the integration of the annotations
provided by several named entity recognition systems. We believe that the CALBC
project can make a significant contribution to build large scale annotated corpus,
which are so necessary to train text mining systems.
It is not our intention to provide a complete review of all biomedical annotated
corpora, instead, we focus on the major biomedical corpora annotated with biomed-
ical relationships. The PDG corpus was automatically constructed using the PPIs
extraction system presented in [Blaschke et al., 1999]. Although, the corpus was
manually verified, it contains some errors caused by the named entity tagger and
the relation extraction module. The corpus consists of 283 sentences and contains
417 PPIs. An important shortcoming of this corpus is that it only contains metadata
information about the PPIs such as the list of interaction types, the list of proteins,
or the string of text in which the interactions occur, but not any annotation. In
addition, this corpus does not contain any linguistic information.
The aim of the Genic Interaction Extraction Challenge (LLL05) [Nedellec, 2005]
was to provide a framework for the comparison of the different approaches to learn
rules for extracting protein/gene interactions from MedLine abstracts concerning bi-
ology. Abstracts were segmented into sentences, selecting only those sentences that
contained at least two gene or protein names. Based on the fact that the relevant
information is mostly local to single sentences [Ding et al., 2002], the interactions
that span several sentences through the use of co-reference were not annotated. Ex-
pert biologists annotated the sentences with biological interactions, indicating the
roles of the agent and target of the protein/gene names in each interaction. The sen-
tences were also annotated with tokens, lemmas and syntactic dependencies by the
use of LinkParser [Sleator and Temperley, 1995] and later manually checked. The
corpus was split into training and test sets. The training set includes 80 sentences
describing 270 positive examples of genic interactions. The test set includes 87 sen-
tences describing 106 positive examples. The negative examples were not explicitly
annotated in the corpus. The data format is similar to that used in the PDG corpus,
but the entities and interactions are clearly marked indicating their positions within
the text.
1http://www.calbc.eu/
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The BioInfer corpus [Pyysalo et al., 2007] is made up of 1,100 sentences from
Medline abstracts and provided in an XML format. Each sentence contains at least
one pair of interacting entities. The sentences were manually annotated with protein,
gene and RNA types as well as the interactions between these entities. A relation-
ship ontology was designed in order to classify the interactions. BioInfer captures
complex relationships such as n-ary relationships (n  2) or nested relationships.
BioInfer is also annotated with syntactic dependencies provided by Link Parser and
later manually reviewed. The corpus contains a total of 33,858 tokens, and hence,
a relatively high average sentence length, around 30 tokens. The corpus contains a
total of 4,573 proteins and 2,662 relationships. The inter-annotator agreement has
not been measured.
The AIMed corpus was created by Bunescu et al. [2005], and is considered as the
de facto standard for the PPIs extraction task [Airola et al., 2008]. This corpus, made
up of 1,000 Medline abstracts, is divided into three datasets which were manually
annotated. The first dataset consists of 750 abstracts tagged for gene/protein names
containing a total of 5,206 names. The second dataset contains 200 abstracts which
were manually annotated with 1,101 PPIs and 4,141 protein names. The third
dataset, made up by 30 abstracts, can be used as a source of negative examples as
their abstracts do not contain any interaction.
The corpus HPRD50 [Fundel et al., 2007a] consists of 50 Medline abstracts. The
biological entities were automatically identified using the ProMiner tagger [Hanisch
et al., 2005]. Then, the abstracts were manually annotated by two annotators with
biochemical background. The inter-annotator agreement was 81%. The corpus con-
tains a total of 138 protein/gene interactions, corresponding to 92 distinct relations
in abstracts.
The corpus IEPA [Ding et al., 2002] contains 303 MedLine abstracts (486 sen-
tences). Each sentence is annotated with PPIs. The corpus contains a total of 335
interactions.
The BioCreAtIvE-PPI corpus [Krallinger et al., 2008] was built on the Gene-
Tag corpus. One thousand sentences were randomly selected from this corpus and
annotated with gene/protein interactions. The corpus contains a total of 255 inter-
actions.
The above corpora focus on the biological domain. BioText [Rosario and Hearst,
2004b] is a corpus for evaluation of mining disease-treatment relations. Unfortu-
nately, this corpus is less useful because it contains some annotations which are not
consistent among them.
The CLEF corpus [Roberts et al., 2007, 2009] has been designed to support
extracting information from clinical patient reports. This corpus consists of 150
patient records annotated by at least two annotators with 1,161 clinical entity types
(for example, Condition, Intervention or Drug) and 813 relation instances (some
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Corpus Abstracts Sentences Relations Annotations
PDG – 283 417 PPIs
LLL – 167 376 entities, PPIs, syntactic
dependencies
BioInfer – 1,100 2,662 entities, PPIs, syntactic
dependencies
AIMed (2n
dataset anno-
tated with PPIs)
200 – 1,101 entities, PPIs
HPRD50 30 – 138 entities, PPIs
IEPA 303 486 335 PPIs
BioCreAtIvE-PPI – 1,000 255 entities, PPIs
Li et al. [2008] 240 2,156 entities, biomedical rela-
tions
CLEF 150 – 813 entities, biomedical rela-
tions
Table 3.1: Comparative analysis among the different biomedical corpora annotated
with biomedical relationships.
types of annotated relations are: has location, has indication or has finding). CLEF
is also annotated with modifiers, co-references and temporal expressions. The anno-
tators provided a set of guidelines to ensure consistency and also calculated the inter
annotator agreement (IAA), achieving a 67% of agreement for entities and 72% for
relations.
Li et al. [2008] built a corpus of 200 cancer-related abstracts from Medline, in
order to evaluate a kernel method for biomedical relation extraction. A biomedical
scientist manually annotated biomedical entities such as genes, proteins, functions,
and diseases. The average number of sentences per abstract is 9.08. The corpus
consists of 1,815 sentences in the corpus, 1,361 of them contain two or more entities.
The average number of entities per sentence is 2.81. The corpus contains a total of
8,071 relation instances, 2,156 out of them are identified as true relations, while the
remaining ones are labeled as negative examples.
Recently, Thompson et al. [2009] have built the Gene Regulation Event Corpus
(GREC) in which events relating to gene regulation and expression have been anno-
tated by biologist. The arguments of the event verbs are annotated with a semantic
role (such as agent, theme, location, temporal, etc). In addition, biomedical con-
cepts are annotated using the Gene Regulation Ontology (GRO) [Beisswanger et al.,
2008]. The corpus consists of 240 medline abstracts, containing a total of 3,067 anno-
tated events and 5,026 biological concepts. High levels of agreement are achieved for
both the identification of semantic arguments and the assignment of semantic roles
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to these arguments (88% or above) and for biological category assignment (around
95%).
3.1.1. Open Issues on biomedical corpora for relation ex-
traction
After analyzing previous biomedical corpora, we point some issues concerning
relation extraction:
1. Most corpora reviewed here focus on describing the relationships between bi-
ological entities, but none contains DDIs.
2. The full articles have not been used to produce this kind of corpus yet. The
corpora are made up of abstracts. The average number of sentences per ab-
stract does not exceed 10 sentences. Abstracts are summaries which lost large
part of the information contained in their full articles.
3. Corpora are tagged at sentence level and the interactions that span several
sentences are not annotated.
4. The complex relationships are only annotated in the BioInfer corpus.
5. BioInfer is the only corpus in which the interactions are classified and mapped
to a domain ontology.
6. The size of the different corpora never exceeds 1,000 sentences with an average
of 836 interactions per corpus. BioInfer and GREC are the largest corpora with
2,662 relationships and 3,067 events, respectively.
7. The roles of the interacting proteins are only annotated in the LLL corpus.
8. Information about the annotation process is rather scarce. Most of the re-
viewed corpora do not have (or provide) any information about the inter-
annotator agreement nor annotation guidelines.
9. Several corpora have been automatically annotated, and later manually veri-
fied. This may mean that they still contain residual errors introduced by the
automatic modules.
10. Regarding linguistic information contained within the corpora, LLL, BioInfer
and GREC are the only corpora containing syntactic information. Other lin-
guistic phenomena such as negation, temporal information or anaphora have
been hardly tackled. Anaphoric expressions and abbreviations have been an-
notated in the MedStract corpus. BioScope[Szarvas et al., 2008] is a annotated
corpus for negations.
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11. Structured data files, HTML or XML format have been also used for data
representation.
One of the major contributions of this thesis is to construction of the first anno-
tated corpus of DDIs, the DrugDDI corpus. This corpus allow us to automatically
evaluate the different approximations proposed in this thesis to extract DDIs. In ad-
dition, we think that the corpus can also encourage the NLP community to research
in the pharmacological domain. We have developed the DrugDDI corpus using the
XML format. We believe that the use of an standard format will encourage a greater
use of this corpus. The corpus contains shallow syntactic and semantic information
provided by MMTx. Pharmacological substances as well as other biomedical con-
cepts are automatically annotated. The corpus may also be used to extract other
kind of relationships such as drug adverse reaction, food-drug interactions, or drug
targets (relation between proteins and drugs). DDIs are manually annotated with
the assistance of an expert pharmacist. In addition, the DrugDDI corpus has a
considerable size, larger than most in the biomedical corpora.
3.2. The DrugDDI corpus
The above section shows that there are several annotated corpora with entities
and their relations for biomedical domain [Bunescu et al., 2005, Ding et al., 2002,
Kim et al., 2003, Nedellec, 2005, Pyysalo et al., 2007], however, DDIs are not in-
cluded. While the NLP techniques are relatively domain-portable, corpora are not.
The lack of an extensively annotated corpus can easily became a bottleneck to ap-
ply NLP techniques, specially supervised machine learning algorithms, for extracting
DDIs
This section describes the process of the construction and annotation of the
DrugDDI corpus. DrugDDI is aiming at providing the gold standard for the appli-
cation and evaluation of the NLP techniques in the pharmacological domain.
3.2.1. Collecting the corpus
As source of unstructured textual information on drugs and their interactions, we
have used the DrugBank database [Wishart et al., 2006, 2007a]2. This database is a
rich resource which combines chemical and pharmaceutical information of approxi-
mately 4,900 pharmacological substances. DrugBank provides synoptic data about
the nomenclature, structure and physical properties of drugs and their drug tar-
gets. This type of information is oriented to biochemists and biologists. DrugBank
also offers very detailed clinical information about drugs including pharmacology,
2http://www.drugbank.ca/
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metabolism and indications. This information is often used by healthcare profes-
sionals. Hence, DrugBank has been widely used in several contexts including drug
design, drug target discovery or drug interaction prediction, among many other
applications. In addition, DrugBank is an online and free resource.
Figure 3.1: Drugcard of carpofren in DrugBank.
For each drug, DrugBank contains more than 100 data fields such as drug syn-
onyms, brand names, chemical formula and structure, drug categories, ATC and
23
AHFS codes (codes of standard drug families), mechanism of action, indication,
dosage forms, toxicity, among other ones. In particular, DrugBank offers a com-
plete collection of DDIs, which was compiled from several resources, checked by an
accredited pharmacist and entered manually. This collection consists of 714 food-
interactions and 13,242 drug-drug interactions. The interactions are contained in
the structured information fields ’Food Interactions’ and ’Drug Interactions’.
Figure 3.2: Drug and Food interactions fields for heparin in DrugBank.
Additional information can be found in the field ’Interactions’. This field contains
a link to a document describing DDIs in unstructured text.This document not only
contains a detailed description on the interactions contained in the above structured
fields, but also offers information on other interactions which have not collected in
them. For example, figure 3.3 shows that heparin interacts with drugs such as
doxorubicin, droperidol, ciprofloxacin, or mitoxantrone. None of them is registered
in the above interaction tables. We have used the ’Interactions’ field as a source of
unstructured textual information on DDIs.
DrugBank provides a file with the names of approved drugs, approximately 1,450.
We randomly chose 1,000 drug names and used the RobotMaker 3 application to
download the interaction documents for these drugs. The interactions contained in
the ’Drug Interactions’ tables were also downloaded. These interactions allows us
3http://openkapow.com/
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Figure 3.3: Interactions field for heparin in DrugBank
to quantitatively compare the list of automatically DDIs extracted using our system
with those contained in an existing resource such as DrugBank. Thus, we can know
if our proposed methods are able to detect new interactions that have not been
registered in their structured fields yet.
We could only retrieve a total of 930 documents since some drugs do not have any
linked document. Due to the annotation process is a very laborious, cost-intensive
and time consuming task, we decided to reduce the number of documents to be
annotated and only considered 579 documents. We would like to increase the size of
annotated corpus. The rest of documents, 352, was dedicated to study the linguistic
phenomenon of the pharmaceutical literature. Thus, the corpus is divided into two
subsets. Let us name the set of 579 annotated documents as annotated dataset, and
the rest of documents as unannotated dataset.
3.2.2. Processing the corpus
To provide precise description of the text processing stage, we must first intro-
duce the Unified Medical Language System (UMLS) [Bodenreider, 2004, Humphreys
et al., 1998]. UMLS is a set of resources developed by the National Library of
Medicine (NLM) whose main objective is to assist in the developing of natural lan-
guage technology for biomedical texts. UMLS has three major knowledge sources:
the Metathesaurus, the Semantic Network and the Specialist Lexicon.
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The Metathesaurus is the most comprehensive ontology of the biomedical domain
since it integrates a wealth of biomedical terminological resources such as MeSH
[Lipscomb, 2000], Diseases Database 20004, SNOMED [Spackman et al., 1997], Gene
Ontology [Ashburner et al., 2000], HUGO Gene Nomenclature Database [Povey
et al., 2001] and Micromedex DRUGDEX 5 among many others.
All concepts in the Metathesaurus are assigned to at least one semantic type
from the UMLS Semantic Network, providing a consistent categorization of all con-
cepts represented in the UMLS Metathesaurus. The Semantic Network contains 135
semantic types such as ’Pharmaceutical substance’ (phsu), ’Amino Acid, Peptide,
or Protein’ (aapp), ’Disease or Syndrome’ (dsyn) or ’Gene or Genome’ (gngm).
Finally, the Specialist Lexicon is a biomedical lexicon with syntactic, morpho-
logical and orthographic information.
We use the MMTx tool [Aronson, 2001b] to syntactically and semantically an-
alyze the documents in the corpus. The basic function of this program is to map
text to concepts in UMLS Metathesaurus. MMTx has been widespread used in
IE, Information Retrieval, and Data mining applications [Meystre and Haug, 2006,
Dı´az-Galiano et al., 2009]. MMTx performs sentence splitting, tokenization, POS-
tagging, shallow syntactic parsing, and linking of phrases with UMLS concepts.
Figure 3.5 shows part of the output provided by MMTx for a given document
and its transformation to XML format. First, MMTx splits the text into sentences.
Second, the phrases in each sentence are identified and classified. MMTx uses the
the SPECIALIST minimal commitment parser [McCray et al., 1994] to produce a
shallow syntactic parsing of the texts. Table 3.6 shows the different types of phrases
that MMTx can identify. If MMTx is not able to determine the type of a given
phrase, then MMTx assigns it the label UNK, indicating that its type is unknown.
For each phrase, it is offered its type, the number of tokens, text and an identifier
in the XML document (see figure 3.5).
Then, the parser uses the SPECIALIST lexicon to assign the POS tags to the
tokens, and relies on the Xerox part-of-speech tagger [Cutting et al., 1992] when
a token has several tags in the lexicon in order to decide the correct tag. Each
token is annotated with its POS tag, its word, and a boolean value indicating if it
is the head of the phrase (ISHEAD). In addition, the starting and ending offsets of
each token within the text are stored in the attributes start and end, respectively.
These character offsets allow to map from the annotation to the raw text easily. For
example, the figure 3.5 shows the tokens contained in the phrase with alprazolam,.
The XML format provides a maximum flexibility for the use of the DrugDDI
corpus. In addition, the corpus is distributed in a standoff annotation format that
involves storing annotation and text separately [Leech, 1993]. An advantage of the
4http://www.diseasesdatabase.com/
5http://www.micromedex.com/products/drugdex/
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Figure 3.4: MMTx processes.
annotated dataset unannotated dataset total
documents 579 351 930
sentences 5,806 3,255 9,601
phrases 66,021 35,678 101,699
tokens 127,653 69,030 196,683
Table 3.2: Statistics about the DrugDDI corpus
standoff annotation format is that the original texts can be immediately retrieved
without need of recovering it from the annotations. Besides, this format preserves
useful information about the structure of the texts.
Table 3.2 provides information about the number of sentences, phrases and to-
kens in the DrugDII corpus. As it can be seen from table 3.2.2, the average number
of sentences per document (10.3) is greater than in the MedLine abstracts. The
average number in the corpus developed in [Li et al., 2008] was 9.08 sentences, while
Yu [2006] estimated it in 7.2± 1.9 sentences.
Table 3.3 shows the distribution of the different types of phrases in the corpus.
We can note the NP, VP and PP are the types of phrases that occur more often.
We also note that the type UNK occurs with high frequency. This is due to the doc-
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Type of Phrase Annotated Dataset Unannotated dataset total
Noun (NP) 18,238 9,982 28,220
Prepositional (PP) 7,607 4,005 11,612
Verbal (VP) 17,271 9,059 26,330
Adjectival (ADJ) 367 176 543
Adverbial (ADV) 2,321 1,332 3,653
Conjunctions (CONJ) 5,772 3,033 8,805
Unknown (UNK) 8,069 4,642 12,711
Table 3.3: Distribution of phrases in DrugDDI
Type of Word Annotated Dataset Unannotated dataset total
adj 10,945 5,963 16,908
adv 4,434 2,534 6,968
aux 5,755 2,877 8,632
compl 523 255 778
conj 5,395 2,814 8,209
det 6,647 3,524 10,171
modal 2,312 1,254 3,566
noun 41,264 22,488 63,752
number 2,507 1,542 4,049
prep 14,129 7,659 21,788
pron 1,164 599 1,763
untagged 47,92 2,247 7,039
verb 8,844 4,746 13,590
mark 18,942 10,528 29,470
Table 3.4: Distribution of tokens in DrugDDI
Element Avg. per Doc Avg. per Sentence Avg. per Phrase
tokens 211.5 20.5 1.9
phrases 109.3 10.6
sentences 10.3
Table 3.5: Average number of sentences, phrases and tokens in the DrugDDI corpus.
uments often contains tables and other kind of enumerations that contain character
specials that the parser is not able to identify.
Table 3.4 shows the distribution of the different types of tokens in the corpus.
The tag untagged is assigned when the tagger is not to able to assign any tag because
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Figure 3.5: Example of a document processed by MMTx.
Type of Phrase Examples
Noun phrase (NP) Drug Interactions, the cytochrome P450 3A4 enzyme
system
Prepositional phrase (PP) with drugs, of azole antimycotics, of orally administered
midazolam
Verbal phrase (VP) administered,inhibit. decrease
Adjectival phrase (ADJ) hypersensitive
Adverbial phrase (ADV) concurrently, not, to significantly
Conjunctions (CONJ) and,or, since
Table 3.6: Type of phrases identified by MMTx.
the token does not exist in the lexicon or is a special token such as a quote, that the
tagger is not able to identify. We define the category mark to group the punctuation
marks and other special characters such as asterisk, dash, braces, binary operators,
logic operators, among many others.
Once the shallow syntactic parsing has been performed, MMTx looks for the
phrases in the UMLS Metathesaurus. For each phrase, a set of variants is generated
using the SPECIALIST lexicon and linguistic techniques to generate its variants.
The set of variants consists of the text of the phrase, and its acronyms, abbreviations,
synonyms, derivational, inflectional and spelling variants. These variants are looked
for in the Metathesaurus, retrieving those concepts that contain at least one of the
variants are retrieved. Each concept is evaluated against the text of the phrase using
several linguistic metrics to determine its similarity. Finally, those concepts with a
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highest similarity are selected as the final mapping. For each concept in the final
mapping set, MMTx provides its concept unique identifier (CUI), its concept name,
and its semantic types. This way, MMTx allows to recognize a variety of biomedical
entities occurring in texts. Finally, the output of MMTx is transformed into XML
format (see figure 3.5).
Figure 3.6: Mapping to UMLS concepts for the Aspirin phrase.
Figure 3.6 shows the final mapping retrieved by MMTx for the phrase Aspirin.
For this phrase, the final mapping consists of an unique concept, Aspirin, with CUI
C0004057, and semantic type Pharmacological substance. However, the mapping
for a given phrase may consist of a combintation of various candidates involved in
disjoint parts of the phrase. For example, in the sentence Alcohol has a synergistic
effect with aspirin in causing gastrointestinal bleeding, the mappings for the phrase
a synergistic effect consists of the Metathesaurus concept Effect (C1280500 ) and
either the concept Synergism (C0599739 ), or the concept Synergist (C0920877 ).
3.2.2.1. Failure Analysis of MMTx
Unfortunately, MMTx makes several mistakes. Some mistakes that we detected
for the annotation process are described briefly next. However, we omit a deeper
discussion about them, since the failure analysis of MMTx is out of scope of this
thesis.
MMTx sometimes fails to resolve the correct syntactic type of phrases when
they are preceded by a conjunction. For example, MMTx was not able to classify
correctly the last phrase (nefazadone) in the following coordinate structure (the
correct type is NP):
We have also observed a similar situation for the coordinate structures that
involve the verbs to increase or to decrease. These verbs are classified as noun
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Example 1 MMTx fails in classifying the phrase nefazadone
[ketoconazole]NP , [ritonavir]NP , [nelfinavir]NP , [clarithromycin]NP and
[nefazadone]UNK .
phrases by MMTx when they are part of a coordinate structure. The following
sentences taken from the corpus show some examples of this case.
Example 2 MMTx often fails in classifying verb phrases in coordinate structures
Drugs that may either [increase]NP or [decrease plasma phenytoin
concentrations]NP include: phenobarbital, vaiproic acid, and sodium valproate.
Valproic acid has been reported to both [increase]NP and [decrease ethosux-
imide levels]NP .
Coadministration of NIZORAL Tablets and drugs primarily metabolized by the cy-
tochrome P450 3A4 enzyme system may result in increased plasma concentrations
of the drugs that could [increaseNP or prolong both therapeutic and adverse effects.
The plasma concentration of imipramine may increase when the drug is given con-
comitantly with hepatic enzyme inhibitors and [decrease]NP by concomitant admin-
istration of hepatic enzyme inducers.
MMTx fails to split the phrases when they contain some special character such
as ’/’. For example, the phrase No formal drug/drug interaction is incorrectly
segmented into two different phrases: No formal drug and /drug interactions.
MMTx also fails to resolve common abbreviations, for example, the phrase e.g.
is classified with the following combination of UMLS concepts: Endosinusial Route
of Drug Administration (C1522661 ) and APC gene (C0162832 ). This mistake only
happens when the phrase e.g. is immediately preceded by a left parenthesis.
Concerning semantic ambiguity, we have observed that some phrases can be
linked with several concepts, or even with several combinations of them. MMTx
often suggests several senses, but is not able to distinguish the most appropriate one.
In the following sentence This medicine should not be taken with MAO inhibitors.,
the phrase with MAO inhibitors is classified by MMTx with the two following UMLS
concepts:
1. Monoamine Oxidase Inhibitors (C0026457), a Pharmacological substance (phsu).
2. MAO Inhibitors - Consent Type (C1548880), a Health Care Activity (hlca)6.
but only the first is the appropriate concept in this context. A reasonable cause
can be that the UMLS Metathesaurus contains a large number of ambiguity cases
represented by separate concepts, each of which refers to one of the individual senses.
6This semantic type can be defined as an activity of or relating to the practice of medicine or
involving the care of patients.
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However, we believe that the main reason is that the variants of each phrase are
generated without taking into account the context information of it.
This problem is even greater when the phrase can be linked with a combination
of concepts. For example, MMTx provides seven different combinations of concepts
for the phrase No formal drug interaction studies, as follows:
1. Formation (C1522492) + Drug Evaluation (C0013175) + Drug Interactions
(C0687133)
2. Manufactured form (C0376315) + Drug Evaluation (C0013175) + Drug Inter-
actions (C0687133)
3. Manufactured form (C0376315) + Drug Evaluation (C0013175) + Event Qual-
ification - Interaction (C1546938)
4. Manufactured form (C0376315) + Drug Evaluation (C0013175) + Social In-
teraction (C0037420)
5. Qualitative form (C0348078) + Drug Evaluation (C0013175) + Drug Interac-
tions (C0687133)
6. Qualitative form (C0348078) + Drug Evaluation (C0013175) +Event Qualifi-
cation - Interaction (C1546938)
7. Qualitative form (C0348078) + Drug Evaluation (C0013175) +Social Interac-
tion (C0037420)
Regarding the co-reference resolution, phrases such as this disease, the antibiotic,
this drug are linked with generic concepts such as Disease (C0012634), Antibiotics
(C0003232), or Pharmaceutical Preparations (C0013227), respectively. However,
these phrases should be classified into the specific concepts to which they refer in
the text.
These are only some of the failures generated by MMTx. A more detailed dis-
cussion of the failures of MMTx can be found in the following works [Divita et al.,
2004, Bashyam et al., 2007, Meng et al., 2005]. A deeper analysis of them could
contribute notably to the improvement of the MMTx tool, but it is out of scope of
our objectives in this thesis.
3.2.3. Annotating the corpus
This section describes the process followed in the annotation of drug and their
interactions in the DrugDDI corpus.
As it was seen in the previous subsection, the sentences are analysed by MMTx
that provides syntactic and semantic information. In particular, MMTx allows us to
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recognize and annotate a variety of biomedical entities occurring in texts according
to the UMLS semantic types. For example, the figure 3.7 shows the semantic infor-
mation retrieved by MMTx for the phrases The anticoagulant effect and of heparin.
While the former is classified with the semantic type Organ or Tissue Function
(ortf) (a physiologic function of a particular organ, organ system, or tissue), of hep-
arin is classified with three different semantic types: Biologically Active Substance
(bacs), Carbohydrate (carb) and Pharmacological Substance (phsu).
Figure 3.7: UMLS concepts retrieved by MMTx for the phrases The anticoagulant
effect, of heparin and of probenecid
The UMLS Semantic Network7 was reviewed in order to identify the seman-
tic types that can represent drugs useful in this work. Initially, we proposed the
following semantic types 8:
Clinical Drug (clnd): A pharmaceutical preparation as produced by the manu-
facturer. The name usually includes the substance, its strength, and the form,
but may include the substance and only one of the other two items. Exam-
ples: Zovirax Cold Sore 5% cream, sleeping pill, Acetohexamide 250 MG Oral
Tablet.
Pharmacological Substance (phsu): A substance used in the treatment or pre-
vention of pathologic disorders. This includes substances that occur naturally
in the body and are administered therapeutically. Examples: Antiemetics,
Cardiovascular Agents, Codeine, Morphine Sulfate.
Antibiotic (antb): A pharmacologically active compound produced by growing
microorganisms which kill or inhibit growth of other microorganisms. The
7http://semanticnetwork.nlm.nih.gov/Download/index.html
8Definitions from http://semanticnetwork.nlm.nih.gov/Download/RelationalFiles/SRDEF
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direct ancestor of this semantic type is the phsu semantic type. Examples:
Antibiotics, Cephalosporins, Methicillin.
An experienced pharmacist reviewed the semantic annotation provided by MMTx
and recommended us the inclusion of the following UMLS semantic types as possible
types of interacting drugs:
Biologically Active Substance (bacs): A generally endogenous substance pro-
duced or required by an organism, of primary interest because of its role in
the biologic functioning of the organism that produces it. Examples: Enzyme
Precursors, Gastric Acid, Growth Substances.
Chemical Viewed Structurally (chvs): A chemical or chemicals viewed from the
perspective of their structural characteristics. Some examples are Ammonium
Compounds, Cations, Siloxanes, Sulfur Compounds.
Amino Acid, Peptide, or Protein (aapp): Amino acids and chains of amino
acids connected by peptide linkages. Examples: Acetylcysteine, Glycoproteins,
Peptidyl-Dipeptidase A, glycylglutamine.
Table 3.7 shows the distribution of these semantic types in the corpus. If a term
is classified by several drug types, it is only to be counted once. The average number
of drugs per document is 24.9, and the average number of drugs per sentence is 2.4.
Semantic Type Annotated Set Unannotated set Total
clnd 106 65 171
phsu 12,767 7,069 1,283,781
antb 695 369 1,064
chvs 60 28 88
bacs 215 110 325
aapp 1,087 619 1,706
Total 14,930 8,260 23,190
Avg. per document 25.8 23.5 24.9
Avg. per sentence 2.6 2.5 2.4
Table 3.7: Distribution of the UMLS semantic types for drugs in the DrugDDI
corpus
Drug families (e.g., analgesics, anticoagulants, salicylates, etc) are also tagged
by MMTx with some of the above semantic types. The automatic extraction of
interactions involving drug families is a desirable outcome of our research. If a given
interaction involving a drug family is known, then the drugs of this family can be
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modified by the pharmaceutical industry in order to avoid that interaction. Example
3 contains an interaction involving the drug familiy Urinary Alkalinizers and the
specific drug Aspirin.
Example 3 Drug Family-Drug Interaction
Urinary Alkalinizers decrease aspirin effectiveness by increasing the rate of salicylate
renal excretion. Interaction between a drug family and a particular drug
In addition, MMTx allows to classify abstract entities such as medicine, drug,
medication as pharmacological substances. The abstract pharmacological substances
are usually classified with some of the following concepts: pharmacological sub-
stance (C1254351 ), or, pharmaceutical preparations (C0013227 ). We have decided
to preserve this annotation because some interactions involve a specific drug and an
anaphoric expression. The recognition of these abstract drugs allows to include in
the corpus those interactions that span several sentences by the use of co-reference
expressions. For example, the sentence This medicine can interact with Warfarin
contains two pharmacological substances: a specific drug name aspirin, and an ab-
stract drug name medicine that refers to a specific drug previously mentioned in the
text.
The corpus contains a total of 1,637 terms that map with pharmacological sub-
stance or pharmacological preparation concepts (999 in the annotated dataset). This
means that the 7% of all phrases classified as drugs by MMTx, are not physical drugs,
but also abstract drugs such as this drug, the medication or the medicine.
The main value of the DrugDDI corpus comes from its annotation since all the
documents have been marked-up with drug-drug interactions by a researcher with
pharmaceutical background and a pharmacist.
Annotated Set Unannotated set Total
sentences that contain 0 drugs 857 623 1,480
sentences that contain 1 drug 1,175 589 1,764
sentences that contain 2 drugs 1,416 750 2,166
sentences that contain 3 drugs 2,358 1,293 3,651
sentences with at least 2 drugs 3,774 2,043 5,817
Table 3.8: Proportion of drugs in sentences.
Only those documents in the annotated dataset have been tagged with drug in-
teractions. Besides, we have only annotated the DDIs at sentence level, that is,
those interactions than span several sentences have not been annotated. We have
focused on the sentences with at least two drugs.
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The annotated dataset contains a total of 3,775 sentences than contain two or
more drugs (see table 3.8), although only 2,044 contain at least one interaction. A
total of 3,160 drug-drug interactions have been identified with the assistance of a
pharmacist. Figure 3.8 shows an example of an annotated sentence that contains
three interactions. Each interaction is represented as a DDI node in which the names
of the interacting drugs are registered in its NAME DRUG 1 and NAME DRUG 2
attributes. The identifiers of the phrases containing these interacting drugs are
also annotated. This provides an easily access to the related concepts provided by
MMTx.
Figure 3.8: Example of DDI annotations.
Ideally, we should also annotate additional information about each interaction
such the roles of each drug, its mechanism, its relation to the doses of both drugs, its
time course, the factors that alter an individual’s susceptibility to it, its seriousness
and severity, and the probability of its occurrence, when these data are available in
the text. We are planning to expand the annotations to include this type of data.
Furthemore, it would be desirable to classify the DDIs according to a drug knowledge
database. Example 4 contains some sentences annotated with interactions. The
corpus also contains sentences that can be used to obtain explicit examples of non-
interactions (see example 5).
Total No DDI with DDI
Files: 579 164 415
Sentences: 5,806 3,762 2,044
Total of annotated DDIs: 3160
Table 3.9: Basic Statistics on annotated dataset of the DrugDDI corpus.
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Example 4 Examples of annotated interactions
(1) Interaction between a specific drug and a drug family: [Aspirin]drug
is contraindicated in patients who are hypersensitive to [nonsteroidal anti-
inflammatory agents]drugfamily.
(2) A sentence containing several interactions: [Dexbrompheniramine]drug can
interact with [alcohol]drug or [other CNS depressants]drugfamily[]
(3) A probable interaction (that is, it may not happen): [Propantheline]drug and
[diphenoxylate]drug may increase [digoxin]drug absorption.. This kind of interac-
tions only happen under given conditions.
(4) An interaction that depends on its drug dosages and its time course: A literature
article reported that when a [60 mg controlled-release morphine capsule]drug
was administered 2 hours prior to a [600 mg Neurontin capsule (N=12)]drug,
mean gabapentin AUC increased by 44% compared to gabapentin administered with-
out morphine
Example 5 Negation of DDIs.
In vitro binding studies with human serum proteins indicate that glipizide binds dif-
ferently than tolbutamide and does not interact with salicylate or dicumarol.
Allopurinol did not increase the marrow toxicity of patients treated with cyclophos-
phamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.
Avg. per document
Number of sentences: 10.03
Number of sentence that contain at least a DDI: 3.53
Number of sentences that contain no DDI: 6.50
Number of DDIs: 5.46 (0.54 per sentence)
Table 3.10: Average number of sentence and DDIs per document.
3.2.3.1. DDIAnnotate tool
Although, there exist several annotation tools for creating annotated biomedical
corpora with such as BioNotate [Cano et al., 2009] or @Note [Lourenc¸o et al., 2009],
they do not allow to annotate DDIs in an adequate way. Thus, we decided to
developed a client application DDIAnnotate (see figure 3.9) implemented in Java
language, in order to help annotators in their task. The tool has an intuitive user
interface where the documents are displayed and drugs drugs occurring in text are
highlighted. There are six different colors for the highlighting, indicating each one of
the semantic types that represent drugs. To annotate the interactions, the annotator
only has to select a sentence, and then, to indicate the interacting drugs (comboxs
Drug 1 and Drug 2, and add -green arrow - the interaction to the list of interactions
for this sentence. The annotator must add an interaction for each pair of interacting
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drugs. The user may also annotate the severity or the certainty degree for the drug
interaction, however, we have not annotated this kind of information yet. We are
planning to implement a new version to annotate other information about drug-drug
interactons such as the roles of each drug, doses, time course, among other features.
We are also planning to study the BioNotate tool that allows to annotate documents
in a collaborative way.
Figure 3.9: DDIAnnotate tool.
3.3. Conclusion
In this chapter, we have described the main corpora available in the biomedi-
cal domain showing that most biomedical annotated corpora for relation extraction
are focused on the biological domain and DDIs are not covered. The size of these
corpora is quite small and usually does not exceed one thousand sentences. The
biomedical entities are automatically annotated, and then manually reviewed, but
information about the annotation process is rather scarce. Most of the reviewed cor-
pora do not have (or provide) any information about the inter-annotator agreement
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nor annotation guidelines. Regarding linguistic information contained within the
corpora, LLL and BioInfer are the only corpora that contain syntactic information.
We have built the first annotated corpus for drug interaction. To the best of our
knowledge, the problem of producing an annotated corpus for DDI extraction has
not been explored to the depth and extent reported in this chapter, and the result-
ing corpus is the most richly semantically annotated resource for pharmacological
text processing built to date. The DrugDDI corpus9 is available for research but
cannot be used for commercial purposes. The availibility of this annotated corpus is
a clear incentive for the development of drug interaction extraction approaches since
DrugDDI provides a gold-standard data for their evaluation. A common shared cor-
pus should increase the research and rapid advances in the field. The corpus consits
of 579 documents from the DrugBank database. The average number of sentence
per document is 10.3, and the average number of tokens per document is 211.5.
DrugDDI contains a total of 3,160 DDIs that have been annotated at sentence level.
The average number of interactions per document is 5.46 and per sentence 0.54.
DrugDDI corpus has been annotated with linguistic information including sentence
boundaries, tokenization, phrase boundaries and phrase semantic classification pro-
vided by MMTx. Unfortunately, MMTx introduces several errors in its different
levels of analysis, that we have not reviewed yet. Thus, some interactions have
not been annotated because their drugs were not recognized by MMTx. We hope
to encourage many researchers to make use of DrugDDI corpus for their research,
and expect feedback from them that would be the most valuable source for further
improvement of the corpus. Some of our future taks are:
1. Annotate the interactions at document level. Then, we will be able to evaluate
the contribution of our anaphora resolution methods.
2. Review the linguistic information provided by MMTx.
3. Analyze the text with a parser trained on biomedical texts, such as Genia
dependency parser [Sagae, 2007] or the parser proposed by Lease and Charniak
[2005].
4. Increase the pharmacological information about the interactions including in-
formation such as the roles of the drugs, the mechanism of the action, the drug
dosages, the time, the severety, among other.
5. Increase the size of the corpus.
6. Work with a major number of annotator and to measure the inter-agreement
annotator as well as a comprehensive annotation guidelines that to be useful
to other annotators.
9It will be published at http://www.inf.uc3m.es/component/comprofiler/userprofile/isegura
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7. Manually review the semantic annotation provided by MMTx with the assis-
tant of several pharmaceutical experts as well as to measure the inter-annotator
agreement.
8. Annotate negations.
Finally, we would like to note the EMEA corpus10 as a possible source of informa-
tion textual for the construction of annotated corpora for pharmaceutical domain.
This is a parallel corpus that contains a total of 48087 documents for 22 languages
from the European Medicines Agency 11. This corpus belongs to the collection of
corpus provided by the OPUS project12, which is an attempt to collect translated
texts from the web, to convert and align the entire collection, to add linguistic anno-
tation, and to provide the community with a publicly available parallel corpus. To
our knowledge, the corpus EMEA does not contain any semantic information yet.
An interesting and challenging project is the Linking Open Drug Data (LODD)13.
This project aims to link the various sources of drug data together in order the
researchers, physicians and patients can take advantage of the connected data sets.
In addition, we believe that the integration of data from these drug sources can be
a valuable instrument in improving the performance of the biomedical NLP tasks,
in particular, named entity recognition.
10http://www.let.rug.nl/ tiedeman/OPUS/EMEA.php
11http://www.emea.europa.eu/
12http://www.let.rug.nl/ tiedeman/OPUS/
13http://esw.w3.org/topic/HCLSIG/LODD
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Chapter 4
Drug Name Recognition and
Classification
4.1. Introduction
The recognition of drug names is not only an essential prerequisite step for the
automatic discovery of DDIs from biomedical texts, but also required in other kinds
of applications, such as Information Retrieval, Information Extraction, Information
Management and new knowledge discovery in the pharmacological domain.
Drug name recognition aims to find drugs in biomedical texts and classify them
into predefined categories (drug families), such as analgesics, antihistamines, an-
tivirals, etc. This process is a challenging task, given the difficulties implied in
biomedical text processing:
1. With the rapidly changing vocabulary, new drugs are introduced very fre-
quently, while old ones are made obsolete. It is difficult to maintain and up-
date terminological resources constantly. Although frequently updated, such
resources cannot keep up with the accelerated pace of the changing terminol-
ogy. Thus, systems capable of automatically detecting candidate terms for
augmenting these resources would help in speeding up the time-consuming
task of maintenance.
2. Naming conventions are available for a variety of domains in the biomedicine
field, for example, in the pharmacological domain, the WHO International
Nonproprietary Names (INNs) Program [Drugs and Policy, 2006] defines a set
of nomenclature rules to identify and classify generic drugs. However, these
conventions are not strictly followed. Despite this fact, integrating this type
of information can help in gaining basic insights into the underlying meanings
of the drugs in question and, therefore, help in the classification of them.
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3. Drug name recognition also requires a considerable linguistic analysis of drug
entities. For example, an automatic IE system for DDIs should detects not
only drug names occurring in the text, but also anaphoric expressions (such as
it and the drug) that refer to interacting drugs. This problem will be tackled
in chapter 5.
Drug Date of Approval
Xiaflex (collagenase clostridium histolyticum) February 3, 2010
Oleptro (trazodone) February 2, 2010
Victoza (liraglutide) Injection January 25, 2010
Ampyra (dalfampridine) January 22, 2010
Actemra (tocilizumab) January 8, 2010
Zyprexa Relprevv (olanzapine) December 11, 2009
Kalbitor (ecallantide) December 1, 2009
Agriflu (influenza virus vaccine, inactivated) November 27,2009
Qutenza (capsaicin)h November 16, 2009
Lysteda (tranexamic acid) November 13, 2009
Istodax (romidepsin) November 5, 2009
Pennsaid (diclofenac sodium) November 4, 2009
Table 4.1: Recent drug approvals: brand names are shown first, followed by the
generic names enclosed between parenthesis
Figure 4.1 shows the pipeline architecture of our drug-drug interaction prototype.
First, texts are processed by the MMTx program, which allows to recognize a variety
of biomedical entities, among them drugs. Then, drugs found in such texts are
classified into drug families . Over this basis, anaphora resolution is carried out
to account for both nominal phrases referring to drugs and pronouns. Finally, the
relation extraction module exploits the output of these previous modules in order
to account for drug-drug interactions in biomedical documents.
This chapter describes the module for drug name recognition and classification,
called DrugNer. This module extends the approach presented by Aronson [2001a], in
which MMTx is applied to recognize biomedical concepts in texts. Our module also
exploits the shallow syntactic analysis of texts provided by MMTx. Subsequently, a
set of nomenclature rules recommended by the WHO International Nonproprietary
Names (INNs) [Drugs and Policy, 2006] provides valuable insights to identify and
classify drug names. First of all, the rules help in the identification of drug names
that have not been detected by MMTx. In addition, these nomenclature rules can
also classify drug names according to pharmacological or chemical groups, that is,
drug families. Drug families can represent a valuable clue for the detection of DDIs in
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Figure 4.1: DDI Extraction prototype. The second module tackles the detection
and classification of the drugs occurring in texts.
biomedical texts. In the vast majority of cases, drugs that belong to the same family
usually share the basic chemical structure and mechanism of action [Gilman et al.,
1992, Russell, 2007], though there are exceptions. Therefore, if an interaction of a
particular drug is known, there is a reasonable probability that another drug with
similar chemical structure and metabolic pathway will also exhibit this interaction
[Bottorff, 2006].
The chapter is organized as follows. The following section presents a brief sum-
mary review on related work in Biomedical Named Entity Recognition. The module
for drug name recognition proposed in this thesis is described in section 4.3. The
process of construction of the corpus used for the development and evaluation of
DrugNer and experimental results are presented in section 4.4. We have developed
a tool to highlight the pharmacological substances in texts, which is described in
section 4.5. Section 4.6 offers some conclusions as well as unresolved issues.
4.2. Biomedical Named Entity Recognition
Biomedical Named Entity Recognition (BNER) is defined as the task of recog-
nizing and categorizing entity names in biomedical domains. This task is a prior and
essential step for mining useful knowledge from the biomedical literature. Identifying
these biomedical entities is crucial for facilitating the retrieval of relevant documents
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and the identification of relationships between them, such as PPIs, DDIs, food-drug
interactions, disease-gene relations, drug targets, among others.
Despite the availability of many well-known nomenclatures for biomedical enti-
ties, it is certainly a nontrivial task since these resources do not address certain issues
such as changing vocabulary, ambiguity, synonymy and abundant use of acronyms,
among others.
In this section, the current progress in biomedical name entity recognition is
explained through some selected papers that clearly show methodological improve-
ments. The papers are classified into the following three groups:
1. Dictionary-based approaches which try to find names of the terminological
resources in the literature.
2. Pattern-based approaches which manually or automatically construct patterns
to directly match them to candidate named entities in the literature.
3. Machine learning approaches which employ machine learning techniques, such
as Hidden Markov Models (HMMs)
4. , Support Vector Machines (SVM) and Conditional Random Fields (CRFs) to
develop statistical models for biomedical named entity recognition.
These approaches are, of course, not necessarily exclusive, indeed, some of the
introduced papers merge two or more of them in order to deal with different aspects
of the problem.
4.2.1. Dictionary-Based Approaches
Publicly available biomedical sources and databases such as UMLS [Humphreys
et al., 1998], Gene Ontology [Ashburner et al., 2000], GenBank [Benson et al.,
2007], FlyBase [Drysdale and Crosby, 2005], UniProt [Bairoch et al., 2005], Dis-
ease Database 1, among others, provide comprehensive lists of biomedical entities.
This fact has promoted that most of the early approaches have been heavily de-
pendent on such lists. In general, the basic idea of dictionary-based approaches is
to match dictionary entries exactly against text. Thus, these approaches can pro-
vide ID information on recognized terms, which is very useful to integrate extracted
information with data from information sources.
Krauthammer et al. [2000] propose a system for recognizing gene and protein
names that used the BLAST tool [Altschul et al., 1997] for DNA and protein se-
quence comparison. First, the system translates both dictionary entries and input
texts into sequences of nucleotides, which can be compared by BLAST, and then
1http://www.diseasesdatabase.com/
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performs approximate string matching. Thus, it could recognize protein and gene
names that have not been registered yet. The system was manually evaluated on a
set of two papers, achieving a f-measure of 75%.
Hanisch et al. [2002] build a unified dictionary of genes and proteins by merging
HUGO Nomenclature [Povey et al., 2001], OMIM database [Maglott et al., 2002],
and UniProt. Texts are tokenized, in order, to look for each token in the dictionary.
The method was evaluated on 470 Medline abstracts semi-automatically annotated,
reporting a f-measure of 92.4%.
Tsuruoka and Tsujii [2004a] have focused on the problem of spelling variations.
Biomedical named entities usually have many spelling variations, for example, the
protein name Anti-p24 (HIV-1) monoclonal antibody CB4-1 can be represented with
different spelling variants such as monoclonal anti-p24 (HIV-1) antibody CB4-1,
anti-p 24(HIV-1) monoclonal antibody CB 4-1 or anti-p24(HIV1) monoclonal anti-
body CB41. Two methods are proposed and evaluated on the Genia corpus [Ohta
et al., 2002, Kim et al., 2003]. The first method uses approximate string searching
techniques and achieves a f-measure of 64.7%. The second expands a protein name
dictionary by a probabilistic variant generator and achieves a f-measure of 66.6%.
Sirohi and Peissig [2004] compare the use of various drug lexicons to automat-
ically extract medication information from electronic medical records. Three drug
lexicons are used as sources for medication extraction: first, containing drug name
and generic name; second with drug, generic and short names; third with drug,
generic and short names followed by filtering techniques. The effect of each lexicon
is evaluated on a collection of 100 documents which contains a total of 641 medi-
cations. Extraction with the first drug lexicon resulted in 85.2% recall and 96.9%
specificity (this metric is defined in section 2.2). The integration of the short names
increases the recall to 96.4%, but decreases the specificity to 80,1%. Finally, the
use of a set of filtering techniques with the previous lexicons increases the speci-
ficity to 98.8% while slightly decreasing the recall to 95.8%. Thus, this combination
extracts the highest number of medications while keeping the number of extracted
non-medications low.
The method proposed by Schuemie et al. [2007] combines information from sev-
eral gene and protein databases such as Entrez Gene [Maglott et al., 2006], the
Mouse Genome Database (MGD) [Blake et al., 2003], FlyBase and Sacchromyces
Genome Database [Cherry et al., 1998] for automatic generation of a comprehensive
dictionary. Schuemie et al. [2007] also use a set of rules to generate spelling varia-
tions. Convert numbers to greek letters, remove the word delimiter between letters
and numbers or rewrite numbers as roman numerals are some examples of the rules
proposed. The BioCreAtIvE corpus [Hirschman et al., 2005] and the Gena dataset
[Koike and Takagi, 2004] are used to evaluate the method. The results show that
the rules proposed achieve higher levels of recall without sacrificing precision. In
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addition, high recall levels are achieved by the combination of different databases,
and applying these spelling-variation rules.
Yang et al. [2008] propose a dictionary-based approach that expands a bioentity
name dictionary by the identification of abbreviations. Some post-processing meth-
ods are also applied including Pre-keyword and Post-keyword expansion, Part of
Speech (POS) expansion, merge of adjacent bio-entity names and the exploitation
of contextual clues. The experiments are conducted using the JNLPBA2004 [Kim
et al., 2004], achieving a f-measure of 68.80%.
More recently, a dictionary for the identification of small molecules and drugs has
been developed in [Hettne et al., 2009]. The dictionary combines information from
UMLS, MeSH [Elwood et al., 1948, Lipscomb, 2000], ChEBI [Degtyarenko et al.,
2008], DrugBank [Wishart et al., 2006, 2007a], KEGG [Kanehisa and Goto, 2000],
HMDB [Wishart et al., 2007b], and ChemIDplus[Tomasulo, 2002]. The combined
dictionary achieves a precision of 67%, recall 40% (recall is 80% for trivial names).
Many existing systems adopt a hybrid approach for improving the performance
of BNER systems by combining methods from two or more approaches. Tsuruoka
and Tsujii [2004b] developed a two-phase method to address the limitations of the
dictionary-based approaches. Firstly, a probabilistic generator produces morpho-
logical variations of protein names included in the UMLS Metathesuarus. Then, a
protein name dictionary is expanded by scanning texts for protein name candidates.
Finally, a Na¨ıve Bayes classifier is used to filter out the irrelevant candidates of short
names. The method is evaluated on the Genia corpus and achieves a f-measure of
66.6% with a precision of 71.7% and a recall of 62.3%.
Abbreviations and acronyms are frequently used in the biomedical texts to re-
name drugs and other concepts. The high ambiguity of these terms and the lack
of acronym dictionaries turn the automatic resolution of them into a very hard
task. Gaudan et al. [2005] combine an automatic analysis of Medline abstracts and
linguistic methods to build a dictionary of abbreviation/definition pairs. The dic-
tionary is used for the resolution of abbreviations occurring with their long-forms.
Ambiguous global abbreviations are resolved using SVM that have been trained on
the context of each instance of the abbreviation/sense pairs, previously extracted
for the dictionary. The system achieves a precision of 98.9% and a recall of 98.2%.
Recently, an innovative service, REFLECT [Pafilis et al., 2009], has been devel-
oped by European Molecular Biology Laboratory (EMBL) 2 to improve access to
biological information in context. This service uses a dictionary to recognize gene,
protein and small molecule names. Each recognized entity is linked to documents
that show additional information such as synonyms, database identifiers, sequence,
domains, 3D structure, interaction partners, subcellular location, and related lit-
erature. In addition, it lets end-users systematically tag gene, protein, and small
2http://www.embl.de/
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molecule names in any web page. The service can be installed as a plug-in in the
navigators.
Dictionary-based methods are very precise, however, they present several draw-
backs such as low recall due to synonyms and spelling variations, and the inability
to discover newly published names that have not yet covered by any resource. In
addition, false recognition mainly caused by short and ambiguous names degrades
overall precision.
4.2.2. Pattern-Based Approaches
While dictionary-based approaches can deal only morphological variations, pattern-
based approaches deal with a broader range of variations such as word-order and
syntactic variations. Basically, pattern-based approaches exploit the contexts in
which the entities appear in the text. These contexts can be discovered and ex-
pressed as patterns in order to locate new entities.
Fukuda et al. [1998] develop the PROPER (PROtein Proper-noun phrase Ex-
tracting Rules) system for protein name recognition based on the use of simple lexical
patterns and orthographic features. The method first identifies core terms, those
which contain special characters (such as upper cases, commas, hyphens, slashes,
brackets or digits), and feature terms, those which describe biomedical functions of
compound words (for example, protein and receptor). Core and feature terms are
then concatenated by utilizing hand-crafted patterns and the boundaries are ex-
tended to adjacent nouns and adjectives. The method is evaluated on 30 abstracts
achieving 94.70% precision and 98.84% recall (f-measure=96.7%).
The AbGene system [Tanabe and Wilbur, 2002] is one of the most popular
pattern-based approaches for BNER, in which the Brill tagger [Brill, 1992] is adapted
to recognize single word protein and gene names. A set of 7000 sentences is manually
annotated with gene and protein entities. This corpus (called ABGene corpus) is
used to define a set of hand-built patterns based on lexical features to filter out
false positives and recover false negatives. The patterns are applied to identify the
context in which protein and gene names are used. The system achieves a precision
of 85.7% and a recall of 66.7%.
The YAPEX system, presented in [Franze´n et al., 2002], combines lexical and
syntactic information, heuristic rules and a document-local dynamic dictionary. The
syntactic information is used to identify single and multi-word protein names. A
corpus of 200 abstracts, called as YAPEX, is manually annotated to evaluate the
system. Its test corpus consists of 101 MedLine abstracts, containing a total of 1936
annotated protein names. The system achieves a f-measure of 67.1% (recall of 61.0%
and a precision of 62.0%).
Nenadic et al. [2003] introduce an integrated framework for terminology-driven
mining from biomedical literature. The framework integrates the following compo-
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nents: automatic term recognition, term variation handling, acronym acquisition,
automatic discovery of term similarities and term clustering. The term variant recog-
nition takes into account orthographical, morphological, syntactic, lexico-semantic
and pragmatic term variations. In particular, they address acronyms as a common
way of introducing term variants in biomedical papers. Term clustering is based
on the automatic discovery of term similarities. They use a hybrid similarity mea-
sure, where terms are compared by using both internal and external evidence. The
measure combines lexical, syntactical and contextual similarity. Experiments on
terminology recognition and clustering have been performed on a corpus of 2082
Medline abstracts related to nuclear receptors. They achieve around 99% preci-
sion at 74% recall in acronyms recognition, and around 70% precision in clustering
semantically similar terms.
Seki and Mostafa [2005] propose a hybrid method that combines a set of hand-
built patterns, a dictionary and a probabilistic model for locating complete protein
names. Words such as binding, related, associated, as well as suffixes such as -ine,
-tide or -yl are some of the surface clues that are used to define the patterns. The
probabilistic model uses word classes based on suffixes and word structure for dealing
with data sparseness problem. The dictionary is compiled from the Swiss-Prot and
TrEMBL protein databases [Boeckmann et al., 2003]. The method is evaluated on
the YAPEX corpus, achieving a f-measure of 63.3% (recall of 66.9% and precision
of 60.1%).
In the approach presented in [Torii et al., 2004], a set of patterns based on features
that appear within the entity name as well as contextual information is manually
defined to classify the entities. The experiments were conducted on the Genia Cor-
pus. The approach achieves a f-measure of 86% with a precision of 87% and a recall
of 86%. Later, Torii and Liu [2006] evaluated the performance of headwords and
suffixes in predicting semantic classes of biomedical terms. New semantic classes are
defined by modifying an existing UMLS semantic group system and incorporating
the Genia ontology. Headwords and suffixes that are significantly associated with
a specific semantic class are defined. The terms in UMLS are reclassified by these
semantic headwords and suffixes. The performance of semantic assignment using
semantic suffixes reached an f-measure of 86.4% with a precision of 91.6% and a
recall of 81.7%.
The PASTA (Protein Active Site Template Acquisition) [Humphreys et al., 2000,
Gaizauskas et al., 2003] is a pipeline of processing components that performs the
following major tasks: tokenization, sentence splitting, lexical lookup of terms in
terminological lexicons to identify and correctly classify instances of the term classes,
syntactic and semantic processing of terms, construction of a discourse model of
the input text based on the semantic representation of each sentence, and finally,
a template extraction module that looks in the discourse model and outputs the
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templates. The PASTA system achieved a f-measure of 85% on a set of 61 abstracts.
The system presented in Caporaso et al. [2007] uses regular expressions to identify
mutations from text. They built a development data set (305 abstracts containing
605 mutations), and a test data (with 910 mutation mentions from 508 abstracts).
Annotation is performed with Knowtator [Ogren, 2006], using an ontology that was
developed for describing point mutations. The development data set is used to
design the regular expressions. The systems achieves a precision of 98.4%, a recall
of 81.9%, and a f-measure of 89.4%.
Pattern-based approaches have achieved remarkable performance. However, the
main drawback of these approaches is the need to manually construct patterns that
must be defined by domain experts. This is a time-consuming task. Xu et al. [2008]
propose a bootstrapping system for learning pattern that allows to build a disease
dictionary from abstracts. The system extracts diseases by matching the set of seed
patterns in the parse tree of the sentences. Then, it also discovers new patterns
from the extracted diseases and adds them to the set of seed patterns. The system
repeats this process a fixed number of interactions. The built dictionary consists
of 1,922,283 disease names. The dictionary is used to identify disease names in 100
manually annotated abstract. It achieves a precision of 80%, a recall of 78% and a
f-measure of 81%.
Another of the shortcomings of the pattern-based approaches is that they are
not flexible and cannot easily adapt to identify other biomedical entities, because
naming conventions are often very different in the biomedical subdomains.
4.2.3. Machine Learning Approaches
In [Collier et al., 2000], a Hidden Markov model (HMM) is trained with bigrams
based on lexical and character features. Experiments are performed on a corpus
of 100 abstracts manually annotated by domain-experts with term classes such as
proteins and DNA. The model achieves a F-measure of 73%.
The approach presented in [Lee et al., 2003] is based on the use of SVM. It
was evaluated on the Genia corpus, and reported a f-measure of 69.2%. NLProt
[Mika and Rost, 2004] is a hybrid system that combines a pre-processing dictionary
and rule-based filtering step with several separately trained SVM models to identify
protein names. The system achieves a f-measure of 75% on the YAPEX corpus.
The system PowerBioNe [Zhou et al., 2004] uses a HMM based named entity
recognition that integrates various features such as word formation pattern, mor-
phological pattern (prefix and suffix) and part of speech tags. The system also uses
a k-NN algorithm to resolve the data sparseness problem. In addition, the system
provides a pattern-based method to automatically extract rules to deal with the
cascaded entity name phenomenon. The system is evaluated on the Genia corpus
and achieves a f-measure of 66.6%.
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Kou et al. [2005] propose two hybrid methods, SemiCRFs and dictionary HMMs.
SemiCRFs is an extension to Conditional Random Fields (CRF) that enables a
more effective use of dictionary information as features. Dictionary HMMs convert
a dictionary to a large HMM that recognizes phrases from the dictionary, as well
as variations of these phrases. These methods are evaluated on the YAPEX corpus
achieving a f-measure of 66.1% and 51% respectively.
Takeuchi and Collier [2005] apply SVM for the identification and semantic anno-
tation of scientific terminology in the domain of molecular biology. The model uses
various features such as surface words, orthographic features, head noun features
and contextual information. The model achieves a f-measure of 74% on a set of 100
abstracts.
Bunescu et al. [2005] compare various methods for the recognition of protein
names such as SVMs, Maximum Entropy, Memory-based Learning (MBL) or Trans
formation-based Learning (TBL), RAPIER (a system for relational learning of pat-
tern match rules) [Califf and Mooney, 1999], among others. These methods are
evaluated on 748 abstracts which are manually annotated with human genes and
proteins. The best performance is achieved by the Maximum Entropy method with
a f-measure of 57.9%.
Dimililer and Varoglu [2006] apply SVM to the identification and automatic an-
notation of biomedical named entities in the domain of molecular biology. They use
and compare well-known features such as word formation patterns, lexical, morpho-
logical, and surface words on recognition performance. The method is evaluated on
the JNLPBA 2004 corpus, achieving a f-measure of 69.87%.
Wu et al. [2006] also present a recognition system based on SVM. The features
set is a combination of lexical and contextual features. A corpus of 100 abstracts in
the domain of molecular biology is collected from Medline and annotated with gene
names. The experiments show that the system achieves an f-measure of 81.57% with
a precision 81.40% and a recall of 81.74%.
Ponomareva et al. [2007] have developed a HMM-based biomedical NER system
that takes into account only parts-of-speech as an additional feature. This morpho-
logical information allows to detect the entity boundaries and to tackle the problem
of nonuniform distribution among biomedical entity classes. The system achieves
an f-measure of 65.7% with a precision of 62.4% and a recall of 69.4%.
Vlachos [2007] compares two such systems, one based on a HMM and one based
on CRF and syntactic parsing. Three different corpora from the FlyBase database
have been built. The first corpus consits of 5 full papers and the second one of
16,609 abstracts. Both corpora are parsed by the RASP parser [Briscoe et al.,
2006] and automatically annotated with gene names using longest-extent pattern
matching. The third corpus (described in [Vlachos and Gasperin, 2006]) consists of
82 abstracts that are annotated by a computational linguist and a FlyBase curator
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. The method based on a HMM achieves a f-measure of 81.86% with a precision of
89.14% and a recall of 75.68% and overcomes the hybrid method combining CRF
and syntactic parsing, which obtains a f-measure of 74.72%, a precision of 90.89%
and a recall of 63.43%.
BioCreative I [Yeh et al., 2005] and II [Smith et al., 2008] gene mention tasks
have been of crucial importance to encourage research on gene name recognition. A
corpus of 20,000 abstracts is selected and annotated for training and testing purpose
with the AbGene tagger [Tanabe and Wilbur, 2002]. The best systems were based
on the use of machine learning techniques. The best performance in BioCreative
II is obtained by the system [Ando, 2007], achieving a f-measure of 87.2% (the
highest achieved f-measure for the previous task was 83.6%). The system used
a general purpose named entity recognition framework [Ando and Zhang, 2005].
This recognizer consists of a regularized linear classifier trained utilizing standard
features such as word strings and character types. Other participating systems [Kuo
et al., 2007, Huang et al., 2007, Klinger et al., 2007] were based on CRF, or in a
combination several machine learning methods such as CRFs and SVM. A detailed
description of the participating systems can be found in [Smith et al., 2008] and
[Yeh et al., 2005].
The system Banner [Leaman and Gonzalez, 2008] is an open-source system based
on CRF method and the use of orthographical, morphological and shallow syntax
features. The system is evaluated on the corpus created for the BioCreative 2 Gene
Mention Tagging Task [Wilbur et al., 2007, Smith et al., 2008], achieving a precision
of 85.09% and a recall of 79.06%. One of its major advantages is that it does
not make use of neither semantic features nor domain rules, so maximizing domain
independence.
Recently, Gurulingappa et al. [2009] have developed a system that combines
IE and machine learning techniques to classify drugs. Terms expressing information
about drugs are used as features within a machine learning framework to predict class
labels from the anatomical therapeutic chemical (ATC) classification for unclassified
drugs. The system is tested on a portion of the ATC classification containing drugs,
achieving an accuracy of 77.12%.
Machine learning techniques are able to identify biomedical entities without hu-
man intervention. However, in order to achieve good recall, these techniques need
large annotated corpora. Thus, they depend heavily on the annotated corpora
for training and testing. Corpus annotation is expensive work, usually involving
the need of domain experts, extensive time and labor. Few corpora are available
for biomedical named entity recognition. They are usually limited to protein and
gene, usually exhibit a small size and do not contain annotations on other types of
biomedical entities, such as drugs. Therefore, these limitations have made it difficult
to apply supervised machine learning techniques to recognize biomedical entities.
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4.2.4. Unsolved Issues in Drug Name Recognition
The analysis of the state of art shows that while most studies of BNER have
mainly focused on genes and proteins, the drug names have not widely addressed.
There are several open issues such as ambiguous names, synonyms, variations and
newly published names related to the drug name recognition. Some challenges of
this task are:
1. Face anaphora problem: drug names as well as other biomedical named enti-
ties can be expressed in various linguistic forms including plurals, compounds
and anaphoric expressions. Therefore, drug name recognition also requires a
considerable linguistic analysis. For example, an automatic information ex-
traction system for DDIs should detect not only drug names occurring in the
text, but also anaphoric expressions, such as it and the drug, that refer to in-
teracting drugs, as illustrated in example 6. Thus, the system must handle the
fact that a possible interaction may occur between levofloxacin and warfarin,
by resolving the noun phrase this drug with the drug name levofloxacin. Such
anaphoric expressions subsequently may be replaced with their antecedent
drug names as defined in the preceding context. This problem will be tackled
in the following chapter 5.
2. Face management of terminological resources: with the rapidly changing vo-
cabulary, new drugs are continually created while older ones are made re-
named, which makes difficult to keep up to date the terminological resources.
3. Face synonymy problem: drug names are synonymous with other drug names.
For example, adofen, affectine, alzac, ansilan, deproxin, erocap, fluctin, fluc-
tine, fludac, flufran, flunil, and 27 other trade names all are brands of the
generic drug fluoxetine.
4. Face ambiguity problem: Drug names often have the same name as an common
English word such as Because (a contraceptive) or Duration (nasal spray).
Thus, terms in free text may be ambiguous and resolve to multiple senses,
depending on the context in which they are used.
5. Face acronyms and abbreviations problem: abbreviations and acronyms are
frequently used in the biomedical texts to rename drugs and other concepts.
The high ambiguity of these terms and the lack of acronym dictionaries turn
the automatic resolution of them into a very hard task.
6. Interpret drug naming conventions: drug naming conventions are available,
however, these conventions are not strictly followed. Despite this fact, in-
tegrating this type of information can help gaining basic insights into the
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underlying meanings of the terms in concern, and, therefore, helping in the
classification of the terms.
Regarding the drug name classification, the drugs can be categorized in differ-
ent ways according to their mechanism of action, their indications or their chem-
ical structure. Currently, there are several drug classification systems such as the
Anatomical Therapeutic Chemical (ATC) Classification System3 defined by the
World Health Organization (WHO) or the AHFS Pharmacologic-Therapeutic Clas-
sification4 used in hospitals in the United States. Each classification system has its
advantages and limitations and its usefulness depends on the purpose, the setting
used and the user’s knowledge of the methodology. Among the various systems pro-
posed over the years, only the ATC system [WHO, 2003] has survived to attain a
dominant position in drug utilization research worldwide. ATC divides drugs into
different groups according to the organ or system on which they act and/or their
therapeutic and chemical characteristics. However, ATC does not provide compre-
hensive coverage of all generic drugs and the brand drugs are not classified in it.
On the other hand, electronic biomedical resources such as UMLS yield semantic
categorizations too broad to classify concepts of specific domains such as the phar-
macological ones.
The pharmacological and/or chemical group to which a drug belongs can be
an essential clue to automatically detect information regarding its interactions or
adverse effects. In the vast majority of cases, drugs that belong to the same family
usually share the basic chemical structure and action mechanism [Russell, 2007],
although there are exceptions. Thus, if the interaction of a particular drug is known,
it is quite likely that another drug with similar chemical structure and the same
pathway of metabolism will show the same interaction [Bottorff, 2006]. Therefore,
providing a comprehensive and suitable drug classification framework can be crucial
to successful extraction of DDIs.
Example 6 Sentence containing an anaphoric expression (this) that refers to the
drug name levofloxacin
Levofloxacin, a fluoroquinolone, is one of the most commonly prescribed antibiotics
in clinical practice. Several case reports have indicated that this drug may signifi-
cantly potentiate the anticoagulation effect of warfarin.
3http://www.who.int/classifications/atcddd/en/
4http://www.ahfsdruginformation.com/class/index.aspx
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4.3. DrugNer: drug name recognition and classi-
fication
This section describes the technique followed for drug name recognition and
classification, called DrugNer. Based on the approach [Aronson, 2001a], we decided
to study the performance of the MMTx program to identify drug names in texts.
We needed an additional tool or method to classify the drugs into drug families,
because MMTx (more specifically the UMLS semantic network) provides a too broad
classification, only distinguishing between antibiotics and the rest of pharmacological
substances.
Basically, DrugNer combines the information obtained by the MMTx program
and nomenclature rules recommended by the WHO International Nonproprietary
Names (WHOINN) Program [Drugs and Policy, 2006] to identify and classify drug
names. As it is was explained in the previous chapter, MMTx allows to analyze
the text syntactically splitting it into components including sentences, paragraphs,
phrases, lexical elements and tokens. Moreover, MMTx tries to link the text of each
phrase with some concept from the UMLS Metathesaurus. Concepts are classified
with at least one of the semantic types from the UMLS semantic network. The
definition of these semantic types as well as a more detailed description of the
analysis provided by MMTx can be found in chapter 3. This way, MMTx allows
to identify drugs and other biomedical concepts. In the experiments presented in
this chapter, DrugNer only considers the semantic types pharmacological substance
(phsu) and antibiotic (antb) to identify the terms that refer drugs. Once texts have
been processed by MMTx and terms occurring in the text annotated and related
to concepts of the UMLS Metathesaurus, a rule-based module classifies the drug
names occurring in texts in pharmacological or chemical families.
The rules are based on the common affixes (also called as stems) selected and
defined by the WHOINN program. These common affixes, currently in use, represent
classes of substances that are pharmacologically or chemically related to. By using
common affixes the medical practitioner, the pharmacist, or anyone dealing with
pharmaceutical products can recognize that the substance belongs to a group of
substances having similar pharmacological activity or chemical structure. Table 4.3
shows some of the affixes used in the classification of drug names. The full list can
be obtained from the document [Drugs and Policy, 2006] which contains the affix
classification system used by the INN Program to categorize the main activity of
pharmaceutical substances.
The affix classification system consists of two different types of categorizations:
pharmacological or chemical. Thus, it is less consistent than the Anatomical Ther-
apeutic Chemical (ATC)5 classification system in which the drugs are divided into
5http://www.whocc.no/atcddd/
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Figure 4.2: DrugNer architecture
different groups according to the organ or system on which they act and their chem-
ical, pharmacological and therapeutic properties. Despite the inconsistencies of the
WHOINN classification, we have decided to use it because it provides the affixes
as well pharmacological and chemical information that could also be very useful in
predicting DDIs occurring in texts. The term drug family is frequently used and can
be interpreted as pharmacological group, though it is also often used to designate
chemical group. We have decided to use the term family instead of group, since
this term is broader and more general and because it allows us to include both the
pharmacological and chemical groups.
The affixes together with their corresponding pharmacological or chemical groups
are compiled in a list. This list is scanned in order to build the suitable regular
expression for each affix. For example, for the affix -flurane, the regular expression
should be [A-Za-z0-9]*flurane, so any alphanumeric string that ends with the suffix
-flurane is recognized by this regular expression. Similarly, for the affix -adol-, the
regular expression should be [A-Za-z0-9]*adol[A-Za-z0-9]*.
Once the regular expressions have been built, the text of each phrase is matched
against the regular expressions in order to detect the possible affixes that can classify
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Affixes Regular Expression
-flurane [A-Za-z0-9]*flurane
-bersat, -toin [A-Za-z0-9]*[bersat|toin]
-giline, -moxin [A-Za-z0-9]*[giline|moxin]
Table 4.2: Examples of regular expressions for drug name recognition.
the phrase. In the case in which several regular expressions can be matched with
the input text, the longest affix is selected (see table 4.3). When a correct affix is
found, appropriate information about the pharmacological or chemical family and
the definition associated with the affix is added to the phrase. In addition, its
corresponding information from UMLS Metathesaurus (CUI, definition, semantic
types) is also extracted. This process could be configured to keep all the candidate
affixes, and the selection of the most suitable affix could be made by the end user
of the DrugNer Viewer tool (see section 4.5).
Although MMTx data is updated each year, the latest available release of MMTx
(2.4.C) is on the basis of the 2006AA UMLS knowledge sources (March 2006). Thus,
MMTx cannot detect those new concepts that have been included in UMLS after
that date. Therefore, our main hypothesis is that the affixes recommended by the
WHOINN not only allow the classification of the drugs, but also could help to find
possible new drug candidates that have not been detected by MMTx. Thus, the
affixes were applied on two different set of phrases. The first set is made up of
phrases for which MMTx did not found any candidate concept in UMLS. These
phrases may be possible new candidates for drug names, that are not included in
UMLS Metathesaurus. The second set consists of phrases that have been classified
by MMTx as pharmacological substances (phsu) or antibiotics (antb).
4.4. Evaluation
In this work, the Medline bibliographic database6 is used as the main data source
because of its wide coverage of biomedical sciences and its public availability. A
corpus of 849 abstracts is compiled from PubMed using the phrase drug-drug inter-
action.
MMTx detects a total of 106,576 phrases. 7.5% of them (8,093 phrases) are
categorized as pharmacological substances (7,691) or as antibiotics (402) in UMLS.
Of those phrases, 49.8% (53,037) belong to other semantic types such as organic
chemical, lipid, carbohydrate, among others, which are out of the scope of the present
study. For the rest of the phrases, (45,449), MMTx did not find any concept in
6http://www.ncbi.nlm.nih.gov/pubmed/
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Affixes Family
-flurane General anaesthetics, volatile
-bersat, -toin Anticonvulsants
-adol-, -azocine, -eridine, -ethidine, -fentanil,
nal-
Narcotic analgesics
-ac, -adol-, -arit, -bufen, -butazone, -coxib, -
icam, -fenamate, -nixin, -profen, -metacin, -
adom, -fenine
Analgesics-antipyretics
-fylline, -racetam, -vin- Analeptics
-azenil, -azepam, -bamate, -carnil, -peridone, -
perone, -pidem, -plon, -pride, -quinil, -spirone,
-zafone
Anxiolytic sedatives
-perone Antipsychotics (neuroleptics)
-oxetine Antidepressants
-giline, -moxin MAO inhbitors
-pin(e), -pramine, -triptyline Tricyclic antidepressants
-anserin, -setron Serotonin receptor antagonists
-caine Local anaesthetics
-curium, -ium Neuromuscular blocking agents
-azoline, -drine, -frine, -terol Adrenergic agents
-serpine Adrenergic neurone blocking agents
-verine Spasmolytics, general
-afil, -dil, -entan Vasodilators
-dipine, -fradil, -pamil, -tiazem Coronary vasodilators, also calcium
channel blockers
-nicate Peripheral vasodilators
-astine Antihistaminics
-tadine, -tidine Histamine H1, H2 receptor antago-
nists
-bradine, -denoson, -vaptan Cardiovascular agents
-dan, -rinone, -afenone Cardiac glycosides and drugs with
similar action
-afenone, -aj-, -cain-, -ilide, -isomide, -kalant Agents influencing heart muscle ex-
citability and conductivity
-azosin, -dralazine, guan-, -kalim, -kiren, -
(o)nidine, pril(at), -sartan
Antihypertensives
-fibrate, -nicate, -vastatin Antihyperlipidaemic drugs
-cog, -cogin, -fiban, -gatran, -parin Agents influencing blood coagula-
tion
-arol, -grel-, -irudin, -pafant, -troban Anticoagulants
Table 4.3: Some affixes recommended by WHOINN.
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Drug Suitable affixes Most suitable
affix
Azelnidipine -dipine, -pine, -ine, -ni- -dipine
Lopinavir -navir, -vir- -navir
Amiodarone -arone, -one, -io- -arone
Minocycline -cycline, -ine -cycline
Sulfinpyrazone -azone, -zone, -one -azone
Aripiprazole -piprazole, -prazole -piprazole
Furafylline -fylline, -ine -fylline
Gemcitabine -citabine, -abine, -ine -citabine
Mometasone -metasone, -one -metasone
Simvastatin -vastatin, -stat- -vastatin
Table 4.4: Examples of matching phrases and affixes.
UMLS that covered them. Table 4.4 shows the main characteristics of the compiled
corpus7 for the evaluation of DrugNer.
Characteristics Number
Abstracts 849
Sentences 10,146
Phrases 106,579
Phrases not classified by MMTx 45,449
Phrases classified as phsu or as antb in UMLS 8,093
Phrases classified with other semantic types in UMLS 53,037
Table 4.5: Characteristics of DrugNer corpus.
In order to identify new candidates of generic drugs not detected by MMTx, the
affix-based module is applied to the phrases that have not been detected by MMTx
(45,449), identifying 255 initial candidates. A pharmacist manually evaluated this
set, ruling out 74 phrases (false positives introduced by the affixes) and declaring
the rest, 181, as generic drugs. Some of the identified drugs are presented in table
4.4.
To calculate the total coverage of our system it is necessary to take into account
those drugs that have not been detected either by MMTx or by affixes (false nega-
tives). Due to the excessive number of phrases (45,194) to evaluate, a set of lexical
patterns was used to filter terms such as numeric expressions, verbs, adverbs and
common nouns of biomedical domain, reducing the set to 5,964 phrases. Finally, a
7The corpus is publicly available: http://basesdatos.uc3m.es/index.php?id=359
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Name Affix Family Num
Ciclofenac -ac Antiinflammatory 5
Efepristin -pristin Antibacterial 7
Armodafinil -nil Anxiolytic sedatives 10
Dabigatran -gatran Antithrombotic agents 3
Aplaviroc -vir- Antivirals 1
Maraviroc -vir- Antivirals 5
Vicriviroc -vir- Antivirals 3
Darunavir -navir Antivirals 39
Dasatinib -tinib Antineoplastic agents 7
Sunitinib -tinib Antineoplastic agents 28
Nilotinib -tinib Antineoplastic agents 2
Vorinostat -inostat Histone deacetylase inhibitors 7
Sitagliptin -gli- Oral antidiabetics 7
Tanespimycin -mycin Antibiotics 5
Table 4.6: Examples of drugs detected only by the affix-based classification.
Name Drug Family
Posaconazale Triazole drug
Rapamcyin Immune suppression drug
Gadobenate dimeglumine Contrast agent for magnetic resonance
Riluzole Nervous system drugs
2-Methoxyoestradiol Angiogenesis inhibitors
Table 4.7: Examples of drugs detected neither by MMTx nor by affix-based classi-
fication.
manual evaluation shows that only 20 of them are drugs. Table 4.4 shows some of
them.
Precision and recall are standard measures for evaluating the performance of
Information Retrieval and Extraction Systems. In our case, recall can be described as
the ratio between a number of correctly recognized drugs and all the drugs occurring
in the corpus. Precision is the ratio between the number of correctly recognized drugs
and all the drugs recognized by DrugNer (see table 4.4). Table 4.4 shows the overall
performance obtained using only MMTx and combining MMTx and the affix-based
classification.
An important contribution of this work is the classification achieved by the af-
fixes recommended by the WHOINN Program that MMTx is not able to provide.
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Drugs detected by MMTx 8,093 (97.6%)
Drugs only detected by affixes 181 (2.2%)
Drugs detected neither by MMTx nor by stems 20 (0.2%)
Total: 8,294
Table 4.8: Drugs in the corpus.
Recall(%) Precision(%) F-measure(%)
MMTx 97.5 100 98.73
MMTx + affixes 99.8 99.1 99.45%
Table 4.9: Overall performance of the DrugNer module.
Our hypothesis is on the basis of the idea that the affix-based classification could
allow detection of the pharmacological or chemical family of the drugs classified as
pharmacological or as antibiotics by MMTx, achieving, in this way, a more infor-
mative and suitable categorization of them. Initially, the affixes are able to classify
48.5% (3,926) of the phrases that are detected and categorized as drugs by MMTx
(8,093). In order to assess the precision of the affix-based classification, the pharma-
cist manually evaluates the phrases. The ATC classification system and other drug
information resources are used to assist in this evaluation. In this case, precision
is defined as the ratio between the number of correctly classified drugs and all the
classified drugs by the affix-based module. The evaluation shows that 2,941 have
been correctly classified by the affixes as opposed to 355 that have been wrongly
classified. In other words, the affix-based classification obtains an precision rate
of 74.9%. Short stems such as -pin (tricyclic antidepressants), -ol (alcohols and
phenols), -ox (oral antiacids), -ni- (nicotinic acid or nicotinoyl alcohol derivatives)
are responsible for the incorrect classifications. Thus, research in additional clues is
necessary to detect these drug families.
4.5. DrugNer Viewer tool
A prototype, called DrugNer Viewer, has been developed; it is a visual tool
that highlights the pharmacological substances in texts. DrugNer Viewer allows
exploration of folders and selection of text files. Once the end user has selected a
file, DrugNer processes it to detect and classify the drugs. Finally, DrugNer Viewer
shows the content of file and highlights the drugs occurring in the text (figure 4.3).
In addition, the user can select any of the highlighted drugs, and then, DrugNer
Viewer shows information concerning the selected drug (definition, affixes used in
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its classification and other information from UMLS). DrugNer Viewer can become
a valuable tool for healthcare professionals and scientists, allowing them easy and
rapid access to relevant information about drugs.
Figure 4.3: DrugNer Viewer tool
4.6. Conclusions
Detecting and classifying drug names occurring in biomedical text is a valuable
task in drug discovery knowledge. It is a challenging task due to the difficulties
implied in biomedical text processing such as such as ambiguous names, synonyms,
variations and newly published names. In this chapter, we have presented a hybrid
aproach that combines the use of the MMTx tool and a set of nomenclature rules to
identify and classify drug names. MMTx is an effective program for the automatic
processing of the biomedical texts and has been used extensively for text mining
applications in the biomedical domain [Aronson, 2001a, Li and Wu, 2006, Reeve
et al., 2007]. However, MMTx is not able to provide complete and useful infor-
mation about pharmacological substances. The use of affixes recommended by the
WHOINN Program helps to detect drugs and establish suitable information about
the drugs such as the pharmacological or chemical family. Although evaluation re-
veals that using affixes in isolation is not feasible enough in detecting drugs they help
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to improve the coverage. The affix-based module identifies 255 initial candidates of
whom 74 are not pharmacological substances. Most of these wrong identifications
are given by the short stems that are too ambiguous to correctly detect drugs. In our
experiment, we assumed that the drug name recognition provided by MMTx was
correct, because our main objective was not to evaluate the performance of MMTx,
but to study if the affixes could help to identify new drugs not detected by MMTx.
In future work, we are planning to provide a more realistic evaluation taking into
account the mistakes made by MMTx. It is probable that the performance will be
affected by these mistakes.
As outlined previously, the affixes are able to correctly classify 74.9% of drugs
occurring in the texts. The list of used affixes is not exhaustive and does not cover
all pharmacological or chemical families. Each year, the WHOINN together with
other nomenclature groups8 establish new affixes and rules, in order to govern the
classification of new substances and to standardize pharmaceutical nomenclature.
Unfortunately, these nomenclature rules have not always been observed when nam-
ing a new drug. On the other hand, linking the affixes with the groups of the ATC
classification system is an important challenge to be met in future work, because
the ATC provides a global standard for classifying medical substances and serves as
a tool for drug research. In addition, this classification system is also used for re-
porting ADRs. Recently, Gurulingappa et al. [2009] have developed a system which
predicts the ATC class for unclassified drugs by the use of IE and machine learning
techniques.
Acronyms, frequently used in biomedical texts to rename drugs and other con-
cepts, have not been addressed in this thesis. The high ambiguity of these terms
and the lack of acronym dictionaries make their automatic resolution a difficult task.
Nevertheless, it is essential in order to achieve a complete coverage in the drug name
recognition process.
Building a manually annotated corpus is a time-consuming, labor-intensive and
expensive task. Machine learning methods are not often applied in the biomedical
domain because of the shortage of training data. In addition, the major drawback
of the biomedical corpora for BNER is that the most of them are limited to protein
and gene names. For this reason, the DrugNer corpus could encourage research on
automatic extraction information of DDIs, ADRs and other drug information.
Resolving drug acronyms, extending the set of affixes, including additional clues
for those affixes that are too short and ambiguous are some challenges for our future
research to improve the coverage and the accuracy of drug name recognition and
classification tasks. In addition, the affixes could be helpful in the classification
of other types of concepts such as organic chemical, enzymes, vitamins and others.
Regarding the improvement of the DrugNerTool viewer, we are planning to extend it
8http://www.ama-assn.org/ama/pub/category/4769.html
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to allow the end-users themselves to annotate drug names as well as other biomedical
concepts, and to correct or update the information provided by DrugNer. We are also
planning to link each recognized drug to documents that show additional information
such as database identifiers, synonyms, brand names, pharmacological information
(drug adverse events, indications, mechanism of action, drug targets, etc), chemical
information (structure and formula), and related literature.
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Chapter 5
Anaphora Resolution for
Drug-Drug Interaction Documents
5.1. Introduction
Information Extraction (IE) techniques can be a useful instrument to manage
the knowledge on DDIs. Nevertheless, IE at the sentence level has a limited ef-
fect because there are frequent references to previous entities in the discourse, a
phenomenon known as anaphora.
The extraction of DDIs is a difficult task whose complexity increases when one
or both drugs involved in an interaction are expressed with an anaphoric expression,
as shown in the following text excerpts taken from the DrugBank database.
Example 7 DDIs expressed by anaphoric expressions
Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepres-
sants, thereby delaying elimination and increasing steady-state concentrations of
these drugs.
Triamterene, metformin and amiloride should be co-administered with care as they
might increase dofetilide levels.
All of these examples share a requirement: the need to identify and resolve the
anaphoric expressions for detecting the DDIs. The problem of resolving pronominal
and nominal anaphora to improve a system that detects DDIs is addressed in this
chapter.
Figure 5.2 shows the pipeline architecture of the DDI extraction framework. The
text analysis and drug name recognition modules have been described in the chapters
3 and 4 respectively. Briefly, texts are processed by the MMTx program. This tool
performs sentence splitting, tokenization, POS-tagging, chunking, and linking of
phrases with UMLS concepts. Then, drugs found in such documents are classified
into drug families by the DrugNer component. Over this basis, anaphora resolution
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Figure 5.1: Anaphora resolution can help to improve the performance of the DDI
extraction from texts.
is carried out to account for both nominal phrases referring to drugs and pronouns.
Finally, the output of the previous modules is sent to the relation extraction module
that exploits this information in order to account for DDIs in biomedical documents.
Figure 5.2: DDI Extraction framework
In Natural Language Processing (NLP) research, two major approaches have
been applied to anaphora resolution, heuristics-based and machine learning-based
approaches. The former requires to define and apply the different heuristics, con-
straints or linguistic rules in a predefined order. Contrasting to this approach,
machine learning methods do not require the arduous labor of defining rules manu-
ally, however, their major drawback is that they usually require a large amount of
training data to be effective.
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We have defined two different approaches to address the problem of co-referring
expressions in pharmacological literature. Besides, as this is the first work that
addresses this issue, a corpus has been created in order to analyze the phenomena
and evaluate both approaches.
Our first approach is based on a scoring method similar to other works in the
biomedical domain [Castano et al., 2002, Lin et al., 2004, Kim and Park, 2004a]. It
uses a combination of the domain-specific syntax and semantic information provided
by MMTx with generic heuristics. Evaluation shows that this approach achieves
results similar to other approaches for anaphora resolution in the biomedical domain.
Our second approach uses a set of linguistic rules inspired by the Centering
Theory [Grosz et al., 1995] and constraint satisfaction process over the analysis
provided by MMTx. Semantic information from UMLS is also integrated in order
to improve the recognition and the resolution of drug nominal anaphora. Evaluation
shows how this approach outperforms our first approach and offers an interesting
possibility to be developed for other sub-domains in biomedicine. This linguistic
rule-based approach shows very promising results for the challenge of accounting for
anaphoric expressions in pharmacological texts.
The chapter is organized as follows: Section 5.2 reviews the main approaches
addressed for biomedical anaphora resolution. The corpus building for developing
and evaluating both approaches is presented in the section 5.3. The detection of
anaphoric expressions detection is described in section 5.4. Sections 5.5 and 5.6
describe the scoring-based and centering-based approaches to resolve the antecedent
candidates, respectively. Besides, a baseline system has been developed for drug
anaphora resolution that is shown in section 5.7. Experimental results of both
approaches are shown and compared in section 5.8. Finally, section 5.9 offers some
conclusions and some unresolved issues.
5.2. Related Work in biomedical anaphora reso-
lution
Anaphora resolution is often required to improve the results of relation extraction
task. It is useful to identify the correct arguments of relations in large sentences
with complex structure like subordinate clauses. Besides, it also helps to extract
information beyond the sentence level. It can be found two major approaches in the
literature:
1. Heuristic approaches that integrates different knowledge sources like gender
and number agreement, syntactic patterns or semantic information to obtain
a plausible list of candidates [Poesio et al., 2002, Refoufi, 2006, Wu and Liang,
2009]. The major drawback of these approaches is that it is a very labor-
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intensive and time-consuming task to construct the domain knowledge base
necessary for resolving the anaphora.
2. Machine learning approaches compute the most likely candidate based on pre-
vious examples. These approaches can sort out the referred problem in heuris-
tic approaches, however it usually comes across data sparseness problem of
language modeling, so they require a large amount of data to train the algo-
rithm [Bunescu, 2003, Ng, 2005].
In the biomedical domain, the lack of available corpora motivated that early
approaches were mostly based on heuristics. In this sense, Castano et al. [2002]
present a method for resolving anaphoric expressions for candidates taken from
MedLine articles and abstracts. By defining a different range of resolution scope
for each type of anaphoric expression, it uses different morphological, syntactic and
semantic features such as number or semantic type agreement (UMLS typing-based
system), longest common subsequence for similarity among candidate antecedents
and coercion-type matching (most suitable agent / patient linguistic role according
to the verb) from the most frequent bio-relevant verbs in Medline. Each possible
antecedent of a certain anaphora was given a different cumulative score according to
the significance of its linguistic features and the one with the best salience measure
was chosen. General results are 73.8% f-measure over a corpus of 46 MedLine
abstracts which were annotated by a domain expert.
Lin et al. [2004] also applied this scoring technique but they restrict the types of
nominal anaphoric expressions to be taken into account, enrich the syntactic features
with new values and apply coercion-type matching as before, using Genia corpus.
General results are 92% f-measure in pronominal anaphora and 78% in nominal
anaphora in 32 Medline abstracts (MedStract corpus) [Pustejovsky et al., 2002a].
This approach is improved in [Liang and Lin, 2005] by using new resources like
WordNet or PubMed for finding semantic relationships among concepts not found
in UMLS. They extend the MedStract corpus with 100 Medline abstracts obtaining
87.43% f-measure for pronominal anaphora and 80.61% for nominal anaphora.
Anaphora resolution applied to the field of PPIs can be found in [Kim and Park,
2004a], which presents an anaphora resolution system integrated in a larger PPIs
extraction study, so-called BioAR. It identifies antecedents of pronouns by applying
patterns for parallelism and centering theory [Grosz et al., 1995]. Nominal phrase
anaphors are identified according to the most salient score, using similar features as
in [Castano et al., 2002]. Experimental results are 75% precision and 56.3% recall in
pronoun resolution and 75% precision and 52.2% in definite noun phrase resolution
from 120 unseen biological interactions extracted by BioIE system[Kim and Park,
2004b].
Likewise, in [Sa´nchez et al., 2006] the impact of anaphora resolution on the result
of a protein interaction extraction system is analyzed by using the Guitar system
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[Poesio and Kabadjov, 2004] over the 20 full texts and abstracts of the Medstract
corpus and three articles taken from the Journal of Biological Chemistry. From the
402 PPIs in the corpus, only 20 were conveyed by an anaphoric expression. Results
show 70% recall in anaphora resolution in abstracts and 52.65% in full texts. No
data about precision are available. Results suggest small improvements in protein
extraction.
Regarding machine learning approaches to anaphora resolution in biomedical
documents, Nguyen and Kim [Nguyen and Kim, 2008] carried out a comparative
study with three different corpora: MUC [Hirschman and Chinchor, 1997] and ACE
[Doddington et al., 2004], accounting for the news domain, and Genia for bio-medical
documents. They built a machine learning-based pronoun resolver using a Maxi-
mum Entropy ranker model that selects the most likely antecedent candidate from
a set of candidates by using a huge set of linguistic features divided into baseline
attributes like pronoun type, number, gender, string, distance, etc, (mostly used in
other approaches) and innovative features like grammatical roles, semantically most
appropriate candidate or context information about the anaphoric pronoun. From
the latter group, those that improved baseline for each of the corpus were selected
obtaining 79.55% (Genia), 64.61%(ACE), 60.42%(MUC) in success rate, which can
be defined as the ratio between the number of successfully resolved anaphors and
the number of all anaphors.
Anaphoric expressions are resolved in [Gasperin and Building, 2006] presenting a
semi-supervised approach that makes use of rich domain resources such as the Fly-
Base[Drysdale et al., 2005] database for the training of a gene-name recognizer and
the Sequence Ontology[Eilbeck et al., 2005] for semantic tagging. Nominal phrases
are identified by the use of the domain-independent parser RASP [Briscoe and Car-
roll, 2002]. The system looks for the closest antecedent matching the anaphoric
expression according to a set of linguistic features. It evaluated against two hand-
annotated full papers containing 302 sentences and 314 anaphoric expressions and it.
System reaches 58.8% precision and 57.3% recall. A summary of main approaches
of biomedical anaphora resolution can be found in table 5.1.
To the best of our knowledge, there are no published works tackling the drug
anaphora resolution for the case of pharmacological documents. In this chapter,
we describe two different approaches for anaphora resolution that work on phar-
macological texts following an heuristic approach for anaphora resolution partially
motivated by the lack of a large annotated corpus in this domain. The first approach
is based on a scoring method similar to other works in the biomedical domain [Cas-
tano et al., 2002, Lin et al., 2004, Kim and Park, 2004a]. The second approach
uses a set of linguistic rules inspired by Centering Theory Grosz et al. [1995] and
constraint satisfaction. Both approaches use a combination of the domain-specific
syntax and semantic information provided by MMTx.
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Approach Description Corpus Results
[Castano et al., 2002] Scoring method 46 abstracts F=0.74
MedStract [Lin et al.,
2004]
Scoring method 32 abstracts F=0.92 pronomi-
nal, F=0.78 nom-
inal
[Kim and Park, 2004a] Centering theory for
pronominal anaphora
and scoring method for
nominal anaphora
120 biologi-
cal interac-
tions
F=0.64 pronomi-
nal, F=0.59 nom-
inal
[Liang and Lin, 2005] Scoring method MedStract
+ 100
abstracts
F=0.87 pronomi-
nal, F=0.80 nom-
inal
[Nguyen and Kim, 2008] Maximum Entropy
ranker model
Genia Success rate:
79.55%
Table 5.1: Summary of the main approaches of biomedical anaphora resolution
5.3. Building a corpus to support the anaphora
reference resolution for Drug-Drug Interac-
tions
There is no existing corpus devoted to anaphoric expressions resolution in phar-
macological texts, so a corpus has been built for research and evaluation.
A set of 49 documents from the DrugDDI corpus has randomly been selected
annotated manually by a linguist with the assistance of a pharmaceutical expert.
The annotation has been made on the output of text analysis and DrugNer modules
in XML format.
Each of the documents has on average 40 sentences and 716 words. Table 5.2
shows statistics about the corpus created for evaluation purposes. The third column
represents the number of phrases assigned to some of the UMLS semantic types that
can represent pharmacological substances. These UMLS semantic types referring to
drugs were selected by a pharmacist and are: Clinical Drug (clnd), Pharmacological
Substance (phsu), Antibiotic (antb), Biologically Active Substance (bacs), Chemical
Viewed Structurally (chvs) and Amino Acid, Peptide, or Protein (aapp). A more
detailed description of these semantic types can be found in section 3.2.3.
Anaphora is a linguistic procedure to refer to entities that usually come up in
the recent discourse (antecedents). Its resolution is essential to understanding the
meaning of a certain expression. There are two kinds of anaphora that are prevalent
in biomedical literature:
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Type of Phrase Phrases Drugs
Noun (NP) 4,935 406
Prepositional (PP) 2,157 119
Verbal (VP) 4,347 3
Adjectival (ADJ) 89 1
Adverbial (ADV) 605 0
Conjunctions (CONJ) 1,544 0
Unknown (UNK) 2,535 14
Total : 18,035 689
Total Sentences: 1,975
Table 5.2: Some characteristics of the corpus for anaphora resolution
1. Pronominal anaphora. In this case, an entity is referred to by a pronoun.
The set of more prevalent pronouns was identified in the DDIs corpus: personal
(it, they, reflexive itself, themselves), relative (which, that), distributive (each,
either, neither) and indefinite (all, some, many, one). As this approach fo-
cuses on drug interactions those pronouns that could not refer to drug entities
such as I, me, you, your, who, etc., were ruled out.
2. Nominal (phrase) anaphora. This is the case of an entity being referred to
by a nominal phrase. This approach focuses on the domain-relevant nominal
phrases, that is, those that refer to drugs or drug properties in pharmacological
documents. These phrases consist of the definite article (the), possessives
(its, their), demonstratives (this, these, those), distributives (both, such, each,
either, neither) or indefinites (other, another, all), followed by a generic term
for drugs (such as antibiotic, medicine, medication, etc) or a drug property
or effect. Some examples of drug nominal anaphora are: the drugs, these
anticoagulants, its pharmacological effects, their anticoagulant properties.
A linguist annotated all anaphors in the corpus and their corresponding an-
tecedents in the XML format, so such linguistic relations could be retrieved au-
tomatically. The corpus contains a total of 331 anaphoric expressions. Table 5.3
and Table 5.4 show the distribution of the pronominal and nominal anaphors in the
corpus.
Figure 5.3 shows an example of a sentence processed by MMTx and DrugNer and
annotated with anaphoric expressions. For each phrase, it is offered its type as well as
the CUI, the name and the semantic types of the UMLS concepts provided by MMTx
(just in case, the text of the phrase is founded in the UMLS Metathesaurus). Let us
take as example the prepositional phrase with aprazolam (s28.p369 ) which has been
mapped to the UMLS concept Alprazolam (CUI=C0002333 ) whose semantic types
are Organic Chemical (orch) and Pharmacological Substances (phsu). Moreover,
71
Figure 5.3: Example of sentence processed by MMTx and DrugNer and annotated
with resolved anaphoric expressions
DrugNer classified it into the drug family Benzodiazepine derivative, by the affix
-azolam. The example also contains a pronominal anaphoric expression (phrase ’it’
(s28.p78 )) whose antecedent is annotated by the attribute ID ANTENCENT. In
this case, the antecedent is the phrase of fluvoxamine s28.p71.
Pronominal Anaphora Num
Personal (it, they) 23
Reflexives (itself, themselves) 1
Relatives (which, that) 113
Distributive (both each, either, neither 8
Demonstrative (these, this, those, that) 12
Indefinite (all, some, many, one) 8
Total Phrases: 165
Table 5.3: Distribution of pronominal anaphora in the corpus.
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Nominal Anaphora Num
Definite (the) 37
Possessive (its, theirs) 52
Distributive (both, each, either, neither) 11
Demonstrative (these, this, those, that) 58
Indefinite (other, another, all) 8
Total Phrases: 166
Table 5.4: Distribution of nominal anaphors in the corpus.
5.4. Identification of anaphoric expressions
The anaphora resolution issue can be split into two main steps: identification
of anaphoric expressions and selection of antecedents. This section addresses the
former step that is shared by both of our approaches.
The identification of anaphoric expressions is carried out through several steps
of selective filtering. A first filter restricts the type of the phrase by selecting those
with type NP, PP or UNK (unknown phrase) as possible candidates. Moreover, a
detailed observation of the corpus revealed that MMTx misidentified phrases with
both, either, neither, or each, annotated as CONJ instead of NP. Thus, these kinds
of phrases are also selected as anaphoric candidates.
5.4.1. Identifying pronominal anaphora
Regarding pronominal anaphora, the module selects those phrases referred to in
table 5.3. Singular and plural pronouns in first and second grammatical person are
filtered out because they usually refer to other entities (usually patients or health
care professionals) rather than drugs. Moreover, the pleonastic-it expressions are
excluded by using the rules proposed in Lin et al. [2004]. A pleonastic pronoun
refers to an occurrence of a pronoun that can be used without referring to any
specific entity. These rules are extended to recognize the negation and modal verbs
as possible arguments in this kind of expressions (see table 5.5).
5.4.2. Identifying drug nominal anaphora
In the case of nominal phrase anaphora, the module selects those phrases with
determiners or articles in table 5.4. However, it must be borne in mind that anaphora
is a linguistic device for referring to previous entities in the discourse and this refer-
ence is carried out generically. Drug nominal anaphora are the anaphors that refer
to drugs. This is the reason why a semantic restriction based on the semantic type
of phrases is used to rule out those phrases that are not classified with some of the
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Rules Examples
IT [MODALVERB [NOT]?]? BE [NOT]?
[AJD|ADV|VP]* [THAT|WHETHER]
It is not known whether other pro-
gestational contraceptives are ade-
quate methods of contraception dur-
ing acitretin therapy.
IT [MODALVERB [NOT]?]? BE [NOT]? ADJ
[FOR NP] TO VP
If it is not possible to discontinue
the diuretic, the starting dose of
trandolapril should be reduced.
IT [MODALVERB [NOT]]?
[SEEM|APPEAR|MEAN|FOLLOW] [THAT]*
It does not appear that the SSRIs
reduce the effectiveness of a mood
stabilizer in these populations
Table 5.5: Rules to recognize pleonastic-it expressions.
UMLS semantic types that represent drugs, since we only tackle the resolution of
drug nominal anaphora.
Thus, candidates are selected if they are attached to a drug family (these anal-
gesics, the oral anticoagulant, etc) or to a generic term for drugs (such as this
medicine, the medication or both drugs). Candidates consisting of specific terms for
drugs like the serum digoxin concentration, the warfarin drug, etc., are disregarded.
To achieve this restriction, the approach uses the concept-unique identifier (CUI )
provided by MMTx to distinguish between phrases linked to abstract or concrete
drugs. Therefore, only phrases attached to the concept pharmacological substance
(CUI=C1254351 ), their direct hyponyms and their hyponym descendants will be
selected. Besides, those hyponyms included in the Medical Entities Dictionary rep-
resenting specific terms for drugs were ruled out.
Candidate anaphors consisting of a possessive article have a different semantic
restriction. These phrases are usually linked to a combination of several UMLS
concepts, calledMultiMap, one of them representing an abstract drug or drug family
and the other representing a property, activity, or an effect of the drug classified
with some of the semantic types Qualitative Concept or Activity. For example, the
nominal phrase with its anti-estrogenic activity is linked to the combination of two
UMLS concepts:
Estrogen Antagonists (CUI=C0014930 ), concept classified with the semantic
type pharmacological substance (phsu). Estrogen Antagonists is a drug family.
Activity (CUI=C0441655 ), concept classified with the semantic type Activity
(acty).
A future work is to include additional UMLS semantic types such as Quantitative
Concept, Functional Concept or Temporal Concept, in order to provide greater cov-
erage of the drug properties and qualities.
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Once a nominal candidate has been selected, it is necessary to determine its
grammatical number. Unfortunately, MMTx does not provide this information, so
every phrase’s head noun was matched against a set of lexical patterns (see table
5.6) to decide its number.
Number Lexical pattern
Plural: [A-Z]+(S|IES|OES|XES|SHES|CHES|SES|ZES)
Exception for singular: [A-Z]+(U|S)S
Table 5.6: Lexical patterns for deciding grammatical number.
Finally, for distinguishing nominal phrases and pronouns consisting of units both,
either, neither from correlative expressions, a regular expression (see table 5.7) is
developed.
Rule Example
[BOTH|EITHER|NEITHER][NP|PP|UNK]
[AND|OR|NOR] [NP|PP|UNK]
These pharmacokinetic effects seen
during diltiazem coadministration
can result in increased clinical ef-
fects (e.g., prolonged sod ation)of
both midazolam and triazolam.
Table 5.7: Regular expression for detecting correlative expressions.
5.5. Scoring-based method for resolving antence-
dent candidates
The first approach is based on a scoring method similar to other works in the
biomedical domain [Castano et al., 2002, Lin et al., 2004, Kim and Park, 2004a].
It uses a combination of the domain-specific syntax and semantic information pro-
vided by MMTx with generic heuristics. Once the anaphoric expressions have been
identified, the antecedent candidates must be found in the text.
Corpus observation showed that most antecedents usually occur in the previous
context of their referring expressions, so only phrases in the range of two sentences
are considered. According to this scope, this method selects those phrases whose
syntactic type is NP, PP or UNK and semantically classified with some of the UMLS
semantic types that represent drugs as possible candidates.
This semantic restriction is not applied for pronominal anaphora resolution since
antecedents are not semantically determined by their pronominal anaphoric expres-
sions.
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From the resulting list, number agreement between anaphora and its candidate
antecedent is checked out. The same lexical patterns (table 5.6) as for the analysis
of anaphoric expressions are applied to determine the number of the antecedent.
Besides, a regular expression is applied to detect coordinate structures occurring
inside a sentence, that are taken as possible antecedents in plural grammatical num-
ber. This pattern is helpful to resolve those anaphors matching plural antecedents
if they are expressed by mean of a coordinate structures as shown in table 5.8. In
this case, it is necessary to resolve that the pronoun they refers to all drugs included
in the coordinate structure: fluoxetine, sertraline and paroxetine.
Rule Example
([NP|PP|UNK],)* [NP|PP|UNK]
[AND|OR|NOR] [NP|PP|UNK]
While fluoxetine, sertraline and
paroxetine inhibit P450 2D6, they
may vary in the extent of inhibition.
Table 5.8: Rule to detect coordinate structures.
Once the list of antecedent candidates is determined, the method assigns a
salience measure to each antecedent candidate according to distance. The closer
a certain candidate and anaphora are, the more probable it is that the candidate
will be selected as the antecedent. The formula used is:
distance score(candidatei) = N ∗ [
dmax − di
dmin − di
] (5.1)
where
N is the maximum weight assigned to the distance factor. The experiments
determined that the most appropriate value of the parameter N is 3.
dmax is the distance between the most faraway candidate and anaphora ac-
cording to the number of phrase elements between them,
dmin is the distance between the closest candidate and the anaphora, and
di is the distance between the anaphora and the candidate to be evaluated.
In addition to the distance factor, the longest common subsequence shared be-
tween the anaphora and the antecedent is also considered. The function for weight
assignation according to common morphological subsequence is expressed as follows:
morphological score(candidatei) = N ∗ (1− [
min− LCS(anaphor, candidatei)
min
]) (5.2)
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where
N is the weight assigned to this factor (N=1.5 in experiments),
min is determined by selecting the smaller length between the anaphora and
the candidate and
LCS is the shared length between the anaphora and the candidate.
Finally, the sum of both scores is assigned to the candidate. The candidates
are ordered by score and only those exceeding the threshold (1.5) were selected; if
candidates did not go beyond this value, the anaphora was unresolved.
5.6. Linguistic rules-based method for resolving
antecedent candidates
This section explains the second of the two approaches for drug anaphora reso-
lution proposed in this thesis. This approach uses a set of linguistic rules inspired
by Centering Theory Grosz et al. [1995] and constraint satisfaction over the analysis
provided by MMTx.
In this method, the detection of antecedents issue can be descomposed in two
different phases: determination of anaphor scope and selection of antecedents.
5.6.1. Determination of the anaphora scope
The range of searching for a possible antecedent is not unlimited. As referred,
this approach makes use of the framework called Centering [Grosz et al., 1995] to
account for the way information is linguistically structured and focused . Entities
(centers) referred to in an utterance serve to link that utterance to others in the
segment that contains them. The main claims of this theory applied to anaphora
resolution are the following:
1. The choice of a center (antecedent) for a certain anaphora is from the set of
entities (centers) of the previous utterance (locality).
2. Entities mentioned in an utterance are more central than others according to
the function:
subject > object > other (5.3)
3. Each anaphoric expression in an utterance has exactly one antecedent (center).
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Thus, based on the third claim, the anaphoric expressions are associated to just
one antecedent. This antecedent is taken from the previous ordered sequence of
entities (centers), (first and second claims). Basically the method tries to match
an anaphoric expression against candidates in the same sentence sorted by position
from left to right. The more central an entity is, the higher the possibility it is to
be located on the left side of a sentence, since subjects are usually at the beginning.
In case no antecedent matches, it moves backward up to the previous sentence and
searches for antecedents from left to right again.
However, it was observed that the Centering Theory cannot account for certain
types of anaphoric expressions whose antecedents are in most cases to be found
locally. Relative, reflexive and possessive anaphoric expressions find their antecedent
in the previous context in most of the cases, so it was decided not to apply Centering
Theory on this kind of expressions and link them to the closest nominal phrase that
satisfied their semantic and morphological restrictions.
Figure 5.4: Summary of the Linguistic rules-based approach
5.6.2. Antecedent selection
Finally, for each of the candidates selected in the previous phase, the method
checks one by one whether their linguistic features are consistent with features of
the anaphoric expression, as follows:
1. Nominal phrases and pronouns have to present number agreement with their
antecedents. Nominal phrases in coordinative or appositive relation are taken
as the same center (antecedent) by the pattern defined in 5.8.
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2. Additionally, nominal phrase anaphors following centering restrictions are de-
termined to match nominal phrases representing drugs, in particular those
phrases classified by MMTx according to some of the UMLS semantic types
that represent drugs. Likewise, these phrases must not be composed of ab-
stract drugs (drug families or phrases such as the medicine or this drug), but
a drug specifically.
5.7. A baseline for drug anaphora resolution
As there is no previous work on anaphora resolution in pharmacological texts,
it was decided to develop an ad-hoc baseline strategy for anaphora resolution that
simply selects the closest nominal phrase. Anaphoric expressions considered are
those referred to in tables 5.3 and 5.4 .
For testing the performance of the baseline system, the F-score measure with
β = 1, also called balanced F-score, is used. This is a weighted harmonic mean
of precision and recall. Precision is the ratio between the anaphors successfully
resolved by the approach and the anaphors proposed by the approach. Recall is the
ratio between the anaphors successfully resolved by the approach and the number
of anaphors occurring in the corpus. Results obtained for the baseline system are
shown in the following tables.
Type Total Precision Recall F
Personal 23 0.26 0.26 0.26
Reflexive 1 1 1 1
Relative 120 0.83 0.81 0.82
Distributive 8 0.33 0.12 0.18
Demonstrative 11 0 0 0
Indefinite 8 0.25 0.12 0.16
Global results 164 0.67 0.65 0.66
Table 5.9: Baseline for pronominal anaphora resolution.
5.8. Experiment results of the anaphora resolu-
tion
This section shows and compares the results obtained with the two methods for
drug anaphora resolution. Results of the anaphora resolver are compared to those
provided by the manually annotated corpus.
Regarding the scoring-based method, from the 330 anaphoric expressions ob-
tained for the types analyzed in the corpus, 265 are detected by the method and
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Total Total Precision Recall F
Definite 37 0 0 0
Possessive 52 0.53 0.42 0.47
Distributive 11 0.20 0.27 0.23
Demonstrative 58 0.03 0.01 0.02
Indefinite 8 0 0 0
Global results 166 0.23 0.15 0.18
Table 5.10: Baseline for nominal anaphora resolution.
222 are successfully resolved, that is, attached to the correct antecedent. Results
are the following:
Baseline Scoring
Total Precision Recall F-baseline Precision Recall F-approach Inc
330 0.49 0.40 0.44 0.77 0.62 0.69 0.57
Table 5.11: Global results of the baseline and the scoring-based approach
Baseline Scoring
Type Total P R F P R F Inc
Personal 23 0.26 0.26 0.26 0.52 0.52 0.52 1.00
Reflexive 1 1 1 1 1 1 1 0
Relative 120 0.83 0.81 0.82 1 0.92 0.96 0.17
Distributive 8 0.33 0.12 0.18 0.85 0.75 0.8 3.44
Demonstrative 11 0 0 0 0.33 0.09 0.14 ∞
Indefinite 8 0.25 0.12 0.16 0.8 0.5 0.61 2.81
Global results 164 0.67 0.65 0.66 0.9 0.82 0.85 0.29
Table 5.12: Results of the scoring-based method for pronominal anaphora resolution.
Baseline Scoring
Type Total P R F P R F Inc
Definite 37 0 0 0 0.63 0.37 0.47 ∞
Possessive 52 0.53 0.42 0.47 0.67 0.67 0.67 0.43
Distributive 11 0.20 0.27 0.23 0.60 0.54 0.57 1.48
Demonstrative 58 0.03 0.01 0.02 0.53 0.25 0.34 16
Indefinite 8 0 0 0 0.33 0.12 0.34 ∞
Global results 166 0.23 0.15 0.18 0.61 0.42 0.50 1.78
Table 5.13: Results of the scoring-based method for nominal anaphora resolution.
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The scoring-based approach obtains a 57% relative improvement over the baseline
model in overall results. The difference is even more pronounced for the case of
nominal anaphora resolution with an increase of 178%. The increment is calculated
with the following function:
Inc =
Fapproach − Fbaseline
Fbaseline
(5.4)
Clauses in the corpus are characterized by frequent coordinate and subordinate
structures, along with numerous prepositional phrases which explain the difficulty
of the task and the results of the baseline. From the results it is clear that linguistic
information is needed in order to deal with anaphora in this kind of documents. The
contribution of semantic resources like MMTx becomes evident when comparing the
approach against the baseline.
Pronominal anaphora resolution performs better than its counterpart not only
in precision but also in recall. Likewise, the good performance in the resolution of
relative pronoun antecedents must be emphasized, explained by the fact that these
units are mostly located directly to the left of the anaphoric expressions. In addition,
as pointed out in [Poprat and Hahn, 2007], pronominal anaphora is easier to resolve
than the nominal one because the latter requires an encyclopedic knowledge source.
Regarding the linguistic rules-based approach, from the 331 anaphoric expres-
sions considered, 265 are detected by the method and 232 are successfully attached
to an antecedent. Global results of both baseline and this approach are shown in
table 5.14. Results for the different types of anaphora are shown in tables 5.15 and
5.16.
Baseline Linguistic Rules
Total Precision Recall F-baseline Precision Recall F-approach Inc
331 0.49 0.40 0.44 0.84 0.7 0.76 0.73
Table 5.14: Global results of the baseline and the linguistic rules-based approach
The results obtained by the linguistic rule-based approach achieved an increment
of 73% respect to the baseline and outperforms the scoring-based approach for drug
anaphora resolution. This is explicable since previous approach emphasized the
proximity of the candidate to the anaphoric expression and antecedents can be
found at the beginning of the same or previous sentence as it is pointed out by
[Grosz et al., 1995].
As it occurred with the scoring-based method, pronominal anaphora resolution
performs better than nominal anaphora resolution. The following example shows a
case in which the centering theory, in particular, its third claim, fails in resolving
the drug nominal anaphora these drugs :
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Baseline Linguistic Rules
Type Total P R F P R F Inc
Personal 23 0.26 0.26 0.26 0.91 1 0.95 2.65
Reflexive 1 1 1 1 1 1 1 0
Relative 120 0.83 0.81 0.82 1 0.99 0.99 0.21
Distributive 8 0.33 0.12 0.18 0.85 0.87 0.86 3.78
Demonstrative 11 0 0 0 0.33 0.27 0.29 ∞
Indefinite 8 0.25 0.12 0.16 0.57 0.62 0.59 2.69
Global results 164 0.67 0.65 0.66 0.92 0.904 0.91 0.38
Table 5.15: Results of Centering-based approach for pronominal anaphora.
Baseline Linguistic Rules
Type Total P R F P R F Inc
Definite 37 0 0 0 0.54 0.59 0.56 ∞
Possessive 52 0.53 0.42 0.47 0.76 1 0.86 0.83
Distributive 11 0.20 0.27 0.23 0.77 0.90 0.82 2.57
Demonstrative 58 0.03 0.01 0.02 0.81 0.48 0.60 29
Indefinite 8 0 0 0 0.40 0.37 0.38 ∞
Global results 166 0.23 0.15 0.18 0.71 0.47 0.56 2.11
Table 5.16: Results of Centering-based approach for nominal anaphora.
Based on the third claim of the Centering theory, the anaphora these drugs has
a only antecedent. That is, only the phrases in plural form or coordinate structures
are considered as antecedent candidates. Thus, though flecainide and amioradone
satisfy the semantic restriction (because they are classified as pharmacological sub-
stances), they are not selected as antecedent candidates since they are neither singu-
lar form nor build a coordinate structure. Then, the method looks for the antecedent
from left to right in the previous sentence, and finds the coordinate structure Quini-
dine and procainamide doses that satisfies the number and semantic agreements.
However, the correct antecedents for the anaphora are flecainide and amioradone.
5.9. Conclusions
Compiling a comprehensive database of DDIs is a relation extraction task that
requires the resolution of anaphoric expressions in biomedical and pharmacological
texts. It is believed that anaphora resolution would improve the recall of any ex-
traction method and it would be particularly useful for semiautomated compilation
of DDIs.
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Example 8 Centering theory fails in resolving the anaphora these drugs
Quinidine and procainamide doses should be reduced by one-third when either is
administered with amiodarone. Plasma levels of flecainide have been reported to
increase in the presence of oral amiodarone; because of this, the dosage of flecainide
should be adjusted when these drugs are administered concomitantly.
Figure 5.5: Comparasion between results obtained by the three approaches for
Pronominal Anaphora Resolution.
Figure 5.6: Comparation between results obtained by the three approaches for Nom-
inal Anaphora Resolution.
We have defined two approaches for drug anaphora resolution. The first approach
is based on a scoring system and obtains results that are similar to those of other
systems referred to in the biomedical domain [Castano et al., 2002, Lin et al., 2004,
Kim and Park, 2004a, Liang and Lin, 2005], but it is, to our knowledge, the first
research that tackles this issue for the case of DDI documents. It shares with these
works the use of a set of linguistic features and a semantic resource. However, it
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is believed that features weighted in previous approaches [Castano et al., 2002, Lin
et al., 2004, Liang and Lin, 2005] such as number agreement constraint must always
be satisfied.
The second approach for anaphora resolution uses Centering Theory in order
to select the scope of the anaphoric expressions and assign the correct antecedent.
In contrast, a simpler heuristic that selects the closer nominal phrase has been
experimentally useful in this domain for some types of expressions, relative pronouns
and possessive nominal anaphors.
A key component of both approaches is the use of several domain resources,
including the MMTx biomedical parser and the UMLS meta-thesaurus. Other ap-
proaches that have dealt with biomedical documents have used domain-independent
parsers that do not adequately handle the syntactic complexity of biomedical lan-
guage, including terminology. Unfortunately, MMTx only provides shallow syntactic
information, so it can be expected that full syntactic parsing improves the perfor-
mance of the linguistic rule-based analyzer. UMLS has been useful in order to
identify the anaphoric expressions and implement semantic restrictions to candidate
resolution.
Our results are not directly comparable to other works, but partially:
1. Syntax changes from a domain to another. Most approaches in the biomedical
domain deal with documents from MedLine accounting for any biomedical
topic, whereas our documents focus on DDIs. Subsequently, we consider that
language style of our documents must be linguistically oriented to the reflection
of such relations. Only works [Kim and Park, 2004a] and [Sa´nchez et al., 2006]
deal with documents accounting for PPIs.
2. Works mostly address the anaphora resolution issue by using a set of mor-
phosyntactic properties, so resolution is going to be determined by the way
that a document has been analyzed. For example, expressions like these drugs
or this medication are required to be analyzed by a knowledge resource that
identifies and analyze them both syntactically (they are nominal phrases in
the subject, object or other type of position in the sentence) and semantically
(they stand for drugs). Some approaches make use of open-domain analyzers
like RASP [Gasperin and Building, 2006].
3. Conversely, other approaches make use of the Genia corpus that has been
manually tagged and it does not contain annotation errors (this has a definite
influence over results). The degree of precision in annotation is extremely
important since results depend on such results. Both approaches presented in
this chapter make used of MMTx, that although has shown to be useful for the
analysis of biomedical texts, has several syntactic and semantic parsing failures
[Divita et al., 2004] that influence negatively the results of both approaches.
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To our opinion, from the list of approaches reviewed in this chapter, [Kim and
Park, 2004a] is close to both approaches proposed in this chapter. As discussed,
such an approach addresses the issue of anaphora resolution in the domain of PPIs,
has developed an ad-hoc tool called BioIE to deal with morphosyntactic complexity
of this kind of documents and resolution problems have been faced with an approach
that also used Centering Theory. As table 5.1 shows our work obtains similar results
to [Kim and Park, 2004a] for nominal phrase anaphora resolution and better results
for pronominal anaphora.
Future work will consider the overall contribution of the anaphora resolution
approaches to the broader task of DDI extraction. Sa´nchez et al. [2006] have shown
that the impact of anaphora resolution on the result of a protein interaction extrac-
tion system is very slightly. The DrugDDI corpus is only annotated at sentence level.
Although, a pronominal anaphora usually refers to an expression in its same sen-
tence, in the case of a nominal anaphora, the antecedent usually occurs in previous
sentences. Thus, we believe that the real contribution of the anaphora resolution can
only be measured if the DDIs are annotated at document level. Therefore, we are
planning to annotate the DrugDDI corpus at document level, and then, to evaluate
the contribution of the anaphora resolution task.
Although sources providing information on interactions such as Medline abstracts
and DrugBank may share a common literary style, the distribution of interactions
is very different and it also deserves investigation.
Additional extensions of this work include to extend the coverage of the approach
to other kinds of biomedical entities (such as genes, diseases or drug targets), the
increasing of the size of the corpus in order to make more reliable conclusions, and
the application of machine learning techniques that have been successfully applied
in other domains. Moreover, semantic information about drug families provided
by the DrugNer can be valuable in the resolution of certain nominal anaphors (see
example 9).
Example 9 DrugNer could classifies venlafaxine like a antidepressant drug, and
this information can help to correctly resolve the anaphor the antidepressant effect.
Coadministration of naloxone with venlafaxine did not modify the antidepressant
effect
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Chapter 6
Related work for Relation
Extraction in the biomedical
domain
6.1. Introduction
The goal of relation extraction task is to detect semantic relations between enti-
ties in text. This task usually forms part of some application or pipeline processes to
support other systems such as Information Retrieval or Question Answering systems
in different domains. In particular in the biomedical domain, relation extraction can
be used to discovery relevant relationships such as PPIs or DDIs. Example 10 shows
some types of relations in different domains.
Example 10 Examples of relationships in various domains
born-in: [Zapatero]PERSON was born in [Valladolid]LOCATION
protein-protein interaction: [HOX11]PROTEIN interacts with [protein phos-
phatases PP2A]PROTEIN
drug-drug interaction: [Fluvoxamine]DRUG given with [warfarin]DRUG may in-
crease the possibility of bleeding.
food-drug interaction: Consumption of [grapefruit juice]FOOD increases the
plasma concentration of [terfenadine]DRUG.
Although, in general, relationships can involve three o more entities, most of the
existing approaches for relation extraction have focused on the extraction of binary
relationships. [Sarawagi, 2007] proposes three different scenarios in which the binary
relation extraction can be posed: (1) given two annotated entities in an input text,
the goal is to find out the type of relationship between both entities, (2) given a
relationship R and an entity name E, the goal is to extract all entities that have the
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relationship R with E in a input text, and (3) given a set of predefined relationships,
the goal is to detect all occurrences of those relationships in texts.
Relationship extraction is a complex task that requires to integrate different lev-
els of linguistic processing such as tokenization, PoS tagging, syntactic and semantic
sentence parsing. A detailed review of the most common types of resources useful
for relation extraction task is presented in [Sarawagi, 2007]. We summarize some of
those clues:
Context information, that is, the tokens around and between the two entities.
For example, a DDI is strongly indicated by the presence of the bigram interact
with between the two drug names.
Part of speech tags are very useful to identify the entities (which are typi-
cally nouns and noun phrases) and verbs (which are crucial to defining the
relationship between entities).
Full Syntactic parse trees provide more valuable than POS tags because they
group words in phrase types such as noun, prepositional or verb phrases, which
help in understanding the relationship between the entities. For example,
figure 6.1 shows a parse tree in which the three coordinating noun phrases:
nisindione (NP5), dicumarol (NP6) and warfarin (NP7), and the conjunction
and (CC) are grouped into the upper noun phrase (NP3). This facilitates
to find out the interaction between the aforesaid drugs and Propylthiouracil.
However, syntactic parsing is a very cost and time-consuming task.
Dependency graphs are an alternative of parse trees. A dependency tree repre-
sents the grammatical relations between words in a sentence, so its dependency
graph links each word to the words that depend on it.
Example 11 Context Information useful to detect DDIs and adverse drug reactions
(ADRs): the underline words in the below sentences can be useful clues to detect
the relationships between the marked entities
(1)[Aspirin]DRUG can interact with [Heparin]DRUG
(2)[Aspirin]DRUG may increase serum levels of [methotrexate]DRUG
(3)[Aspirin]DRUG may increase the risk of [gastrointestinal bleeding]SY MPTOM
(4)[Beta-blockers]DRUG taken for heart disease or high blood pressure can worsen
[asthma]DISEASE
Example 12 A more reliable extraction of the interaction relationship between the
below drugs is possible if the word interact is tagged as a verb instead of a noun.
(1)Aspirin/noun can/verb interact/verb withprep Heparinnoun
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Figure 6.1: Example of parse tree
At it can be seen from the above examples, each of the levels of processing
yields to a particular structural representation of its output. For instance, while
a sequence of tags is provided in the levels of tokenization and PoS tagging, the
structural representation yielded by the syntactic parsing level is a parse tree, and
a graph in the dependency parsing level. Handling the diversity of the different
representations is a difficult challenge [Sarawagi, 2007].
The goal of biomedical relation extraction is to detect occurrences of a prede-
fined type of relationship between a pair of given entity types. These relationships
may be very general such as any biochemical association or very specific such as
protein interactions or pharmacokinetic interactions between drugs. Typically, the
outcomes of this task are stored in databases, which can either consulted directly
by the users or exploited by data mining algorithms to infer new knowledge. Al-
though in the last decade, this task has received much attention, it is very difficult
to compare the results obtained by the different research groups, not only because
they use different datasets, but also because they deal with different types of rela-
tions. Thus, the performance of this task depends on the type of relationship to
be extracted and literature corpus to be processed. Most investigation has centered
around biological relationships (genetic and protein interactions) due mainly to the
available of annotated corpora in the biological domain, a fact that facilitates the
evaluation of different approaches.
This chapter presents a review on the existing approaches to extract biomedical
relations from texts. In general, current approaches can be divided into three main
categories: linguistic-based, pattern-based and machine learning-based approaches.
We now briefly describe the main categories as follows:
1. Linguistic-based approaches. The general idea of these approaches is to employ
linguistic technology such as parsing techniques to grasp syntactic structures
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or semantic meanings that could be helpful to discover relations from unstruc-
tured text. These methods can be further classified into two types, based on
the complexity of the linguistics methods, as shallow parsing or deep parsing.
2. Pattern-based approaches. These methods design a set of domain-specific rules
(also called patterns) that encode and capture the various forms of expressing
a given relationship.
3. Machine Learning-based approaches. As opposed to the previous approaches
which need laborious effort to define a set of rules or grammars, machine
learning methods allow to acquire and code all the necessary knowledge au-
tomatically. Machine learning approaches can be further classified into two
types, based on the kind of instance representation:
a) Feature-based methods. These methods extract a flat set of features from
the input and represent each instance as a feature vector. Then, a clas-
sifier (such as a decision tree or a SVM) is trained using these data in-
stances.
b) Kernel-based methods. Relation instances are enconded as structural rep-
resentations such as bag of words, word sequence, parse tree or depen-
dency graph. Then, a kernel function must be designed to capture the
similarity between structures.
However, many of the existing works adopt hybrid approaches to overcome the
difficulties and benefit from the advantages of using each approach. In particular,
linguistic techniques such as tokenization, PoS tagging and syntactic parsing, are
widely used by both pattern-based and machine learning-based approaches. In the
following sections, we present the main works for each category in more detail. In
the last section some unsolved problems are presented.
6.2. Linguistic-based approaches
Linguistic-based approaches employ different linguistic techniques to obtain use-
ful information for discovering relations from unstructured text. Based on the com-
plexity of these techniques, we categorize them into two types: shallow parsing and
deep parsing.
Shallow parsing techniques aim to retrieve syntactic information efficiently and
reliably from text, by sacrificing completeness and depth of analysis. The shallow
parser EngCG [Voutilainen and Heikkila, 1993] was used by Sekimizu et al. [1998]
to obtain morphological and syntactic information exploited to detect the subjects
and objects of the verbs expressing interactions between proteins. Pustejovsky et al.
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[2002c] built a cascaded finite state automata to recognize inhibit relations. A set
of 500 abstracts was manually annotated by experts in biology. Results showed a
precision of 90% and a recall of 57%. Leroy et al. [2003] used a shallow parser based
on four cascades finite state automates to structure the relations between individual
entities. These automates are based on closed-class English words and model generic
relations not limited to specific words. The parser can also recognize coordinating
conjunctions and captures negation in text. Three cancer researchers evaluated 330
relations extracted from 26 abstracts of interest to them. There were 296 relations
correctly detected from the abstracts resulting in 90% precision of the relations and
an average of 11 correct relations per abstract.
The systems based on deep parsing deal with the entire sentence structure and
therefore are potentially more accurate. [Temkin and Gilder, 2003] used a lexical
analyzer and a general context-free grammar (GFG) to extract protein, gene and
small molecule interactions from unstructured text. Domain specific structures are
carried out by the grammar, significantly reducing the complexities of natural lan-
guage processing. The system achieves a recall rate of 63.9% and a precision rate of
70.2%.
In [Rinaldi et al., 2004], a probabilistic dependency parser is used to identify
interactions between genes and proteins. The parser uses a hand-written grammar
combined with a statistical language model that calculates lexicalized attachment
probabilities. Later, Rinaldi et al. [2007] have also employed a probabilistic depen-
dency parser, Pro3Gres [Schneider et al., 2007], to output functional dependency
structures. Based on these structures, interactions between proteins and genes were
extracted. Experiments are conducted on two different corpora: Genia and ATCR
(which consists of 147 abstracts automatically annotated using the Biolab Experi-
ment Assistant (BEA) tool1). Precision values range from 52% to 90% and recall
values range from 40% to 60%.
[Fundel et al., 2007b] have developed the RelEx system based on the dependency
parse trees to extract relations in biomedical texts. It is applied to one million ab-
stracts to extract gene and protein relations. About 150,000 relations were extracted
with an estimated performance of both 80% precision and 80% recall.
BioPPIExtractor [Yang et al., 2009b] is a PPI extraction system for biomedical
literature. This system applies CRF model to tag protein names in biomedical text,
then uses a link grammar parser to identify the syntactic roles in sentences and at last
extracts complete interactions by analyzing the matching contents of syntactic roles
and their linguistically significant combinations. Link grammar parsers are similar
to dependency parsers, but they do not include the head-dependent relationship.
In addition, the system includes an anaphora resolution module that focuses on
third person pronouns and reflexives. The system was evaluated on the DIP corpus
1http://www.biovista.com/bea/main.php?pid=111
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achieving a precision of 55.41%, a recall of namely 41.62%, and a f-measure of
47.53%.
System Approach Relation Corpus Results
[Pustejovsky et al.,
2002c]
Shallow parsing inhibit
relations
500 ab-
stracts
P=90%
[Leroy et al., 2003] Shallow parsing biological
relations
26 abstracts
contain-
ing 330
relations
P=90%
[Temkin and Gilder,
2003]
Context-free gram-
mar
PPIs 100 ab-
stracts
F1=66.9%
[Rinaldi et al., 2007] Probabilistic de-
pendency parser
PPIs Genia,
ATCR
P=52-90%,
R=40-60%
RelEx dependency parse
trees
PPIs One million
abstracts
F1=80%
BioPPIExtractor CRF model + Link
grammar parser
PPIs DIP F1=47.53%
Table 6.1: Main linguistic-based approaches for biomedical relation extraction
The comparison among the different works is not possible because many of them
have been evaluated on different corpora. Therefore, it is risky to make conclusions
on the performance of the different techniques. In general terms, the shallow parsing-
based approaches perform well for capturing relatively simple binary relationships
between entities in a sentence, but fail to extract more complex relationships ex-
pressed in various coordinate and relational clauses [Zhou and He, 2007]. Further-
more, many of the shallow parsing-based approaches lack an adequate and rigorous
evaluation. Deep parsing-based methods seem to achieve better performance than
shallow parsing techniques by analyzing the whole structure of sentences. Among
the reviewed systems, RelEx shows the best results with a significant difference
between them and those reported by Rinaldi et al. [2007] or the BioPPIExtractor
system, however they are all based on dependency parsing. We believe that the
performance of these approaches is strongly influenced by the shortage of biomedi-
cal parsers. General purpose parsers, which have been trained on generic newswire
texts, are not able to deal with the complexity of the biomedical sentences that
tend to cause problems due to their long length and high degree of ambiguity [Sid-
dharthan, 2006]. On the other hand, analyzing the whole sentence structure incurs
higher computational and time complexity.
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6.3. Pattern-based approaches
Similar to linguistic-based methods, pattern-based approaches can make use of
syntactic information to achieve better performance, although it can also work with-
out prior parsing and tagging of the text.
Ono et al. [2001] present a system for extracting information on PPIs from the
scientific literature. They manually defined A total of 20 patterns to extract PPIs.
The system only employs a protein name dictionary, surface clues on word patterns
and simple part-of-speech rules. Negation structures are also tackled. The system
achieves high recall and precision rates for yeast (recall=86.6% and precision=94.3%)
and Eschirichia coll (recall=82.5% and precision=93.5%).
The SUISEKI [Blaschke and Valencia, 2002] system uses a set o rules based on
morphological, syntactical, and contextual information to detect gene and protein
names and interactions in scientific texts. Sentence negations and the distance
between two protein or gene names are also considered. A probability score is
induced for each predefined rule depending on its reliability and used it as a clue
to score the interaction events. They used a collection of almost 50.000 abstract to
build the system, but only 100 sentences were used to evaluate the precision and
100 abstract to estimate the recall. The system achieves a recall of 68.7% and a
precision of 44.9%.
The system BioRAT [Corney et al., 2004] focuses on the extraction of PPIs
and is able to analyze both abstracts and full-lenght papers. Protein names are
recognized using a set of gazetteers that are compiled from sources such as MeSH,
Swiss-Prot [Boeckmann et al., 2003] and other hand-made lists. A set of lexico-
semantic patterns is defined manually to identify PPIs. To evaluate the system, they
collected 394 interactions from the DIP database. These interactions correspond to
229 abstracts. The dataset is called as DIP corpus. Overall, BioRAT achieves 39%
recall with 48% precision.
The system IntEx [Ahmed et al., 2005] has been developed to extract gene and
protein interactions from biomedical text. Gene and protein names are tagged by
the combination of several biomedical terminological resources such as UMLS, Ge-
neOntology and LocusLink database, and a set of regular expressions is also used
to recognize the names not found in the resources. Pronoun resolution is also tack-
led by a very simple heuristic based on the proximity and the number of the noun
phrases. Then, the system uses a link grammar to split complex sentences into sim-
ple clausal structures made up of syntactic roles. Finally, interactions are extracted
from simple sentence clauses by syntactic role matching using a basic set of patterns.
Experiments are performed on the DIP dataset. This dataset was created for the
evaluation of the BioRAT system [Corney et al., 2004], which is described in the
following section. IntExt overcomes the results of BioRAT, reaching a precision of
65.66% and a recall of 26.94%.
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Few proposals have tackled the treatment of the negation phenomena and modal-
ity [Morante and Daelemans, 2009], however these phenomena are crucial for the
correct interpretation of relationships. Negative sentences may also contain evidence
of use to biologists and healthcare professionals, and speculative sentences should
also be presented with lower confidence. The systems NegExt[Chapman et al., 2001]
and Lexer [Mutalik et al., 2001] are based on the use of regular expressions to iden-
tify negative PPIs that are expressed with explicit negative particles such as no and
adverbial not. [Sa´nchez-Graillet and Poesio, 2007] have developed a heuristic-based
system to extract negation of PPIs by the use of affixes and a set of inherently nega-
tive words. Kim et al. [2006] have focused on the extraction of contrastive relations
like but not.
Hand-built pattern-based approaches achieve good performance. However, it
is essential domain experts get involved in the definition of the patterns. This
task requires labor-intensive manual processing. On the other hand, these patterns
cannot easily adapt to other subdomains. Several approaches have addressed these
shortcomings by automatically learning rules or patterns from texts.
In [Phuong et al., 2003], sentences are parsed by a link grammar parser and used
to learn extraction rules automatically from a set of seed hand-tagged sentences.
Interactions are detected by using of heuristic rules based on morphological clues
and domain specific knowledge. A set of 550 sentences was compiled to perform
the experiments. The system is evaluated on a set of 550 sentences, achieving a
precision of 87% and a recall of 60%.
Huang et al. [2004a] propose to use a dynamic programming algorithm to com-
pute distinguishing patterns by aligning relevant sentences and key verbs that de-
scribe PPIs. Then, these automatically constructed patterns are used to identify
PPIs by a matching algorithm. A set of 1563 sentences is used to learn patterns
and 354 sentences are used to test the matching algorithm The system achieves a
precision rate of 80.5% and recall rate of 80.0%. An extended approach is presented
in [Hao et al., 2005] whose goal is to improve the patterns. This second approach
designs a minimum description length (MDL)-based pattern-optimization algorithm
to reduce and merge patterns. Several experiments were performed on 963 sentences
in which 1435 interactions were manually detected. This approach achieves better
precision (85.1%) than the previous one, but a lower recall (55.8%) (f-measure of
67.40%). Later, Huang et al. [2006a] proposed a hybrid approach based on the
combination of shallow parsing and pattern matching, to extract PPIs from scien-
tific biomedical texts. Shallow syntactic and semantic information is used to resolve
appositions and coordinate structures. Clause splitting based on a set of rules is
also applied to obtain relative clauses. Thus, long sentences are split into sub-ones,
from which relations are extracted by a greedy pattern matching algorithm. The
patterns are automatically generated using the algorithm proposed in [Hao et al.,
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2005]. A collection of 920 sentences was manually annotated by experts, detecting
1423 relationships. The approach achieves an average f-score of 80% on individual
verbs, and 66% on all verbs.
A common characteristic of the majority of the participating systems at the the
Interaction Pair Task (IPT) in the BioCreative challenges [Krallinger et al., 2008,
2009] is the usage of pattern matching techniques. In the BioCreative II challenge,
The best results were achieved by the system presented in [Huang et al., 2008]. This
system, firstly, filters out the articles that are irrelevant. Protein and organisms
are recognized by using the databases SwissProt and the NCBI taxonomy [NCBI],
respectively. Every protein pair is viewed as an interaction candidate. Then, a
set of patterns is generated using the semi-supervised method for learning patterns
proposed in [Ding et al., 2007]. The system was trained on a corpus of 740 full
articles and evaluated on a test set of 358 articles, showing a precision of 38.9%, a
recall of 30.7% and a f-measure of 28.9%, which reflect the complexity of the task.
In the last BioCreative II.5 challenge, most of the participating systems were also
based on the use of pattern matching methods to extract PPIs [Verspoora et al.,
2009, Hakenberg1a et al., 2009, Sætre et al., 2009]. Sætre et al. [2009] have developed
a system for relation extraction called AkaneRe, which has been applied to the IPT
task. Texts are analyzed with the Genia-tagger [Tsuruoka et al., 2005] and the Genia
Dependency parser [Sagae, 2007]. The protein names are recognized by a maximum
entropy markov model trained on the corpus Genia. Then, the system generates
templates which are grouped by clustering. The system achieved a precision of 18%,
a recall of 27% and a f-measure of 17%. The same system was also evaluated in
the BioNLP shared task [Kim et al., 2009], showing the following scores: a precision
of 54%, a recall of 28% and f-measure of 37%. Verspoora et al. [2009] use a set of
hand-built patterns and defines a semantic grammar to detect interactions among
the co-occurrences of the proteins. This system achieved a precision of 33.3%, a
recall of 22.4% and a f-measure of 25.2%.
Kolarik et al. [2007] have described an approach for the identification of new In
the pharmacological domain, Kolarik et al. [2007] propose to use the lexico-syntactic
patterns for identifying and extracting relevant information on drug properties. The
goal of the system is to support support database content update by providing
additionally drug descriptions of pharmacological effects not yet found in databases
like DrugBank. The experiments focus on finding out drug families in texts. The
system was evaluated on texts from MedLine and from the database DrugBank.
The evaluation shows that phrases could be identified with a high performance
in DrugBank texts (F-score=89%) and in Medline abstracts (F-score=83%). The
evaluation of terms extracted from Medline shows that 29-53% of them are new
valid drug property terms. Thus, they could be assigned to existing and new drug
property classes not provided by the DrugBank database. Pharmspresso [Garten
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and Altman, 2009] is a text analysis tool to extract pharmacogenomic concepts and
gene-drug interactions from full text articles. An ontology was manually defined
with concepts and relationships of interest in the biological domain, in particular,
human genes, polymorphisms, drugs and diseases and their relationships. Then, the
Textpresso tool [Muller et al., 2004a], which is a template-based text search engine,
uses the concepts and relations in the ontology to build regular expressions and look
for the templated relationships in text. This tool analyzies text to find references
to human genes, polymorphisms, drugs and diseases and their relationships. A
gold-standard of 45 hand-annotated articles was used to evaluate the tool, which
identified 78%, 61%, and 74% of target gene, polymorphism, and drug concepts,
respectively.
System Approach Relation Corpus Results
[Ono et al., 2001] Lexico and syntac-
tic patterns
PPIs – F1=87.6-
90.2%
SUISEKI Morpho-syntactic
patterns
PPIs 100 sen-
tences
F1=54.3%
BioRAT lexico-semantic
patterns
PPIs DIP F1=43.03%
IntEx Link gram-
mar+patterns
PPIs DIP dataset F1=38.9%
[Phuong et al., 2003] link grammar
parser + pattern
learning
PPIs 550 sen-
tences
F1=71.02%
[Hao et al., 2005] pattern learning PPIs 1435 PPIs
in 963
sentences
F1=67.40%
[Huang et al., 2006a] shallow parsing and
pattern matching
PPIs 1423 PPIs
in 920
sentences
F1=66%
[Huang et al., 2008] semi-supervised
pattern learning
PPIs BioCreative
dataset
F1=28.9%
AkanePPI dependency pars-
ing, pattern match-
ing
PPIs BioCreative
dataset
F1=19%
[Verspoora et al.,
2009]
semantic grammar
+ pattern pattern
matching
PPIs BioCreative
dataset
F1=25.2%
Table 6.2: Main pattern-based approaches for biomedical relation extraction
As it happens in linguistic-based approaches, pattern-based approaches are not
comparable since their experiments are performed on different corpora. Most of the
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previous works developed and annotated themselves their corpora. It is very striking
the difference between the results presented in the BioCreative challenges and those
reported by the other works. This may be due to that the texts in the BioCreative
datasets are more complex than those used in the other approaches. Pattern-based
approaches usually achieve high precision, but low recall. They are not capable of
handling long and complex sentences, so common in biomedical texts. There are
several linguistic phenomena including negation, modality and mood, which can
alter or even reverse the meaning of the sentence, however, they are not addressed
by the pattern-based approaches. Furthermore, these approaches are also limited by
the extent of the patterns, since interaction descriptions that span several sentence
cannot be detected by them. Thus, these approaches are not able to correctly process
anything other than short and straightforward sentences [Zhou and He, 2007], which,
on the other hand, are quite rare in biomedical texts.
6.4. Machine learning approaches
Machine learning methods for biomedical relation extraction have gained growing
interest in recent years due to their good results achieved in general domain. On the
contrary to the pattern-based methods, machine learning approaches do not require
to manually encode relevant knowledge, but they formulate the relation extraction
problem as a classification task and employ learning algorithms to automatically
extract knowledge from texts. Examples of machine learning algorithms are support
vector machines, neural networks, k-nearest neighbor algorithm, hidden markov
models, and na¨ıve Bayes. In addition, these approaches can be easily extended
to new set of data or a new task or domain. However, one major drawback of
these algorithms is that they generally require computationally expensive training
and testing on large amounts of annotated data. Positive and negative examples
must be represented in a suitable format in order to train an algorithm. We can
distinguish, depending on the kind of representation, two categories: feature-based
and kernel-based methods.
6.4.1. Features-based methods for Relation Extraction
In this subsection, we study the main characteristics of feature-based approaches
and review the most relevant works in this field. These methods extract a flat set of
features from the input and represent each instance as a feature vector. The feature
vectors are used to train an algorithm. Features are extracted from sentences by
the application of text analysis techniques including tokenization, POS tagging,
shallow or deep parsing, named entity recognition, among others. Sarawagi [2007]
provides a review on how the features can be extracted from the different levels of
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linguistic processing. The feature set should be complete, that is, it must include all
features potentially useful for the classification problem. Features can be classified
into two different categories: (1) properties of a single token including entity type,
PoS tag, lemma and other attributes of the tokens, and (2) relations between tokens:
sequence, syntactic or dependency relations between tokens. Typically, most used
features are:
Words between entities (including themselves).
Types of entities (person, location, gen, protein, etc)
Number of words between both entities
Syntactic parse tree of a sentence can offer more complex and discriminative
features. A common feature is the syntactic path between the two entities in
a parse tree, or a subtree.
Dependency graph of the relation instance, that is, information on dependen-
cies among the words in it.
Number of entities between the two entities, whether both entities belong to
same chunk
The system proposed in Rosario and Hearst [2004a] deals with the recognition of
entities such as treatment and disease, and the classification of seven relationships
types that can occur between both entities. Five generative graphical models and
a neural network were designed using lexical, syntactic, and semantic features from
MeSH vocabulary. The experiments show that the MeSH concepts help achieve high
classification accuracy.
Xiao et al. [2005] propose a Maximum Entropy (ME) method to extract PPIs
from texts. The system combines lexical (such as surrounding words, key words and
abbreviations), syntactic and semantic features. Experiments were performed on
the IEPA corpus [Ding et al., 2002] (see chapter 3) achieving a recall of 93.9% and
a precision of 88.0%.
A system for extracting disease-gene relations from MedLine is described in
[Chun et al., 2006]. The system recognizes the disease and gene names and se-
lects the sentences that contain at least one pair of disease and gene names. A
dictionary for disease and gene names from six public databases, including HUGO
[Povey et al., 2001], RefSeq and LocusLink [Pruitt and Maglott, 2001], Swiss-Prot,
DDBJ [Miyazaki et al., 2004] and UMLS [Bodenreider, 2004], is constructed and
the relation candidates are extracted by dictionary matching. To build training and
testing sets, around one million of abstracts were collected from MedLine. They
manually checked 1,000 co-occurrences of gene-diseases. The dictionary matching
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method achieves a precision of 51.8% and a recall of 100%. To filter out false posi-
tives introduced by the dictionary matching process, they used a maximum entropy
method to recognize disease and genes names, which achieves to improve the preci-
sion to 78.5%, with a reduction of 13% in recall.
A hybrid method that combines dependency parsing and machine learning al-
gorithms is presented in [Katrenko and Adriaans, 2007]. The experiments were
performed on two different datasets: the Aimed corpus [Bunescu et al., 2005] and
LLL corpus [Nedellec, 2005]. The LLL corpus already consists of the tokenized and
parsed sentences provided by LinkParser [Sleator and Temperley, 1995]. The Aimed
corpus was parsed using the parser MiniPar [Lin, 1999] providing the dependency
parser for each sentence. This method assumes that the entities have already been
identified. The set of features includes information on arguments such as lemmas,
syntactic functions, information on their parents and the direct ancestor for both
arguments. They performed several experiments using three different classifiers:
Na¨ıve Bayes, BayesNet and K-nearest neighbor. Precision ranges between 56% and
81% and recall between 32% and 76%, according to the corpus and classifier used.
The best performance is achieved on the Aimed corpus by the combination of the
three classifiers (f-measure 72.7%). In general, the three classifiers obtained worst
results on the corpus LLL.
BioPPISVMExtractor [Yang et al., 2009a] is a system for PPIs extraction based
on the SVM algorithm. Sentences are parsed using the link grammar parser devel-
oped by Grinberg et al. [1995]. The set of features includes surface word, keyword,
protein name distance and link path features. The system is trained on the IEAP
corpus and tested on the DIP corpus [Corney et al., 2004] (which was developed to
test the BioRAT system). The system achieves a recall of 70.04%, a precision of
49.28% and a f-measure of 57.85%.
In clinical domain, Angus et al. [2008] apply SVM to detect clinically important
relationships (such as has finding, has indication, has location, has target, has finding,
among others). The algorithm is trained and tested on a corpus of 77 patient
narratives which were manually annotated by two clinically trained annotators. The
system achieves an average f-measure of 72%.
In pharmacological domain, Duda et al. [2005] have evaluated the classification
capability of SVM as a method for locating articles about DDIs. They manually
created a corpus of 2000 abstracts of positive and negative drug interaction cita-
tions. The set of features used to train the SVM model is composed of MeSH terms,
CUI-tagged title and abstract text, and stemmed text words. The study shows that
automated classification techniques have the potential to perform at least as well as
PubMed in identifying DDI articles. Another approach with a similar purpose has
been developed in [Rubin et al., 2005]. The goal is to develop an automated method
to identify articles in Medline citations that contain pharmacogenetics data pertain-
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ing to gene-drug relationships. Three types of statistical models and a heuristic
method (a ’gene-drug filter’) are implemented to detect pharmacogenetics articles.
The statistical models include Na¨ıve Bayes, logistic regression, and a log-likelihood
method. A sampling of the articles identified from scanning Medline was reviewed
by a pharmacologist to assess the performance of the method. The system achieves
a f-measure of 88% with a precision of 80% and a recall of 97%.
System Technique Features Corpus Results
[Xiao et al., 2005] ME lexical, syntactic
and semantic
IEPA F1=90.8%
[Chun et al., 2006] Dictionary
Matching +
ME algorithm
words, PoS tags,
acronyms
1,000 co-
occurrences
of gene-
diseases
F1=82.5%
[Katrenko and Adri-
aans, 2007]
Dependency
parsing +
Na¨ıve Bayes,
BayesNet and
K-nearest
neighbor
lemmas, syn-
tactic functions,
parents
AIMed
and LLL
F1=72.7%
[Yang et al., 2009a] link grammar
parser + SVM
surface word,
keyword, protein
name distance
and link path
features
DIP F1=57.85%
[Angus et al., 2008] SVM surface word,
keyword, protein
name distance
and link path
features
77 patient
narratives
F1=72%
[Chen et al., 2009] SVM protein names,
context words,
keywords, dis-
tance, number
of proteins, posi-
tion and distance
between keyword
and protein
BioCreative
dataset
F1=57.8%
Table 6.3: Main feature-based machine learning approaches for biomedical relation
extraction
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Most works have focused on the extraction of PPIs, however, it is not possible
to draw precise conclusions about their performance, because many of them have
been evaluated on different corpora. In this regard, the BioCreative challenges play
a very important role in making possible a realistic evaluation of the different PPIs
extraction approaches. In the last BioCreative II.5 challenge, the best results were
reported by a system Chen et al. [2009] based on SVM classifier. The feature set used
to train the SVM classifier includes the interaction proteins and their context words,
the distance in tokens between the two proteins, the number of other recognized
proteins between the two interacting proteins, interaction keywords, the position of
interaction keywords and the distance in words between the interaction keyword and
the protein nearest to it. They also used 16 syntactic pattern features and 2 boolean
features to indicate if this interaction pair exists in MINT and IntAct databases. The
system achieved a precision of 63.7%, a recall 61.5% and a f-measure of 57.8%. These
results are significantly superior to those obtained by other participating systems,
which are based on the use of pattern matching (the second-ranked [Hakenberg1a
et al., 2009] system in the competition achieved a f-measure of 35%). Therefore, the
use of machine learning techniques such as SVM notably improves the performance
of the PPI extraction systems.
Although feature-based methods have obtained good results in the relation ex-
traction task, they have several drawbacks. The main shortcomings are as follows:
1. The feature extraction process requires extensive domain knowledge and much
time is spent on the task of feature engineering.
2. Features are not able to correctly capture the structural information gathered
in complex structures such as parse trees or dependency graphs, that is, this
type of input information is not easily represented by explicit features.
3. Features from different information sources (lexical, syntactic, semantic) may
be incompatibles with each of other.
4. The great diversity of words produces high or even infinite dimensionality
of the feature space. In these cases, the computation of the feature map
becomes computationally infeasible. In addition, the feature vectors are too
much sparse.
6.4.2. Kernels-based methods for Relation Extraction
Kernels-based approaches [Cristianini and Shawe-Taylor, 2000, Shawe-Taylor
and Cristianini, 2004] provide an effective alternative to feature-based approaches.
Their main advantage is that they can exploit the structural descriptions of words,
phrases and sentences, and process them efficiently. Kernels do not need to represent
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each data instance into a flat set of features, but just define a similarity measure
that determines the similarity between the instances. The intuitive idea behind a
kernel method is to find a mapping of the input space into a new feature (vector)
space in which problem solving is easier.
Formally, a kernel function is a binary function K : XxX− > [0,∞) that maps
a pair of objects x, y ∈ X to their similarity score K(x, y). The kernel function must
satisfy
∀x, y ∈ X : k(x, y) = 〈φ(x), φ(y)〉, (6.1)
where φ : X → F ⊆ Rn is a mapping from the input space X to a vector space
F. The mapping function φ transforms each instance x ∈ X in a feature vector
φ(x) = (φ1(x), φ2(x), . . . , φm(x)), where φi : X → R, with no need to know the
explicit representation of the x. Then, the mapping function φ allows to express
K(x, y) as the dot-product of the features vectors of the input objects x and y.
∀x, y ∈ X : k(x, y) = 〈φ(x), φ(y)〉 =
m∑
i=1
φi(x).φi(y). (6.2)
Figure 6.2: φ embeds the instances into a feature (vector) space. Figure is taken
from [Renders, 2004]
In summary, the kernel method acts as the interface between the input data and
the learning algorithm. The input objects are embedded into a vector space, in
which the learning process takes place by the measuring similarity between objects
[Shawe-Taylor and Cristianini, 2004]. Many machine learning algorithms can be
formulated as kernel-based algorithms. The most popular ones are support-vector
machines, k-nearest neighbors and voted perceptrons.
We now review the major types of kernels and approaches that have been ap-
plied to relation extraction in the biomedical domain. The performance of kernel
approaches is mainly determined by the selection and design of the kernel functions,
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which are based on the representation of the relation instances. The instances can
be presented in a certain representation such as bag-of-words, word sequences, parse
trees or dependency graphs. These representations allow to capture different types
of contextual information.
A bag-of-words is the simplest and most-used representation of relation instances.
Each relation instance is represented as a vector where each component indicates
the occurrence of a particular word in the sentence. The two entities that constitute
the instance can be excluded from its word representation in order to differentiate it
from the rest of the instances. Formally, each relation instance x can be represented
as a vector
φ(x) = (phi1(x), phi2(x), . . . , phin(x)) ∈ {0, 1}
n (6.3)
where φi(x) indicates if the word i occurs in the sentence. Therefore, a word kernel
function (also called bag-of-words kernel) KWORD(x,y) can be defined on such word
representation as the inner product of the vectors φ(x) and φ(y) and returns the
number of words in common between two instances:
KWORD(x, y) = 〈phi(x), phi(y)〉 =
n∑
i=1
phii(x).phii(y) (6.4)
The word kernel is simple and efficient. However, neither the sequence of words
in sentence nor the sentence structure is captured by word kernels. The bag of words
representation loses all the word order information only retaining if the words occur
or nor in the instances.
A relation instance can also be represented as a sequence of words in order
to take into account the the sequential order of words in a sentence. The most
simple way to represent a instance as a sequence is to consider all words except
the two entities. For example, given the sentence Propylthiouracil causes variations
in the anticoagulant effects of drugs such as acenocoumarol, nisindione, dicumarol
and warfarin, the sequence representation for the relation instance (propylthiouracil,
acenocoumarol) is shown in the following example:
Example 13 Word sequence representation for the relation instance (propylth-
iouracil, acenocoumarol)
causes-variations-in-the-anticoagulant-effects-of-drugs-such-as-,-nisindione-,-
dicumarol-and-warfarin
There are many other ways to represent the instances as sequences, for exam-
ple, considering contiguous or non-contiguous subsequences for a given length of a
string, assigning different weight to each gap, or including only particular types of
features in the sequence. Based on the type of representation, it is possible to define
different kernel functions to measure the similarity between two sequences counting
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the subsequences that they have in common. Thus, we can define various ways of
counting:
1. p-spectrum kernel counts how many substrings of a given length (p) two strings
have in common. The contiguity is necessary.
2. Subsequence kernel in which the contiguity is not necessary.
3. Gap-weighted subsequence kernel in which the contiguity is penalized.
The p-spectrum kernel is the most natural way to compare two strings. This
kernel function was proposed by Lodhi et al. [2002] for text classification. Let us
give a simple example to explain the construction of a 2-spectrum kernel. Given
the strings ’bar’,’bat’,’car’ and ’cat’, their 2-spectra φ is shown in table 6.4. All
the other dimensions indexed by other strings of length 2 have value 0, and for this
reason, they have not been shown. The resulting kernel matrix is shown in table
6.5. A detail description of the main sequence kernel functions can be found in
[Shawe-Taylor and Cristianini, 2004]. We now review the main approaches based on
sequence kernel methods.
φ ar at ba ca
bar 1 0 1 0
bat 0 1 1 0
car 1 0 0 1
cat 0 1 0 1
Table 6.4: Example of φ2 taken from [Shawe-Taylor and Cristianini, 2004]
K bar bat car cat
bar 2 1 1 0
bat 1 2 0 1
car 1 0 2 1
cat 0 1 1 2
Table 6.5: Example of 2-spectrum kernel taken from [Shawe-Taylor and Cristianini,
2004]
Bunescu and Mooney [2006] propose a generalization of the sequence kernel given
in Lodhi et al. [2002]. The new kernel uses sequences that combine words and word
classes. Several experiments are performed for extracting PPIs from biomedical
corpora and top-level relations from newspaper corpora. They observed that if a
sentence contains a relationships between two entities, then the relation is generally
represented by some of the following three patterns:
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1. Fore-Between: words before and between the two entities are used to express
the relationship. For example, interaction of Aspirin with Heparin
2. Between: only words between the two entities are essential for asserting the
relationship. For example, Aspirin interacts with Heparin.
3. Between-After : words between and after the two entities are used to express
the relationship. For example, Aspirin and Heparin interact.
Then, given two sentences s and t, the relation kernel computes the number of com-
mon patterns between s and t, only considering the above set of patterns. Therefore,
the kernel K(s,t) is expressed as the sum of the three above sub−kernels, as follows:
K(s, t) = Kbefore(s, t) +Kbetween(s, t) +Kafter(s, t) (6.5)
They also noted that all these patterns use at most 4 words to express the rela-
tionship, not counting the two entities. Thus, they only considered the subsequences
that satisfy some of the three above patterns, with a maximum word−length of 4,
for defining the subsequence kernel. The patterns are completely lexicalized and
consequently their performance is limited by data sparsity. In order to alleviate
the problem of the sparsity, the sequences are represented using words and word
classes such as PoS tags and entity types. The sequence kernel was evaluated on
the AImed corpus, achieving a precision of 65%, a recall of 46.4% and a f-measure
of 54.2%. Experiments were also performed on the ACE 2002 corpus, which allowed
to compare this approach with other types of kernels applied to relation extraction
in the general domain, showing the sequence kernel achieves a better performance
than the tree kernel introduced by Culotta and Sorensen [2004].
Based on the above work, Giuliano et al. [2006] propose two kernels to represent
two distinct information sources: (1) the global context where entities appear and
(2) the local context of each entity. Thus, the whole sentence where the entities
appear (global context) is used to discover the presence of a relation between two
entities. Windows of limited size around the entities (local contexts) provide use-
ful clues to identify the roles played by the entities within a relation (for example,
agent and target of a gene interaction). Then, they defined a third kernel as the
sum of the global context and the local context kernels. This kernel is called shallow
linguistic kernel because it is based solely on shallow linguistic processing, such as
tokenization, sentence splitting, part of speech (PoS) tagging and lemmatization.
Experiments were performed on the two biomedical corpora AImed and LLL. Table
6.6 shows the results obtained by this work adopting the evaluation methodology
OAOD (one answer per occurrence in the document) [Lavelli et al., 2004], that is,
each individual occurrence of a protein interaction must be extracted from the doc-
ument. In this thesis, we have applied this shallow linguistic kernel to the extraction
of DDIs. A more detailed description of this kernel can be found in section 8.2.
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Corpora Kernel P R F1
AImed
KGlobalContext 57.7% 60.1% 58.9%
KLocalContext 37.3% 56.3% 44.9%
KShallowLinguistic 60.9% 57.2% 59.0%
LLL
KGlobalContext 55.1% 66.3% 60.2%
KLocalContext 44.8% 60.1% 53.8%
KShallowLinguistic 62.1% 61.3% 61.7%
Table 6.6: Results of the work [Giuliano et al.,2006] for PPI extraction
A parse tree is a clear example of structure data representing the syntactic struc-
ture of a sentence (see figure 6.3). This kind of structural information can be very
beneficial to detect relations between entities. Thus, the relation instances can be
represented as parse trees, and a tree kernel function measures the similarity be-
tween two relation instances. As it was aforementioned, an important property of
the kernel methods is their ability to retain the structural information of relation
instances. We can define a tree kernel as a function KTREE(T1, T2) that returns a
similarity score for the two trees T1 and T2. The tree kernels can be considered as
convolution kernels since they can calculate the similarity between two trees in a
recursive manner by estimating the similarity of their subtrees [Collins and Duffy,
2002]. Consequently, the tree kernels are able to calculate the structural similarity
effectively.
Figure 6.3: The smallest subtree containing both drugs is the whole parse tree
Below, the main approaches based on tree kernels for relation extraction are re-
viewed. We begin by reviewing the main works in the newswire domain, and that
have been the basis for the approaches developed in the biomedical domain.
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Zelenko et al. [2003] were the first using tree kernels for the relation extraction
task. Sentences are represented as shallow parse trees. A relation instance is repre-
sented as the smallest shallow subtree that contains both entities. Each node in the
tree is augmented with several attributes such as its head (if it is a phrase), its PoS
tag (noun, verb, etc), its entity type (for example, person, organization, etc), or its
role in the relation. These attributes are used to estimate the similarity between the
nodes. Previously to define the kernel function on shallow parse trees, they define
a primitive kernel function to estimate the similarity between the nodes. This simi-
larity function on nodes is computed in terms of the attributes of the nodes. Then,
they define the kernel method in terms of similarity function of their root nodes and
the similarity of their children. The kernels were applied to extract two types of
relations (person-affiliation, organization-location) and evaluated on a corpus of 200
news articles. The F-measure of the results ranged from 80% to 86%.
[Culotta and Sorensen, 2004] propose an extension of the previous approach by
a richer sentence representation and the use of composite kernels to reduce kernel
sparsity. The main hypothesis is that instances containing similar relations will
share similar substructures in their dependency trees. The sentences are analyzed
by the MXPOST parser [Ratnaparkhi, 1996] in order to generate their parser trees,
which are transformed to dependency trees by a set of rules (for example, subjects
are dependent on their verbs and adjectives are dependent on the nouns the modify).
Basing on the work [Zelenko et al., 2003], they represent each relation instance as the
smallest common subtree in the dependency tree that includes both entities. This
choice allows to reduce noise and emphasize the local characteristics of relations. In
addition, each node is augmented with a feature vector that includes attributes such
as the word, its part of speech tag, its entity type, its WordNet [Fellbaum et al.,
1998] hypernyms, and a relation argument indicating if an entity is the first or second
argument in a relation. Then, a tree kernel is defined on dependency trees to estimate
the similarity between relation instances. They also proposed a bag-of-words kernel,
that treats the tree as a vector of features, was also developed and combined with the
tree kernels. Experiments were performed on the ACE corpus, showing a precision of
67.1%, a recall of 35.0%, and f-measure of 45.8%. Other interesting result was that
the tree kernel outperformed the bag-of-words kernel, implying that the structural
information is extremely useful for relation detection. The approach presented in
[Bunescu and Mooney, 2006] seem to obtain better results, however, these are not
not directly comparable since the approaches used different corpora for performing
their experiments.
Based also on the use of the dependency trees, Bunescu and Mooney [2005] de-
signed a kernel method that uses the shortest path between the two entities in a
dependency tree, instead of the smallest subtree containing both entities proposed
in the previous works [Zelenko et al., 2003, Culotta and Sorensen, 2004]. Because
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the dependency graph is always connected, it is guaranteed to find a shortest path
between the two entities. Thus, each relation instance is represented as the short-
est path between the two entities. As these paths are completely lexicalized and
consequently their performance will be limited by data sparsity, they decided to
add classes such as the PoS tags or entity types to the representation of the path.
They defined a simple kernel whose basic idea is that if the two paths have different
lengths, they correspond to different ways of expressing a relationship, and other-
wise, the similarity is the product of the number of common word classes at each
position in the two paths. Formally, given two relation examples x=x1x2. . . xm and
y=y1y2. . . ym, where xi denotes the set of word attributes corresponding to position
i, the kernel method is defined as follows
k(x, y) =

1, n 6= m∏n
i=1 c(xi, yi), m = n
(6.6)
where c(xi, yi) = |xi ∩ yi| is the number of common classes between xi and yi. The
kernel was used in conjunction with SVMs in order to find the hyperplanes that best
separate positive examples from negative examples. ACE corpus 2002 was used
in the experiments. The documents were processed using the OpenNLP package
[Baldridge, 2004]. In addition, they used the entities provided by the gold-standard
corpus. It yields better results than if the entities are recognized automatically.
The shortest-based kernel achieves a precision of 65.5% and recall of 43.8%. Results
showed that this kernel achieved better performance (f-measure 52.5%) than the
composite kernel (f-measure=45.8%) proposed in [Culotta and Sorensen, 2004].
The approach presented in [Eom et al., 2006] used a tree kernel-based method
for PPIs extraction. They retrieved 2000 abstracts by querying with keywords as
protein interaction and the name of concrete proteins. The abstracts are segmented
into sentences. Only those sentences with at least two proteins and an interaction-
related words are selected. The sentences that include PPIs were manually labeled
as positive, otherwise labeled as negative. The final corpus consists of 1135 sentences
of positive examples, and 569 sentences of negative ones. The sentences are analyzed
by the parsers Brill tagger [Brill, 1992] and Collins parser [Collins, 1996]. Basing on
[Zelenko et al., 2003], they only considered the smallest subtrees that contained the
two proteins. To improve the performance, the subtree is augmented with semantic
information such as entity type or interaction-related words. Nodes that are proteins
are labeled with the tag PTN (protein), and nodes that are interaction-related words
are also modified in order to differentiate from general words. They performed 10-
fold cross validation to evaluate the system. Experiments achieved a f-measure of
90.48%, however, the performance cannot be compared to the results presented in
[Giuliano et al., 2006] or [Bunescu and Mooney, 2006], because Eom et al. [2006]
do not use any gold standard corpora such as AIMed or LLL. Experiments shown
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that the approach achieves better performance than a bag-of-word kernel or a na¨ıve
bayes method.
Li et al. [2008] compared and combined different kernels for biomedical relation
extraction, in particular, a bag-of-words kernel, a subsequence kernel and the tree
kernel proposed by [Zelenko et al., 2003], which is augmented by incorporating from
the root node of the smallest subtree to the root of the full parse tree. Thus, this
trace is a sequence word that captures more global context in the full parse tree
in addition to the smallest subtree. The sequence kernel is used to compare the
similarity between traces. In order to evaluate the kernels, they built a corpus of
2,000 cancer-related abstracts from Medline. The biomedical entities and relations
between them were manually annotated by a biomedical expert. The sentences
were analysed by the biomedical parser presented in [Lease and Charniak, 2005].
The corpus contains a total of 8,071 relation instances, 2,156 of them were identified
as true relations, while the remaining were labeled as negative examples. The best
results were achieved by the composite kernel that combines the sequence kernel
and the trace-tree kernel. This composite kernel achieved a f-measure of 67.23%
(R=64.68%, P=70.11%, Accuracy=83.14%). In addition, the experiment showed
that the tree kernel significantly outperforms the sequence and word kernels. This
is due to the tree kernel is able to better capture the structural information between
the entities. In addition, sequence and word kernels may include some noise since
they require comparing all the words and sequences in sentences. The augmented
tree kernel also improved the results with respect to the standard tree kernel.
Airola et al. [2008] proposed a dependency-path kernel to extract PPIs. Each
relation instance is represented with a weighted graph that consists of two uncon-
nected subgraphs. The former represents the dependency structure of the sentence,
and the second the linear order of the words. Based on the shortest path hypothesis
[Bunescu and Mooney, 2005], the nodes on the shortest paths connecting the two
proteins are differentiated with a special tag and the all edges on the shortest path
receive an higher weight, emphasizing the shortest path without disregarding infor-
mation outside of the path. The second subgraph represents the linear structure
of the sentence. In this graph, information such as text, POS tags, entity types
and the order with respect to the proteins is denoted. Experiments were performed
across five corpora annotated for PPIs: Aimed, BioInfer, HPRD50, IEAP and LLL
(see chapter 3), which were processed with the Charniak-Learse parse [Lease and
Charniak, 2005], and the parse tree were transformed into the dependency graphs
by the Standford tools. They evaluated the kernel with 10-fold document-level
cross-validation on all of the corpora. The experiments showed that the values of
f-measure vary remarkably between the different corpora, with results on IEPA and
LLL very higher than on AImed and BioInfer. Since f-measure is very sensitive to
the underlying positive/negative pair distribution of the corpus, they also calculated
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the AUC measure. However, the AUC measures are invariant and falls in range of
83-85%. This is due to the f-measure is not invariant to the distribution of positive
and negative examples. Thus, the greater the fraction of true interactions in a cor-
pus is, the easier it is to reach high performance in terms of f-measure. The fraction
of true interactions out of all candidates is 50% on the LLL corpus, but only 17%
on AImed. The best f-measure (56.4%) was achieved on the AImed corpus.
To best of our knowledge, the only approach dealing with a ternary relation ex-
traction task is proposed in [Liu et al., 2007]. PROTEIN-ORGANISM-LOCATION
relations are identified in the text of biomedical articles. Different kernel functions
are used with an SVM learner to integrate two sources of information from syn-
tactic parse trees: (1) a large number of syntactic features useful for semantic role
labeling task, and (2) features from the entire parse tree using a tree kernel. The
best result is obtained by combining semantic role labeling features with tree ker-
nels (P=75.3%, R=74.5%, F=74.9%). The experiments showed that the use of rich
syntactic features significantly outperforms shallow word-based features.
Although many approaches have been addressed for the biomedical relation ex-
traction task, its direct comparison is impossible since there are many differences
not only in the set of solved relationships, but also the evaluation resources. If we
compare feature-based and kernels-based approaches evaluated on the AIMed, we
observe that kernels do not achieve to overcome the feature-based approaches. For
example, the feature-based presented in [Katrenko and Adriaans, 2007] achieved a
f-measure of 72% compared to 54.2% obtained by Bunescu and Mooney [2006] or
to 59.0% obtained by Giuliano et al. [2006]. The tree kernel-based approach pre-
sented in [Eom et al., 2006] seems to obtain better performance (f-measure=90.48%)
than these sequence kernels, however, they are not directly comparable since Eom
et al. [2006] used a private dataset for performing their experiments. Li et al. [2008]
proposed an interesting comparasion of several kernels. Experiments showed that
the tree kernels overcame the other kernels. The best performance was achieved
by the combination of the different kernels. Unfortunately, a private dataset was
used for the evaluation, and therefore, this approach cannot be compared directly
with others. Airola et al. [2008] evaluated a dependency-path kernel on five dif-
ferent corpora for PPIs extraction. The experiments showed that the best results
(56.4%) are achieved on the AImed corpus. Therefore, the sequence kernel proposed
by Bunescu and Mooney [2006] seems so far the most successful method for PPIs
extraction on the corpus AIMed. Some approaches [Zelenko et al., 2003, Li et al.,
2008] have declared that tree kernels not only outperform feature-based methods,
they also achieve better results than sequence kernels. However, we believe that it
is not possible to give real conclusions on the different approaches, until the experi-
ments are performed on the same corpus.
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On the other hand, tree kernels are relatively slow compared to feature classifiers
and sequence kernels [Bunescu and Mooney, 2005, Li et al., 2008]. The complexity
of tree kernels and the need to evaluate thousands of them during the process of
classification may render them inappropriate for practical purposes. For this reason,
we believe that sequence kernels are more appropriate than tree kernels for DDIs
extraction since these methods should be integrated into a real application in which
the processing time will be a priority.
System Kernel Corpora Results
[Bunescu and
Mooney, 2006]
sequence kernel AIMed F1=54.2%
[Giuliano et al.,
2006]
sequence kernel AIMed, LLL F1=61.7%
[Eom et al., 2006] tree kernel 2000 abstracts F1=90.48%
[Li et al., 2008] bag-of-words, subse-
quence, tree, trace
kernels
2000 abstracts F1=67.23%
[Airola et al., 2008] dependency-path kernel Aimed, BioInfer,
HPRD50, IEAP
and LLL
F1=56.4%
(AIMed)
Table 6.7: Main kernel-based machine learning approaches for biomedical relation
extraction
6.5. Unsolved Issues in Biomedical Relation Ex-
traction
Relation Extraction in biomedicine has been studied for approximately ten years.
Over these years, biomedical relation extraction systems have grown from simple
rule-based pattern matcher to sophisticated, hybrid parser employing computational
linguistics technology or machine learning methods. But, until now, there are still
several severe obstacles to overcome.
With regard to the type of relations addressed, most works have focused on the
extraction of biological relationships such as genetic and protein interactions. To the
best of our knowledge, there is no approach that tackles the automatic detection of
DDIs from biomedical texts. In fact, the only approaches [Duda et al., 2005, Guo and
Ramakrishnan, 2009] focused on DDIs deal with the classification of articles about
DDIs, but do not extract them explicitly. Several approaches [Kolarik et al., 2007,
Garten and Altman, 2009] have addressed the extraction of relevant information for
the pharmacological domain such as drug properties, pharmacogenomic concepts,
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gene-drug interactions, among others, however, none of them has dealt with the
extraction of relevant information for DDI such as the mechanism, the relation to
the drug dosages, the time course, the factors that alter an individual’s susceptibility,
seriousness and severity, the probability of the occurrence, etc.
Regarding the performance of the existing works to cope with the relation ex-
traction problem, firstly we should note that though a wide range of methods have
been addressed, its direct comparison is impossible since there are many differences
not only in the set of solved relationships, but also the evaluation resources and
strategies. At this point, we must highlight the crucial role of the BioCreative chal-
lenges in improving the text mining techniques in the biological domain, providing
a common framework for evaluation. A general characteristic, common to almost
existing works, is the use of information from different levels of linguistic analysis.
Thus, the results depend heavily on good results from previous tasks such as text
processing tasks (tokenization, sentence splitting, PoS tagging, syntactic parsing) or
named entity recognition. Therefore, until these tasks do not deliver good results,
the relation extraction task will continue to deliver relatively poor results.
Linguistic-based approaches and pattern-based approaches perform well for cap-
turing relatively simple binary relationships between entities in a sentence, but fail
to extract more complex relationships expressed in various clauses. The results
reported by these methods are very disparate. In linguistic-based approaches, f-
measure ranges from about 39% to 80%. The worst results are reported by the
IntEx system based on the use of link grammar parser, while the best ones are
achieved by the RelEx system based on dependency parsing. Both approaches were
evaluated on different corpora, so it is daring to draw any conclusion about whether
the good performance of the RelEx system is due to the dependecy parsing or to the
corpus. However, we should note that the BioPPIExtractor, evaluated on the DIP
corpus, achieves lower results than the RelEx system, though both systems are based
on dependency parsing. Regarding the performance of the pattern-based methods,
their f-measure reported by pattern-based methods range from 43% to 71% (but Ono
et al. [2001] who reported a f-measure of 90.2%). Linguistic-based approaches and
pattern-based approaches are not able to handle the complexity of the biomedical
sentences. Most works do not deal with adverbial and prepositional phrases, which
are essential to describe biomedical relations. In biomedical texts, many relation-
ships are often described through disjoint clauses, however, this issue has been has
been rarely addressed. Moreover, very few approaches [Sa´nchez-Graillet and Poesio,
2007, Morante and Daelemans, 2009] take into account other important aspects of
sentence constructions such as mood, modality and negation which can significantly
alter or even reverse the meaning of the sentence.
In general, machine learning-based approaches have achieved better performance
than linguistic-based and pattern-based ones, as demonstrated in the last BioCre-
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ative challenge. However, machine learning-based approaches depend heavily on the
annotated corpora for training and testing. Most available corpora in biomedical
domain focus on PPIs. Corpus annotation is expensive work, usually involving ex-
tensive time and labor. Regarding feature-based methods, they usually use lexical,
syntactic and semantic features. However, they are not able to correctly capture the
structural information gathered in parse trees or dependency graphs. The structural
information is extremely useful for relation detection. Kernel-based methods do not
need to represent each data instance into a flat set of features, but just define a sim-
ilarity measure that determines the similarity between the instances. In the kernel
methods, the instances can be presented in a certain representation such as bag-of-
words, word sequences, parse trees or dependency graphs. As it was aforementioned,
the comparation among the different works is impossible since they have evaluated
their experiments on different corpora. Among the works evaluated on the same
corpus, the sequence kernel presented in [Bunescu and Mooney, 2006] achieves the
best performance. However, these approach do not achieve to overcome the results
obtained by the feature-based method presented in [Katrenko and Adriaans, 2007].
Other works [Eom et al., 2006, Li et al., 2008] declare that the tree kernels achieve
better performance, however, they were evaluated on private datasets. Therefore, it
is essential to make an evaluation of the different kernels using a common corpus in
order to draw real conclusions.
Biomedical relation extraction methods generate poorer results compared with
other domains such as newswire. A possible cause is that few approaches take ad-
vantages of the information about relations included in ontologies [Huang et al.,
2004b, 2006b], which usually are used like simple dictionaries. We believe that a
more extensive and effective use of the biomedical ontologies is a prerequisite to im-
prove the performance of the biomedical relation extraction task. Also, biomedical
text needs to be semantically annotated and actively linked to ontologies. Although,
in general, relationships can involve three o more entities, most of the existing ap-
proaches for biomedical relation extraction have focused on the extraction of binary
relationships. Moreover, the existing approaches usually assume that the argument
entities of the relation occur in the same sentence. Consequently, the extraction
of the complex relationships as well as the relations spanning several sentences are
some of the remaining challenges.
The continuing growth and diversification of the scientific literature will require
tremendous systematic and automated efforts to utilize the underlying information.
Therefore, in the near future, tools for knowledge discovery will play a pivotal role
in biomedical systems. The increasing fervor on the field of biomedical IE gives
the evidence [Zhou and He, 2007]. However, we should point out that there is
a huge gap between life science researches, healthcare professionals and computa-
tional scientists. Bridging the gap between life science scientists and computational
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scientists is crucial to the success of biomedical IE. Currently, this field is dominated
by researchers with computational background; however, the biomedical knowledge
is only possessed by life science scientists. That is crucial for defining standards
for evaluation; for identification of specific requirements, potential applications and
integrated information system for querying, visualization and analysis of data on a
large scale; for experimental verification to facilitate the understanding of biological
interactions. Hence, to attract more biologists and healthcare professionals into the
field, it is important to design simple and friendly user interfaces that make the
tools accessible to non-specialists.
114
Chapter 7
Combining syntactic information
and patterns for Drug-Drug
Interaction extraction
7.1. Introduction
This thesis proposes two different approaches for DDIs extraction task: (1) a
hybrid approach that combines syntactic information and pharmacological patterns,
and (2) a kernel method for DDI extraction. This chapter describes in detail the
first approach, which exploits the information provided by the previous processes
(see figure 7.1) text analysis, drug name recognition and anaphora resolution.
Figure 7.1: DDI Extraction Prototype.
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Although many approaches have been proposed to extract biomedical relations,
few of them achieves successful results. One important reason is that only a few
approaches [Huang et al., 2006a] have dealt with the issue of the grammatical com-
plexity of biomedical texts. However, language structures such as apposition, coor-
dination and complex sentences are very common in the biomedical literature. We
think that the detection of these linguistic phenomena is essential to successfully
tackle the extraction of biomedical relations, in particular, DDIs.
In this chapter, we propose a hybrid method, which combines shallow parsing
and pattern matching, to extract relations between drugs from biomedical texts.
A pharmacist has defined a set of lexical patterns to capture the most common
expressions of DDIs in texts, basing on her professional experience and the corpus
observation. The method is based on the approach described in [Huang et al., 2006a],
which proposes a set of syntactic patterns to split the long sentences into clauses
from which relations are extracted by a greedy pattern matching algorithm. This ap-
proach works on the detection of appositions, coordinate constructions and relative
clauses. Our contribution extends this approach detecting any kind of subordinate
and coordinate clause. Appositions and coordinate structures are interpreted based
on shallow syntactic parsing provided by MMTx. In particular, we define a set of
syntactic patterns to detect them. Subsequently, complex and compound sentences
are broken down into clauses from which simple sentences are generated by a set of
simplification rules. Finally, the lexical patterns are matched against the generated
sentences in order to extract DDIs.
Figure 7.2: Outline of the pattern-based approach to extract DDIs.
At this point, we raise the following question: what depth of analysis is required
to identify and resolve the aforesaid mentioned syntactic structures?. The complex-
ity of the biomedical language presents a compelling computational challenge for
any parser. Complex and long sentences tend to cause problems due to their long
length and high degree of ambiguity [Siddharthan, 2006]. On the other hand, full
parsers are less robust and computationally more expensive than shallow parsers.
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Moreover, to the best of our knowledge, Genia Dependency parser [Sagae, 2007] and
the parser presented in [Lease and Charniak, 2005] are the only full parsers trained
on biomedical texts. In our case, shallow parsing is feasible because we only need
to identify a limited range of grammatical functions and clauses, and full grammat-
ical relations are not needed. Therefore, we have decided to use the information
provided by MMTx for detecting appositions, coordinate structures and clauses.
The chapter is organized as follows. The treatment of coordinate structures and
appositions are described in sections 7.2 and 7.3 respectively. Section 7.4 shows
how clauses boundaries are identified using shallow syntactic information and how
simple sentences are generated from the clauses. Section 7.5 presents a shallow
evaluation of the performance in the resolution of syntactic structures tackled in
this chapter. Section 7.6 introduces the set of pharmacological patterns proposed
by our pharmacist. Section 7.7 describes in detail the experiments and presents the
experimental results. Finally, conclusions and future work are drawn in section 7.8.
7.2. Detecting coordinate structures
Coordination in natural language occurs in a wide range of constructions. The
diversity of sentence types in which coordination occurs has led to it being one of the
most hotly debated, and yet relatively little understood, issues in Linguistic [Dik,
1968, Fabricius-Hansen and Ramm, 1984, Johannessen, 1998, Quirk et al., 1985].
A coordination is a complex syntactic structure that joins two o more sentence
constituents, called conjuncts or conjoines [Van Oirsouw, 1987]. For example, in the
following coordinate structure probenecid, sulfinpyrazone, and phenylbutazone, the
conjunction and coordinates the conjunct probenecid with sulfinpyrazone and with
phenylbutazone. Coordination is an extremely common grammatical phenomenon
in biomedical texts. Coordinate structures can be illustrated by the italic part of
the following sentences taken from DrugBank:
Example 14 Sentences containing coordinate structures.
(1) Broad-spectrum antibiotics may sterilize the bowel and decrease the vitamin K
contribution to the body by the intestinal microflora.
(2) Population pharmacokinetic analyses revealed that NSAIDs, corticosteroids, and
TNF blocking agents did not influence abatacept clearance.
(3) These agents may bind and decrease absorption of levothyroxine sodium from
the gastrointestinal tract.
(4) Proscar is toxic and dangerous.
Sentence (1) shows conjoined sentences, but coordination is also possible for
noun phrases as in sentence (2), verb phrases as in the sentence (3), and adjectival
phrases as in sentence (4). The conjoined sentences are addressed in section 7.4,
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since their treatment is directly related to the division of clauses. The work deals
with the other types of constituents.
Figure 7.3 shows a sentence that contains three interactions. In order to extract
the interactions, it is necessary to interpret the coordinate structure in it. Since
coordinate constituents are semantically close and usually they play the same syn-
tactic and grammatical roles in a sentence, it is necessary to assemble them together
[Huang et al., 2006a].
Figure 7.3: Example of coordinate structure.
Although a wide variety of structures can be conjoined, not all coordinations
are acceptable. Chomsky [2002] concluded that syntactically different categories
cannot be conjoined. This constraint is known as Coordination of Likes Constraint
(CLC) or Law of Coordination of Likes [Williams, 1978]. Coordinating conjunc-
tions, also called coordinators, are conjunctions that connect two or more items of
equal syntactic importance (words, phrases or clauses). Coordinating conjunctions
include for, and, nor, but, or, yet, and so. However, since this section focuses on
coordination between phrases, we have only considered coordinators shown in table
7.1 as possible coordinators to link phrases. The rest (for, but, yet, and so) are
conjunctions that connect clauses.
Coordinators: AND | OR | NOR | AND/OR | AS WELL AS
Table 7.1: Coordinators to link phrases.
Based on the CLC constraint, we initially proposed the set of syntactic patterns
shown in table 7.2 to detect coordinate structures. However, based on the corpus
observation, this constraint is too restrictive for the kind of parsing provided by
MMTx. For example, the sentence shown in figure 7.4 demonstrates that being of
the same syntactic category is too strong as requirement for conjuncts in a coordinate
construction, since a prepositional phrase, of probenecid (s0.p6 ), can be conjoined
with two noun phrases: sulfinpyrazone (s0.p7 ) and phenylbutazone (s0.p9 ).
We have observed in the training corpus that coordinate structures involving
constituents with different syntactic categories are very common. Sometimes it is
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Pattern Example
(NP,)* NP CONJ NP [NSAIDs]NP , [corticosteroids]NP , and , [TNF block-
ing agents]NP did not influence abatacept clearance.
(ADJ,)* ADJ CONJ ADJ Proscar is [toxic]ADJ and [dangerous]ADJ
(VP,)* VP CONJ VP These agents may [bind]V P and [decrease]V P absorp-
tion of levothyroxine sodium from the gastrointestinal
tract.
Table 7.2: Patterns to detect coordinate structures.
Figure 7.4: Parsed sentence by MMTx
due to MMTx is not able to determine the syntactic type of a phrase, classifying it
as unknown phrase (that is, with the tag UNK ) (see example 15). Therefore, the
above syntactic patterns have been merged to contemplate the parsing peculiarities
of MMTx. Table 7.3 presents the new patterns where first row shows a pattern
in which different syntactic types can be combined to detect coordination at the
phrase level. An exception is made for verb phrases, since the coordination between
a verbal phrase and other type of syntactic phrase is a coordination between clauses
(which is tackled in the following section). Thus, the second pattern only allows
to connect the verbal phrases with verbal phrases. The table 7.3 also includes a
syntactic pattern, which was already introduced for drug anaphora resolution in
chapter 5, to detect correlative expressions such as both midazolam and triazolam
(see section 5.4).
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Example 15 Coordinate structures containing UNK phrases.
(1) The data do not suggest the need for dose adjustment of either [Humira]UNK or
[MTX]NP
(2) When [Inspra]UNK and [NSAIDS]NP are used concomitantly, patients should be
observed to determine whether the desired effect on blood pressure is obtained.
Extended patterns for coordinate structures
([NP |PP |ADJ |UNK],)* [NP |PP |ADJ |UNK] CONJ
[NP |PP |ADJ |UNK]
(VP,)* VP CONJ VP
[BOTH|EITHER|NEITHER][NP|PP|UNK] [AND|OR|NOR]
[NP|PP|UNK]
Table 7.3: Extended patterns to detect coordinate and correlative structures.
In order to match the syntactic patterns on a sentence to detect its coordinate
structures, the sequence of the syntactic types of its phrases must be generated from
the shallow syntactic information provided by MMTx. If some pattern matches the
sequence, recognizing one or more structures, then the text of the sentence is re-
generated from the text of its phrases, except the interpreted structures which are
encapsulated and replaced by the tag COORD. Finally, the lexical patterns defined
by the pharmacist are matched against the generated text. If an interaction is de-
tected, the coordinate structures involved in it must be unfolded in order to obtain
the individual interacting elements. This procedure will be described in more detail
in section 7.7.
7.3. Identifying appositions
There are divergent views within Linguistics with regard to what is or is not an
apposition (also called appositional or appositive structure). Fries [1952] and Fran-
cis [1958] restrict the category of apposition to coreferential noun phrases (called as
appositives) that are juxtaposed and refer to the same extralinguistic entity. Curme
[1963] and Jespersen and McCawley [1984] expand this definition with the inclusion
of constructions such as clauses and sentences as possible elements of an apposition.
Burton-Roberts [1975] admits as apposition only those constructions which can be
linked by a marker of apposition (see table 7.5). Quirk et al. [1985] propose three
conditions to define the apposition phenomena: (1) each of appositives can be sepa-
rately omitted without affecting the acceptability of the sentence, (2) each appositive
has the same syntactic role in the resultant sentences, and (3) there is no difference
between the original sentence and either of the resultant sentences in extra-linguistic
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reference. Quirk et al. [1985] also classify apposition into various semantic classes
such as exemplification, appellation, identification, and particularization.
Although the above approaches provide insights into the category of apposition,
they provide either an inadequate or an incomplete description of apposition. The
objective of this thesis is not to provide formal and complete description of apposi-
tion, but rather to identify appositions, in particular, those that contain drugs. We
only deal with appositions that are linked by a marker of apposition. This kind of
apposition appears frequently in the sentences that contain DDIs. Markers are help-
ful cues for detecting these structures. Table 7.5 shows the markers of apposition
that we have used in this approach. Other markers such as particularly, that is or
especially have not been tackled. Appositions that are not linked by any marker are
also frequent in scientific text, however, the lack of marker makes extremely difficult
the detection of this kind of apposition. Moreover, we have observed they hardly
ever occur in expressions describing DDIs.
Patterns
APPOSITIVE [NP |PP |UNK|APPOSITION ]
APPOSITION APPOSITIVE (, )? (()? MARKER [APPOSITIV E(, )?]+
(AND|OR)? (APPOSITIV E)? ())?
Table 7.4: Patterns to detect appositions.
We define a set of syntactic patterns in order to identify the appositions (see table
7.3). Appositions comprise at least two contiguous phrases, the second of which is
marked by clues such as parentheses or markers (table 7.5). This second phrase
may be a coordinate structure. The first pattern APPOSITIVE allows to recognize
the intervening elements in an apposition, that is, their appositives. This pattern
matches a phrase type (provided by MMTx) or an another apposition. In this way,
the pattern is able to recognize nested appositions. Regarding the phrase types, it
has not considered types such as VP, CONJ, ADV, or, ADJ, since our main focus is
to recognize appositions containing drugs. Drugs only appear in noun, preposition
and unknown phrases. The second pattern is used to recognize appositions. This
pattern matches an intervening element APPOSITIVE followed by a marker and
by one or more intervening elements expressed by coordinate phrases. Parentheses
are also included in the pattern.
Example 16 presents some sentences in which its appositions (italic part) have
been recognized by the above patterns. The last sentence contains the apposition
Catecholamine-depleting drugs, such as reserpine, which satisfies the conditions de-
fined in [Quirk et al., 1985]. That is, both appositives share the same syntactic role
in the sentence, and if they are separately omitted from the original sentence, both
resultant sentences are acceptable. Two different DDIs (Catecholamine-depleting
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Marker Example
such as Catecholamine-depleting drugs, such as reserpine, may have an
additive effect when given with beta-blocking agents.
like Buspirone does not displace tightly bound drugs like phenytoin,
propranolol, and warfarin from serum proteins.
including Concomitant use of apomorphine with drugs of the 5HT3 an-
tagonist class (including, ondansetron, granisetron, dolasetron,
palonosetron, and alosetron) is contraindicated.
for example Propylthiouracil may increase the effect of oral blood thinners, for
example warfarin.
e.g. Interactions could occur following concomitant administration of
psychotropic drugs (e.g., narcotics, analgesics, antiemetics, seda-
tives, tranquilizers).
i.e. Diethylpropion may interfere with antihypertensive drugs (i.e.,
guanethidine, a-methyldopa).
Table 7.5: Markers of apposition.
drugs with beta-blocking agents, and Reserpine with beta-blocking agents) can be
extracted from the sentence. Therefore, it is essential to detect and resolve the
appositions occurring in sentences, prior to the application of the lexical patterns
responsible for DDI extraction. The appositions are firstly encapsulated and then
unfolded when the relation is obtained by any lexical pattern. Section 7.7 describes
in detail the stage of matching.
Example 16 Examples of appositions detected by the patterns
(1) Probenecid is known to interact with the metabolism or renal tubular excretion
of [many drugs]NP (e.g., [acetaminophen]NP, [acyclovir]NP, [theophylline]NP, and
[zidovudine]NP)
(2) Mineral oil interferes with the absorption of [fat-soluble vitamins]NP, including
[vitamin D preparations]NP.
(3) Epinephrine should not be administered concomitantly with other [sympath-
omimetic drugs]NP (such as [isoproterenol]NP) because of possible additive effects
and increased toxicity.
(4) It is not known whether other [progestational contraceptives]NP, such as
[implants]NP and [injectables]NP, are adequate methods of contraception during ac-
itretin therapy.
On the other hand, appositions are usually enconded as hypernymic propositions.
In the previous example, the apposition involves a taxonomix relationship between
Catecho-lamine-depleting drugs (hyperonim) and reserpine (hyponym). Therefore,
the detection of appositions can also provide very useful information to classify drugs
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into drug families. For example, Kolarik et al. [2007] defined patterns to capture
appositions that represent relations between a hypernym and one or more hyponyms,
achieving to detect new drug categories not contained in the DrugBank database.
7.4. Clause splitting
A clause is a group of grammatically-related words that contains a subject and a
predicate, though sometimes the subject can be implied. Every sentence consists of
one or more clauses [Trask, 1999]. Sentences can be classified by their number and
type of clauses. Table 7.6 shows this classification and also some sentences taken
from the DrugBank database.
Type Example
Simple sentences, also called inde-
pendent clauses, contain a subject
and a verb, and express a complete
thought.
Aspirin may decrease the effects
of probenecid, sulfinpyrazone, and
phenylbutazone.
Compound sentences contain two
independent clauses joined by a coor-
dinator.
[Concomitant administration of corti-
costeroids with aspirin]Subject1,2 [may
increase the risk of gastrointestinal
ulceration]Indep.Clause1 and [may reduce
serum salicylate levels]Indep.Clause2 .
Complex sentences contain an inde-
pendent clause joined by one or more
subordinate clauses.
[Aspirin is contraindicated in
[patients]Subjectrelative]Indep.Clause [who
are hypersensitive to nonsteroidal
anti-inflammatory agents]RelativeClause.
Complex-compound sentences
contain at least two independent
clauses and one or more subordinate
clauses.
[Coadministration of CRIXIVAN
and [other drugs]SubjectRelative ]Subject1,2
[that inhibit CYP3A4]RelativeClause
[may decrease the clearance of
indinavir]Indep.Clause1 and [may re-
sult in increased plasma concentrations
of indinavir] Indep.Clause2 .
Table 7.6: Classification of sentences.
Biomedical texts usually consists of extremely long sentences. Long sentences
are usually complex or compound-complex sentences, that is, contain two or more
clauses. For example, the last sentence in table 7.6 contains two independent clauses
(marked with indep.clause1 and indep.clause2). Both clauses have the same subject:
Coadministration of CRIXIVAN and other drugs that inhibit CYP3A4. This subject
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also includes a relative clause that inhibit CYP3A4 whose subject is other drugs.
Parsing-based and pattern-based approaches are inefficient to deal with complex
and compound sentences. Parsers are usually trained on common English text cor-
pora and are difficult to extend to new domains. For this reason, they usually fail
particularly on biomedical complex sentences. Regarding the pattern-based meth-
ods, relations are possibly extracted incorrectly when patterns are matched beyond
the scope of one clause or other kinds of grammatical units [Huang et al., 2006a].
For example, the previous example contains a relative clause that inhibit CYP3A4,
which hinders the matching between the sentence and the pattern COADMINIS-
TRATION OF <DRUG> AND <DRUG> (MAY)? (DECREASE|INCREASE|. . . )
<EFFECT>. That is, patterns usually fail in the extraction of relationships from
complex and compound sentences.
Clause splitting is the task of dividing a complex or compound sentence into
several clauses. This section proposes an algorithm for clause splitting that aims
to reduce the complexity of sentences in biomedical texts, in order, to improve
the performance of our pattern-based method for DDI extraction. The algorithm
exploits syntactic and lexical information provided by MMTx. Once sentences have
been split into clauses, a set of simplification rules is used in order to generate new
independent sentences from the clauses. Finally, the lexical patterns defined by the
pharmacist can be applied on the generated sentences in order to extract DDIs.
Figure 7.5 shows an example of a compound sentence containing information
on the possible effects of the co-administration of corticosteroids and aspirin. The
sentence consists of two independent clauses, which must be detected by the algo-
rithm. Taking into account that both clauses share the same subject Concomitant
administration of corticosteroids with Aspirin, two new sentences are generated.
Both generated sentences contain the same interaction between corticosteroids and
aspirin, but describe different effects of the interaction. Then, the pharmacological
patterns are applied on the generated sentences, in order, to extract the interactions
and their related information. In this way, the approach does not only extract the
interaction between corticosteroids and aspirin, but also its different effects. If the
original sentence is not split into their clauses, the pattern is not able to extract
the second effect of the interaction between corticosteroids and aspirin shown in the
original sentence, that is, the reduction of the serum salicylate levels.
We now explain how the sentences are broken into clauses. First of all, it is
necessary to ensure that the sentence is actually a compound or a complex sentence,
because sometimes the coordinators and subordinators do not function like connec-
tors between clauses, but as prepositions, adverbs, etc. A possible heuristic is to
count the number of verb phrases included in the sentence. To give a definition of
verb phrase is not an easy task. In fact, linguists have not even reached an agree-
ment on what the verb phrase should include: only the words that are verbs, or
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Figure 7.5: Example of clause splitting.
also the complements of the verb. While the generative grammarians propose that
a verb phrase consists of various combinations of the main verb and any auxiliary
verbs, plus optional specifiers, complements, and adjuncts, for functionalist linguists
the verb phrases consist only of main verbs, auxiliary verbs, and other infinitive or
participle constructions [Calzolari et al., 2001]. Example 17 shows a sentence in
which the verb phrase is interpreted in two different ways according to the above
definitions.
Example 17 What should a verb phrase include?.
Including complements: Anagrelide [may interacts with any of these
compounds]V P .
Only verbs: Anagrelide [may interacts]V P [with any of these compounds]PP .
We have decided to adopt the last definition, that is, we define a verb phrase as a
syntactic structure that is composed of a main verb and, optionally, of auxiliary and
modal verbs, but the complements are excluded of this structure. Unfortunately,
MMTx offers an even simpler definition of verb phrase, because MMTx labels each
verb as a VP. Forms of to be are labeled as V/be. In order to group the main verb,
its auxiliary or modal verbs, as well as its adverbial complements in the same verb
phrase, we define the VP-pattern shown in table 7.7. The VP-pattern is applied on
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sentences in order to join verb phrases detected by MMTx to extended verb phrases.
If a sentence contains two or more extended VPs, then we can conclude that it is a
complex or compound sentence. However, if a sentence only contains an extended
VP, it is a simple sentence despite containing any conjunction. First column in
table 7.8 shows some sentences parsed by MMTx, while the second column shows
the result of applying our Vp-pattern to them.
VP-pattern [VP|V/be|VPG] (V/be)? (NOT)? (ADV)?
(VP|V/be|VPG)? (TO VP)?
Table 7.7: VP-pattern: a pattern to attach main verb and its complements.
Verb phrases detected by MMTx Verb phrases joined by the VP-
pattern
[Anagrelide]NP [may]V P [interact]V P
[with any of these compounds]PP .
[Anagrelide]NP [may interact]V P [with
any of these compounds]PP .
[Its toxicity]NP [may]V P [be]V/be
[enhanced]V P [by leucovorin]PP
[Its toxicity]NP [may be enhanced]V P
[by leucovorin]PP
[Formal drug interaction studies]NP
[have]V P [not]ADV [been]V/be
[conducted]V P [with ORENCIA.]PP
[Formal drug interaction studies]NP
[have not been conducted]V P [with
ORENCIA.]PP
[The combination]NP [of methotrexate]PP
[with acitretin]PP [is]V/be [also]ADV
[contraindicated]V P
[The combination]NP [of methotrexate]PP
[with acitretin]PP [is also
contraindicated]V P
[Glucocorticoids]NP [have]V P [been]V/be
[shown]V P [to]ADV [reduce]V P
[PROLEUKIN-induced side effects]NP
[Glucocorticoids]NP [have been shown
to reduce]V P [PROLEUKIN-induced
side effects]NP
Table 7.8: How does MMTx label the verb phrases?.
Once it has been determined that the sentence contains two or more clauses,
the following step is to determine the type of sentence. Such information will be
very useful in detecting the clause boundaries. In the English language, a compound
sentence is composed of two or more independent clauses joined by a conjunction
that can be a coordinator (coordinating conjunction), a correlative conjunction or a
independent marker word (see table 7.9). A independent marker word is a connecting
word used at the beginning of an independent clause. Semicolons and commas can
also function as conjunctions. If a independent marker occurs at the beginning of
the sentence, then a semicolon or a comma should separate the clauses. If the second
independent clause starts with an independent marker, then a semicolon or a comma
is needed before the marker [Wingersky et al., 2008]. The independent markers can
also occur in simple sentences, as in the following sentence: However, initial dose
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modification is generally not necessary. Example 18 shows some compound sentences
taken from the DrugBank database.
Conjunctions
Coordinators (coord) for, and, nor, but, or, yet, so.
Correlative conjunctions
[both|either|whether]. . .or
not only. . .but also
Independent markers (ind-
Marker)
However, Moreover, Furthermore, Consequently, Nev-
ertheless, Therefore.
Subordinate conjunctions
(depMarker).
after, although, as, as if, because, before, even if, even
though, if, in order to, since, though, unless, until,
whatever, when, whenever, whether, while.
Table 7.9: Conjunctions.
Example 18 Compound sentences.
(1) [Erythromycin and clarithromycin (and possibly other macrolide antibiotics) and
tetracycline may increase digoxin absorption in patients who inactivate digoxin by
bacterial metabolism in the lower intestine]clause1, so [that digitalis intoxication may
result]clause2 .
(2) Potential for drug interactions exists not only with concomitant medication but
also with drugs administered after discontinuation of amiodarone.
(3) [No drug interaction studies have been conducted for COLAZAL]clause1, how-
ever [the use of orally administered antibiotics could, theoretically, interfere with
the release of mesalamine in the colonclause2 .
(4) [Concomitant use of prophylactic low dose heparin did not appear to affect
safety]clause1, however, [its effects on the efficacy of Xigris have not been evalu-
ated in an adequate and well-controlled clinical trial]clause2.
A complex sentence has an independent clause joined with one or more subordi-
nate clauses. A subordinate clause, or dependent clause, is a clause that is embedded
as a constituent of a main sentence, acting like a noun, adjective, or adverb in the
resulting complex sentence. Subordinate clauses contain both a subject and a verb,
but do not express a complete thought. There are two kinds of subordinate clauses:
adverbial clauses and relative clauses. While an adverbial clause acts as an adverb
modifying another clause, a relative clause describes the referent of a head noun or
pronoun. Relative clauses are embedded in the main clauses by relative pronouns.
These pronouns can refer to persons, animals, places, ideas or things (see table
7.11). As a relative pronoun relates to another noun preceding it in the sentence,
it connects a dependent clause to an antecedent, that is, a noun that precedes the
pronoun. Within the relative clause, the relative pronoun stands for the noun phrase
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that it references in the main clause (its antecedent), which is one of the arguments
of the verb in the relative clause. Therefore, relative pronouns act as the subject or
object of the dependent clause. Relative pronouns can be considered as anaphoric
expressions, and their resolution was described in detail in chapter 5. Relatives
clauses are extremely common in biomedical texts.
A complex sentence always has a relative pronoun or a subordinator that links the
clauses (see tables 7.9 and 7.11). If the complex sentence begins with a subordinator,
that is, the subordinate clause is at the beginning of the sentence, then subordinate
clause should end with a comma. On the other hand, if the independent clause
is attached at the beginning of the main sentence and the subordinator is in the
middle, then no comma is required [Wingersky et al., 2008]. Example 19 shows
some complex sentences taken from the DrugBank database.
Example 19 Complex sentences.
(1) [When amiloride HCl is administered concomitantly with an angiotensin-
converting enzyme inhibitor,]SubordinateClause [the risk of hyperkalemia may be
increased.]MainClause.
(2) [Lithium generally should not be given with diuretics]MainClause because [they
reduce its renal clearance and add a high risk of lithium toxicity.]SubordinateClause.
(3) The extent [to which SSRI-TCA interactions may pose clinical
problems]RelativeClause [will depend on the degree of inhibition and the pharma-
cokinetics of the SSRI involved.]]MainClause.
(4) [Population pharmacokinetic analyses revealed]MainClause [that MTX,
NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept
clearance.]RelativeClause.
(5) [Since the excretion of oxipurinol is similar to that of urate]MainClause, [uricosuric
agents, [which increase the excretion of urate]RelativeClause, are also likely to in-
crease the excretion of oxipurinol and thus lower the degree of inhibition of xanthine
oxidase].
Compound sentences
CLAUSE1(,|;)? [indMarker|coord|;|,] CLAUSE2
indMarker(,)? CLAUSE1[,|;] CLAUSE2
Complex sentences
depMarker(,)? CLAUSEsubordinate, CLAUSEmain
CLAUSEmain [depMarker|;|,] CLAUSEsubordinate
Relative Clauses relPron (NP|PP|UNK|ADJ|APOS|COORD)? VP
[NP|PP|UNK|ADJ|APOS|COORD]
Table 7.10: Initial patterns for clause splitting
Taking into account the above clues, we initially defined a set of lexical pat-
terns for detecting clauses boundaries in compound and complex sentences. These
128
Example 20 Where does the clause end?.
(1) [These reactions consisted of [erythema, pruritus, and hypotension]COORD1]clause1
and [occurred within hours of administration of chemotherapy]clause2.
In this example, the previous detection of the coordinate structure ’erythema, pruri-
tus, and hypotension’ allows to correctly identify the second ’and’ as the coordinator
that joins the two independent clauses. The subject (These reactions) is ommited
in the second clause.
(2) [[[Intestinal adsorbents (charcoal)]APOS1 and [carbohydrate-splitting enzymes (e.
g., amylase, pancreatin)]APOS2]COORD1 ] may reduce the effect of Acarbose]clause1 and
[should not be taken concomitantly]clause2.
In this sentence, the previous identification of the two appositive structures and the
coordinate structure between them allows to identify the second ’and’ as a coordi-
nator between the two clauses: clause1 and clause2. In this sentence, the subject of
the second clause is also omitted (COORD1).
(3) [An increase in serum lithium concentration has been reported during concomitant
administration of lithium with ATACAND]clause1, so [careful monitoring of serum
lithium levels is recommended during concomitant use]clause2 .
In this sentence, the two conjoined clauses are separated by the conjunction ’so’.
MMTx labels this words with the CONJ type, and this label easily allows to identify
the boundaries between the two clauses.
(5) [The biochemical activity of debrisoquin hydroxylase is reduced in a subset
of the caucasian population]clause1 [(about 7-10% of caucasians are so called poor
metabolizers)]clause2
However, although the sentence contains two clauses (the second clause is marked
by commas), the word ’so’ in this sentence functions as an adverb (classified as ADV
phrase by MMTx), and not as conjunction.
patterns are shown in table 7.10. If a sentence matches some of these patterns,
then its clauses can be easily extracted from the matching. Relative clauses are a
especial case, since, they often appear in the middle of a main clause, splitting it in
two parts. For example, the last sentence in Example 19 contains a relative clause
which increase the excretion of urate, which separates the main sentence in two dif-
ferent parts. To separate such clause from the original sentence, its boundaries must
be determined. A special pattern for identifying relative clauses has been defined.
Relative clauses begin with a relative pronoun and containing a subject (though
sometimes the pronoun itself can be the subject) and a verb with its complements.
However, these patterns are not always enough. Determining where a clause ends
is not always a trivial task, since there might be commas or conjunctions internal
to the clause. Moreover, some conjunctions can also function as prepositions (for
example for) or as adverbs (for example yet, so). The problem regarding adverbs is
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Relative Pronouns Grammatical Rela-
tion
Referring to Num
who subject or object people 101
whoever subject people 0
whom object, especially in
non-defining relative
clauses
people 12
whomever object people 0
whose possession people, animals and
things
9
which subject or object animals and things.
Also, it can refer to a
whole sentence
142
that subject or object people, animals and
things in defining rel-
ative clauses; who or
which are also possible
569
whichever,whatever more than one place,
thing or idea
0
Table 7.11: Distribution of relative pronouns in the DrugDDI corpus.
easily resolved (at least in the most of cases) because MMTx labels them as CONJ
phrases when they function as coordinators (though sometimes MMTx mistakes the
phrases or does not be able to determine the types). The previous identification of
appositions and coordinate structures (see sections 7.3 and 7.2) allows to reduce the
number of commas and conjunctions internal to a clause. However, for each comma
or coordinator not included in any apposition or coordinate structure, it is required
to know whether the clause ends or not in it. Therefore, the above patterns have
been replaced with a set of heuristics based on the observation of fifty compound and
complex sentences from the training set. These heuristics are encoded in algorithm
1.
The input of the algorithm is the sentence in which its verb phrases have been
joined by the VP-pattern. First of all, the algorithm must check that the sentence
contains two or more clauses. Then, the sentence is reviewed while it contains any
separator marker. A separator marker can be a coordinator, a independent marker,
a dependent marker, a semicolon or a comma. The coordinators and subordinators
must be labeled by MMTx as CONJ phrases, otherwise, they are not considered
as conjunctions. Then, the algorithm iteratively finds candidate clauses, that is, a
substring of the sentence between markers. If the candidate clause contains a verb
phrase, then is considered as clause. The algorithm is able to decide the kind of
130
Algorithm 1 Clause splitting in a compound or complex sentence S
Require: S !=NULL and its verbs have been joined into VPs by the VP-pattern.
{S is a sentence.}
1: Define NUMVP as the number of verb phrases in S.
2: if NUMVP==1 then
3: S is a simple sentence {S only contains a indepedent clause.}
4: return
5: end if
6: INI :=0. {This is the position where S begins}
7: Look for a separator marker from INI in S, that is, a coordinator, a subordinator,
a independent marker, a semicolon or a comma
{The coordinator or independent marker must be classified as a CONJ phrase
by MMTx.}
8: Save the found marker into the variable MARKER.
9: Define FIN as the position where MARKER begins.
10: while MARKER!=NULL do
11: Define CLAUSE as the substring between INI and FIN.
12: if CLAUSE has any VP then
13: Mark CLAUSE as a clause in S. {The algorithm has found a clause. It
must continue with the search of the rest of clauses}.
14: Initialize CLAUSE to NULL.
15: To re-define INI as the position where MARKER ends.
16: else
17: Look for a separator marker from FIN in S.
18: end if
19: Save the found marker into the variable MARKER.
20: Define FIN as the position where MARKER begins.
21: end while
22: if CLAUSE!=NULL then
23: Mark CLAUSE as a clause.
24: end if
clause, that is, independent or subordinate. A clause is subordinate, if it begins
with a subordinate conjunctions and ends with a comma, or, the clause is attached
at the end of a main clause.
7.4.1. Rules for Sentence Simplification
Once appositions and coordinate propositions have been recognized, and com-
pound and complex sentences have been split into clauses, it is possible to apply a
set of rules for sentence simplification. These rules allow to simplify the complex and
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compound sentences in simple sentences. Then, the pattern-based approach for DDI
extraction will be applied on these simpler sentences. We have adapted some of the
simplification rules presented in [Siddharthan, 2006]. This approach also recognizes
relative clauses, apposition, coordination and subordination, but its goal is not the
relation extraction, but to provide syntactic simplification of sentences. “Syntactic
simplification is the process of reducing the grammatical complexity of a text, while
retaining its information content and meaning” [Siddharthan, 2006]. This process
can improve the performance of several NLP applications such as text summarization
or machine machine translation. Siddharthan [2006] proposes seven simplification
rules to generate new simplified sentences from the clauses of the complex and com-
pound sentences. We have only adapted three of these rules. Table 7.12 presents
the rules adapted in our approach, and examples 21 and 22 contain some sentences
broken up into simpler sentences by these rules. The clause CLAUSEREL(NP ) means
that it is attached to the noun phrase NP.
Simplification Rules Generated sentences
MARKER(,)? CLAUSE1, CLAUSE2
(1) CLAUSE1
(2) CLAUSE2
CLAUSE1(, )? MARKER CLAUSE2
(1) CLAUSE1
(2) CLAUSE2
CLAUSE1 NP CLAUSEREL(NP ) CLAUSE2
(1) CLAUSE1 NP CLAUSE2
(2) NP CLAUSEREL(NP )
Table 7.12: Rules to generate new simplified sentences from the clauses.
Example 21 Simplification of complex and compound sentences
(1) [Because]MARKER [busulfan is eliminated from the body via conjugation with
glutathione]CLAUSE1 [use of acetaminophen prior to (72 hours) or concurrent with
BUSULFEX may result in reduced busulfan clearance based upon the known property
of acetaminophen to decrease glutathione levels in the blood and tissues]CLAUSE2 .
(2) [Although]MARKER [the interactions observed in these studies do not appear to
be of major clinical importanceCLAUSE1 , [BREVIBLOC should be titrated with cau-
tion in patients being treated concurrently with digoxin, morphine, succinylcholine or
warfarin.]CLAUSE2
(3) [Trimeprazine also decreases the effect of heparin and oral anticoagulants,]CLAUSE1
[while]MARKER [MAOIs can increase the effect of trimeprazine.]CLAUSE2
7.5. Evaluating syntactic structures resolution
The evaluation of appositions and coordinate structures resolution was performed
on a set of fifty sentences from the training corpus. The sentences were randomly
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Example 22 The following sentence (containing a relative clause) is transformed
into the two simpler sentences (1) and (2)
Since the excretion of oxipurinol is similar to that of urate, uricosuric agents, which
increase the excretion of urate, are also likely to increase the excretion of oxipurinol
and thus lower the degree of inhibition of xanthine oxidase.
(1) Since the excretion of oxipurinol is similar to that of urate, uricosuric agents
are also likely to increase the excretion of oxipurinol and thus lower the degree of
inhibition of xanthine oxidase.
(2) Uricosuric agents (which) increase the excretion of urate.
selected and manually tested with the assistance of a linguist. Results are shown in
tables 7.13 and 7.14.
Structure TP FN FP P R F
Coordinate 24 14 0 1 0,63 0,77
Appositions 11 2 0 1 0,85 0,92
Table 7.13: Evaluation of appositions and coordinate structures resolution.
We observed that most of the errors were due to tagging and parsing mistakes
made by MMTx. Several studies have dealt with the error analysis of MMTx. Both
the error analysis and the improvement of MMTx are two issues that are out of
scope of this thesis. On the other hand, we are aware that this evaluation is quite
shallow to reach definite conclusions about performance. Future directions include
increasing the size of the corpus, trying to identify and resolve the errors of MMTx in
order to improve the appositive and coordinate structures resolution, and resolving
new kinds of constructions not addressed in the current approach like the kind of
apposition shown in example 23. In addition, we are planning to study the utility
of the Genia-GR [Tateisi et al., 2008] corpus in the evaluation, which consists of 50
abstracts and is annotated with grammatical relations.
Example 23 Appositions not linked by any marker.
Concomitant use of argatroban, an anticoagulant with antiplatelet agents may increase
the risk of bleeding.
A possible interaction between glyburide and ciprofloxacin, a fluoroquinolone antibiotic
has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.
Regarding the evaluation of the clause boundaries detection was also performed
on the aforesaid set of sentences. The results are shown in table 7.14.
Clause splitting is a very complex task, which consists of three tasks: identifying
clause starts, identifying clause ends, and finding complete clauses (many of them
may be nested clauses). The nesting of clauses is very common in biomedical texts.
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Structure TP FN FP P R F
Relatives 6 3 0 1 0,67 0,8
Rest of Clauses 16 7 0 1 0,7 0,82
Table 7.14: Results of clause splitting.
Example 24 Nested clauses
[Coadministration of CRIXIVAN and [other drugs that inhibit CYP3A4]] [may de-
crease the clearance of indinavir] and [may result in increased plasma concentrations
of indinavir].
Our method mainly fails to deal with the resolution of nested clauses (see example
24). However, though it obtains lower results, we believe that it is a good initial
approximation for clause splitting in the biomedical domain. As it is obvious, the
simplification rules also fail when the clause splitting is wrong. Future work should
include providing a more detailed error analysis of our method for clauses splitting
and simplification rules in order to improve the results, evaluating it on the Penn
Treebank used in CoNLL 2001 shared task [Tjong et al., 2001], and annotating a
small set of our corpus with clause boundaries to apply machine learning methods.
These methods have been widely applied to the clauses splitting [Carreras and Mar-
quez, 2005, Nguyen et al., 2009] achieving good results, because they are able to
learn from a relatively small annotated corpus.
7.6. The set of lexical patterns to extract DDIs
Even though the richness of natural language expressions, in practice, DDIs are
often expressed by a limited number of constructions. This fact favors the use of
patterns as an excellent method for their extraction. Based on the observation of
the training set, our pharmacist defined a set of lexical patterns (see table 7.15) to
capture the various language constructions used to express DDIs in pharmacological
texts. Moreover, the pharmacist provided synonyms for the verbs shown in table
7.16 that can indicate a possible interaction between drugs.
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Id Pattern
P1 DRUG MODAL? ADV ? (INTERACT|INTERFERE) WITH WORD0..5
(OF)? DRUG
P2 DRUG MODAL? ADV ? INCREASEsyn WORD0..5 (OF)? DRUG
P3 DRUG MODAL? ADV ? DECREASEsyn WORD0..5 (OF)? DRUG
P4 DRUG MODAL? ADV ? ALTERsyn WORD0..5 (OF)? DRUG
P5 DRUG MODAL? BE ADV ? INCREASEsyn WORD0..5 (BY)? DRUG
P6 DRUG MODAL? BE ADV ? DECREASEsyn WORD0..5 (BY)? DRUG
P7 DRUG MODAL? BE ADV ? ALTERsyn WORD0..5 (BY)? DRUG
P8 COADMINISTRATION OF DRUG (WITH|AND|PLUS) DRUG MODAL?
ADV ? [INCREASEsyn|DECREASEsynINTERACTsyn||ALTERsyn]
P9 COADMINISTRATION OF DRUG (WITH|AND|PLUS)
DRUG MODAL? BE? ADV ? RESULTsyn (TO|WITH|IN)
[INCREASEsyn|DECREASEsynINTERACTsyn||ALTERsyn]
P10 CAUTION MODAL? ADV ? BE? USED WHEN DRUG WORD?
(WITH|AND|PLUS) DRUG BE? ADMINISTERED CONCURRENTLY ?
P11 PATIENTS TREATED (WITH)? DRUG (WITH|AND|PLUS) DRUG
(CONCURRENTLY)? MODAL BE OBSERVED
P12 INTERACTION (OF|BETWEEN) DRUG (AND|WITH|PLUS) DRUG
MODAL? (BE)? WORD0..3 (OBSERVED|INCREASE|DECREASE|ALTER)
Table 7.15: Lexical patterns to extract DDIs.
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MODAL=[CAN|COULD|MAY|MIGHT|SHOULD|MUST|HAVE|HAS|HAD]
BE=[IS|ARE|WAS|WERE|BE|BEEN]
ADV is any adverbial except ’NOT’. For example, also,potentially, etc.
INCREASEsyn=[ELEVATE|ENHANCE|EXACERBATE|EXTEND|INCREASE|INTENSIFY|POTENTIATE|PROMOTE|PROLONG|
RAISE|RISE|STIMULATE]
DECREASEsyn=[AUGMENT|ELEVATE|ENHANCE|EXACERBATE|EXTEND|GO UP|INCREASE|INTENSIFY|POTENTIATE|
PROMOTE|PROLONG|RAISE|RISE|STIMULATE]
ALTERsyn=[ACCELERATE|ANTAGONIZE|ALTER|CHANGE|INDUCE|INFLUENCE|INHIBIT|INTERFERE]
RESULTsyn=[RESULTS|ASSOCIATED|SHOWN|RESULTED|OBSERVED|DETERMINED]
< DRUG PROPERTIES >=[PROPERTY|EFFECT|. . . ]
WHEN=[WHEN|IF|WHETHER]
ADMINISTERED=[CO-ADMINISTERED|COADMINISTERED|ADMINISTERED|TAKEN|GIVEN|USED|EMPLOYED]
PATIENTS=[PATIENTS|SUBJECTS]
TREATED=[TAKEN|TREATED|RECEIVING|TAKING]
Table 7.16: Auxiliary patterns
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7.7. Evaluation
This section explains in detail the experiments that we have carried out. First of
all, we describe our baseline experiment, the most basic experiment in which neither
coordinations, appositions nor clauses are tackled, that is, the pharmacological pat-
terns are directly applied to the text of sentences. The following steps summarize
this process:
Algorithm 2 Baseline procedure: patterns are directly matched against sentences.
1: The text is split into sentences to separately treat each of them.
2: Each sentence is parsed by MMTx providing lexical information, POS tags,
syntactic types, and semantic information on its words, tokens and phrases.
3: The DrugNer (chapter 4) identifies the drug names in sentence.
4: Select those sentences that contain two or more drug names.
5: Replace the drug names by the label DRUG.index, where index shows the order
of each drug in the list of drugs which occur in the sentence. For example, if the
sentence contains three drugs, their names will replaced with DRUG.1, DRUG.1
and DRUG.3 tags.
6: The set of pharmacological patterns is applied to the text of the sentence.
7: When a sentence has been correctly matched with a pattern, it must be checked
if the matching string includes the negative adverb (NOT ). If it is not included,
then a possible interaction has been found.
8: Drug names that occur in the matching are retrieved, and the pair of drug names
is proposed as a drug-drug interaction.
9: Check the pair of corresponding phrases is annotated as a DDI in the DrugDDI
corpus in order to evaluate it.
Table 7.17 shows the global and individual pattern performance of this basic
experiment. The baseline experiment achieves a reasonably precision (67.30%), buy
very low recall (14.07%). The average number of DDIs detected by each pattern is
35.5 (the number total of DDIs in the DrugDDI corpus is 3,160). Regarding the
individual pattern performance, the highest recall is achieved by the pattern P2 and
the highest precision by the pattern P8.
In the second experiment, appositions and coordinate structures are identi-
fied in text by the set of syntactic patterns described in sections 7.3 and 7.2.
The pharmacological patterns have been modified for considering these structures,
that is, they are extended for including the labels APPOSITION and COORD
as possible elements participating in the interactions. Thus, for this experiment,
DRUG:= [DRUG|APPOSITION|COORD]. The procedure of matching pattern for
this experiment is explained in algorithm 3.
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Id TP FP FN P(%) R(%) Fβ = 1(%)
P1 17 11 3010 60.71 0.56 1.11
P2 114 50 2913 69.51 3.77 7.15
P3 65 57 2962 53.28 2.15 4.13
P4 81 37 2946 68.64 2.68 5.15
P5 19 5 3008 79.17 0.63 1.25
P6 9 6 3018 60.00 0.30 0.59
P7 24 7 3003 77.42 0.79 1.57
P8 15 0 3012 100.00 0.50 0.99
P9 31 11 2996 73.81 1.02 2.02
P10 6 1 3021 85.71 0.20 0.40
P11 29 4 2998 87.88 0.96 1.90
P12 16 18 3011 47.06 0.53 1.05
GLOBAL 426 207 2601 67.30 14.07 23.28
Table 7.17: Basic Experiment Results. TP=True Positive, FP=False Positive,
P=Precision, R=Recall.
Figures 7.6 and 7.7 show two sentences which are interpreted by the syntactic
patterns and matched against the lexical patterns in order to extract DDIs.
Example 25 Examples of extended patterns to include appositions and coordinate
structures as possible interacting elements.
P1 (DRUG|APPOSITION|COORD) MODAL? ADV ? (INTERACT|INTERFERE)
WITH WORD0..5 (OF)? (DRUG|APPOSITION|COORD)
P2 (DRUG|APPOSITION|COORD) MODAL? BE ADV ? INCREASEsyn WORD0..5
(BY)? (DRUG|APPOSITION|COORD)
Table 7.18 shows the global and individual pattern performance of the second
experiment. Recall is improved by the inclusion of the appositions and coordinate
structures, however, precision is lower. The average number of DDIs detected by
each pattern is 64.83. The pattern P2 still achieves the highest recall, and the
highest precision by the pattern P10. Therefore, the detection of these structures
achieves to improve the recall (almost 12%) with a significant decrease in precision
of almost 19%. This decrease can be attributed to the errors introduced during the
syntactic processing.
We now explain the last experiment that combines the detection of appositions,
coordinate structures, clause splitting and simplification rules. First of all, apposi-
tions and coordinate clauses are detected applying the previous described procedure
(3) step by step until the sixth step. Then, the algorithm 1 (described in section
7.4) is applied to in order to split the complex and compound sentences into their
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Algorithm 3 Pattern Matching including the detection of appositions and coordi-
nate structures
1: The text is split into sentences. Each sentence is treated separately.
2: Each sentence is parsed by MMTx providing lexical information, POS tags,
syntactic types, and semantic information on its words, tokens and phrases.
3: The DrugNer (chapter 4) identifies the drug names in the sentence.
4: Select those sentences that contains two or more drug names.
5: The shallow syntactic information provided by MMTx is used to generate a
sequence of the syntactic types of the phrases in the sentence.
6: The patterns shown in tables 7.3 and 7.3 are applied to the sequence in order
to detect its appositions and coordinate structures. If some structure is de-
tected, this will be replaced with the label APPOSITION.index or COORD.index,
depending on case.
7: The drug names are replaced by the label DRUG.index
8: The text of sentence is generated by concatenating their text phrases (except
the text of the appositions and coordinate structures).
9: If generated text is matched by some pattern and the matching string does not
contain the negative adverb, a candidate interaction has been found.
10: If the matching string contains appositions or coordinate structures, these must
be unfolded in order to obtain the individual interacting elements (as many as
the number of elements which make up each structure) and build the list of
interactions.
11: The list of interactions is evaluated on the DrugDDI corpus.
clauses. Then, new sentences are generated from these clauses by the simplifica-
tion rules described in subsection 7.4.1. Finally, the previous procedure of matching
pattern (algorithm 3) is applied to these new sentences from the seventh step. The
results are shown in table 7.19. While the inclusion of appositions and coordinate
structures achieved to improve the recall, and therefore, the f-measure, the detection
of clauses has not improved the performance. This is mainly due to many interac-
tions occurring in complex sentence often span several clauses. The lexical patterns
are not able to capture these interactions. Some examples of this kind of sentences
are shown in examples 26.
As it has been aforementioned, the errors introduced during the MMTx analysis
negatively affect the results obtained with our approach. Also, we are aware that our
clause splitting method is too simplistic to deal with the complexity of biomedical
sentences. Another shortcoming of our approach is that the negation has been
addressed by an heuristic too simplistic. So, the sentence shown in example 28
matches the pattern P1, however, it does not represent any interaction. This is
due to the previous negation studies have not shown has not been detected. This
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Id TP FP FN P(%) R(%) Fβ = 1(%)
P1 71 49 2956 59.17 2.35 4.51
P2 212 175 2815 54.78 7.00 12.42
P3 119 147 2908 44.74 3.93 7.23
P4 138 124 2889 52.67 4.56 8.39
P5 40 43 2987 48.19 1.32 2.57
P6 13 20 3014 39.39 0.43 0.85
P7 30 20 2997 60.00 0.99 1.95
P8 27 20 3000 57.45 0.89 1.76
P9 60 28 2967 68.18 1.98 3.85
P10 11 4 3016 73.33 0.36 0.72
P11 38 155 2989 19.69 1.26 2.36
P12 19 35 3008 35.19 0.63 1.23
GLOBALS 778 820 2249 48.69 25.70 33.64
Table 7.18: Results for extended patterns with appositions and coordinate struc-
tures.
could be avoid by a deeper treatment of the negation. Finally, the richness of
natural language causes that our patterns are not enough for identifying many of
the interactions (see examples 27).
Id TP FP FN P(%) R(%) Fβ = 1(%)
P1 71 49 2956 59.17 2.35 4.51
P2 194 154 2833 55.75 6.41 11.50
P3 121 141 2906 46.18 4.00 7.36
P4 137 123 2890 52.69 4.53 8.34
P5 39 36 2988 52.00 1.29 2.51
P6 9 14 3018 39.13 0.30 0.59
P7 28 20 2999 58.33 0.93 1.82
P8 31 28 2996 52.54 1.02 2.01
P9 60 28 2967 68.18 1.98 3.85
P10 3 3 3024 50.00 0.10 0.20
P11 39 154 2988 20.21 1.29 2.42
P12 19 35 3008 35.19 0.63 1.23
GLOBALS 751 785 2276 48.89 24.81 32.92
Table 7.19: Results of the patterns applied to the clauses
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Figure 7.6: Matching procedure
Example 26 DDIs spanning several clauses
[The Cmax of norethindrone was 13% higher] when [it was coadministered with
gabapentin]
[Serum theophylline concentrations increase] when [grepafloxacin is initiated in a
patient maintained on theophylline].
Therefore, [when MIDAMOR and non-steroidal anti-inflammatory agents are used
concomitantly], [the patient should be observed closely to determine if the desired
effect of the diuretic is obtained].
[When such drugs are withdrawn from a patient receiving MICRONASE ], [the pa-
tient should be observed closely for hypoglycemia.]
7.8. Conclusions
In this section, we have proposed a hybrid method that combines the resolution
of complex linguistic constructions and matching pattern.
Regarding the resolution of the linguistic constructions, as it was pointed out in
section 7.5, most of the errors are due to mistakes introduced in the MMTx level
and the difficulty of resolving nested clauses, so frequent in biomedical texts. Future
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Figure 7.7: Example of sentence with an apposition.
Example 27 Patterns are not enough to identify some interactions
In a pharmacokinetic substudy in patients with congestive heart failure receiving
furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral
clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13%
and 15%, respectively, on the second day of therapy and had returned to baseline
values by day 87.
In subjects who had received 21 days of 40 mg/day racemic citalopram, combined
administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalo-
pram AUC and Cmax of 43% and 39%, respectively.
directions include trying to identify and resolve the errors of MMTx, improving our
clause splitting algorithm, proposing new suitable simplification rules to regenerate
the simple sentences from clauses, checking what occurs if the resolutions are ap-
plied in a different order, studying the utility of other corpora such as Genia-GR or
Penn Treebank in the evaluation, and increasing the size of the corpus and annotat-
ing it with these linguistic constructions in order to apply machine learning methods.
Example 28 Negation of interaction.
While studies have not shown DRUG. interact with DRUG., caution should be ex-
ercised, nonetheles, since interactions have been with drug.
Concerning the performance in the extraction of DDIs, the variability of natural
language expression makes it difficult for our method to accurately detect all se-
mantic relations occurring in text since sentences conveying the same relation may
be composed lexically and syntactically differently. Inversely, sentences that are
lexically common may not necessarily convey the same relation. Thus, our lexical
patterns are not enough to identify many of the interactions. Future work will in-
clude application of the SPINDEL system [de Pablo-Sa´nchez and Mart´ınez, 2009]
to semi-automatically learn new patterns from biomedical texts. SPINDEL is a
bootstrapping method which has achieved good results for named entity recognition
task in general domain. In addition, we will carry out a more exhaustive treatment
of negation and modality in sentences.
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Chapter 8
Using a kernel-based approach for
Drug-Drug Interaction extraction
8.1. Introduction
The diversity of natural language makes relation extraction a difficult task. In
the biomedical domain, this task is even more complicated due to the complexity of
biomedical sentences. Pattern-based approaches are not able to capture the semantic
relations when there are discontinuous word patterns or long-distance dependencies
among the entities in a sentence [Kim et al., 2008]. As it was seen in chapter 7,
our pattern-based approach obtains relatively low performance. The best results
achieved a recall of 25,7% and a precision of 48,7%. Pattern-based approaches
achieve low recall rates because lexical-syntactic patterns are not enough to detect
all semantic relations occurring in text, since sentences containing the same semantic
relation can be lexically and syntactically different. Inversely, sentences that are
lexically and syntactically similar, may not necessarily contain the same relation.
The objective is to propose an alternative approximation for the extraction of drug-
drug interactions that overcomes the shortcomings of our pattern-based approach
and achieves to improve its results.
Recent studies on relation extraction have shown the advantages of machine
learning approach to this problem [Zhang et al., 2008, Giuliano et al., 2007b, Bunescu
and Mooney, 2005, Jiang and Zhai, 2007, Culotta and Sorensen, 2004, Zelenko et al.,
2003]. In machine learning, we can distinguish two important paradigms: feature-
based and kernel-based systems. In the first paradigm, a set of features is carefully
selected from different levels of text analysis such as tokenization, part-of-speech
tagging or syntactic analysis. However, the huge amount of words may produce
high or even infinite dimensionality of the feature space becoming computationally
infeasible. In addition, features are not able to correctly capture the structural
information from complex structures such as parse trees or dependency graphs. This
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type of representation based on features has been widely used [Kambhatla, 2004,
GuoDong et al., 2005, Jiang and Zhai, 2007]. The second paradigm proposes the
use of the structural representations (such as sequences, parse trees or dependency
graphs) as an alternative to the set of features, offering a good solution to the
shortcomings of the feature-based paradigm. Kernel functions are designed on some
structured representation of the relation instances to capture the similarity between
two relation instances, thus preserving important structural information and without
need to explicitly define a set of features. Recently, these kernel methods have
been successfully applied to the detection of semantic relations in both general and
biological domains [Bunescu and Mooney, 2005, Zhang et al., 2008, Kim et al., 2008].
We can formulate the extraction of DDIs as a binary classification problem.
Given a sentence,
S = w1w2..DRUG1..DRUG2..wn (8.1)
the objective is to find a function F that is able to decide if the drugs DRUG1
and DRUG2 contained in the sentence S express a DDI:
F (T (S)) =
{
1 if DRUG1 and DRUG2 interact
0 otherwise
(8.2)
F can be a discriminative classifier such as Support Vector Machine, Voted Per-
ceptron, Log-linear model, among others. T(S) is the representation of the sentence
S, that can be a set of features extracted from S, or a structured representation of
the sentence. If S is represented by a set of features extracted from it, then, we can
use a similarity function like cosine distance to compare its representation with the
set of positive and negative examples, and so determine if its drugs interact. If a
structured representation is used, then it is necessary to define a similarity metric,
that is a kernel function, in order to estimate the similarity between the structured
representation of the sentence and the structured representations of the positive and
negative relation instances (examples).
Parse trees are a natural representation that allows to directly capture the struc-
tural information within sentences. Several approaches [Zelenko et al., 2003, Li
et al., 2008] have shown that tree kernels not only outperform feature-based meth-
ods, they also achieve better results than sequence kernels. However, tree kernels
are relatively slow compared to feature classifiers and sequence kernels [Bunescu
and Mooney, 2005, Li et al., 2008]. The complexity of tree kernels and the need to
evaluate thousands of them during the process of classification may render them in-
appropriate for practical purposes. For this reason, we believe that sequence kernels
are more appropriate than tree kernels for the extraction of drug-drug interactions
since these methods should be integrated into a real application in which the pro-
cessing time will be a priority.
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Figure 8.1: Sentence representation: Structure-based representation vs feature-
based representation.
In this chapter, we describe our second approximation for DDI extraction based
on the kernel-based approach presented by Giuliano et al. [2006]. This approach
combines two sequence kernel methods to integrate the information of the whole
sentence where the relation occurs and the context information about the interact-
ing entities. Each relation instance is represented as a sequence of words taking
into account the sequential order of words in the sentence. The approach only needs
shallow syntactic information such as sentence splitting, tokenization, part-of-speech
(PoS) tagging and lemmatization to build the structured representations of relation
instances. We have used the java tool for relation extraction (jSRE)1, which is
based on Giuliano et al. [2006]’s approach. jSRE has been used for relation extrac-
tion with good results in both general and biological domains [Giuliano et al., 2006,
2007b]. The fact that this tool only needs shallow syntactic information is crucial
for us since we have analyzed texts using the biomedical parser MMTx, which only
provides shallow syntactic information. General-purpose syntactic parsers such as
[Collins, 1996] or [Charniak, 2000] are not able to deal with the complexity of the
biomedical sentences. There are no syntactic parsers trained on biomedical texts,
except Genia dependency parser [Sagae, 2007] and the parser presented in [Lease
and Charniak, 2005]. We decided to use MMTx instead of the aforesaid parser be-
cause MMTx also provides semantic information that can be exploited to identify
drug names as well as other biomedical concepts. As it will be explained later, the
information provided by MMTx is used to represent each relation instance as a se-
quence of words, PoS tags and the tag DRUG (drug names are labeled with this
label).
1http://tcc.itc.it/research/textec/tools-resources/jsre.html
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The chapter is organized as follows: the method proposed by Giuliano et al.
[2006] is described in detail in section 8.2. Section 8.3 describes the experiments
conducted. Finally, section 8.4 draws some conclusions and unresolved issues, and
suggests directions for future work.
8.2. A shallow syntactic kernel for relation ex-
traction
This section describes the kernel-based approach proposed in [Giuliano et al.,
2006]. As it was explained in chapter 6, kernels-based approaches [Shawe-Taylor and
Cristianini, 2004] provide an effective alternative to feature-based approaches. The
main advantages of these methods is that they can exploit the structural descriptions
of words, phrases and sentences, and process them efficiently. Kernels do not need
to represent each data instance into a flat set of features, but just define a similarity
measure that determines the similarity between instances. The intuitive idea behind
a kernel method is to find a mapping of the input space into a new feature (vector)
space in which problem solving is easier.
Formally, a kernel function is a binary function K : XxX− > [0,∞) that maps
a pair of objects x, y ∈ X to their similarity score K(x, y). The kernel function must
satisfy
∀x, y ∈ X : k(x, y) = 〈φ(x), φ(y)〉, (8.3)
where φ : X → F ⊆ Rn is a mapping from the input space X to an vector space
F. The mapping function φ transforms each instance x ∈ X in a feature vector
φ(x) = (φ1(x), φ2(x), . . . , φm(x)), where φi : X → R, with no need to know the
explicit representation of the x. Then, the mapping function φ allows to express
K(x, y) as the dot-product of the features vectors of the input objects x and y.
∀x, y ∈ X : k(x, y) = 〈φ(x), φ(y)〉 =
m∑
i=1
φi(x).φi(y). (8.4)
Giuliano et al. [2006] have developed two different sequence kernels: global con-
text and local context kernels. Furthermore, since several studies [Zhang et al., 2006,
Li et al., 2008, Kim et al., 2008, Reichartz et al., 2009] have shown that the com-
bination of kernels overcomes the performance of the individual kernels, they also
proposed a linear combination of their global and local kernels. Any kernel func-
tion can work with any kernel-based algorithms. Support-vector machines (SVMs)
or nearest neighbor classification are examples of machine learning algorithms that
can be formulated as kernel-based algorithms. Giuliano et al. [2006] used SVMs,
in particular, the SVM package LIBSVM [Chang and Lin, 2001] to embed their
proposed kernels and perform the experiments.
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8.2.1. Global Context Kernel
The global context kernel defined in [Giuliano et al., 2006] is designed to dis-
cover the presence of a relation between two entities. It is based on the following
observation in the work of Bunescu and Mooney [2006]: “when a sentence asserts
a relationship between two entity mentions, it generally does this using one of the
following three patterns: Fore-Between, Between, and Between-After”. That is, a
relationship between two entities is usually expressed using the words that appear
before and between both entities, or just between them, or between and after the
two entities.
Example 29 Fore-between, between, and between-after contexts
Fore-Between: tokens before and between the two drugs. For instance: Interaction
between 〈DRUG〉 and 〈DRUG〉.
Between: only tokens between the two drugs. For instance: 〈DRUG〉 can interact
with 〈DRUG〉’.
Between-After: tokens between and after the two drugs. For instance: 〈DRUG〉
taken concurrently with 〈DRUG〉, may affect blood levels’.
While [Bunescu and Mooney, 2006] represented each context with subsequence
of words, POS tas, entity and shallow syntactic types, in [Giuliano et al., 2006] each
context is only represented by a bag-of-words. To calculate the similarity between
two different global contexts, they propose a n-spectrum kernel [Shawe-Taylor and
Cristianini, 2004], which counts common ngrams that two contexts have in common.
Formally, given a relation instance R, its global context C is represented as a row
vector, as follows:
φC(R) = (tf(t1, C), tf(t2, C), . . . , tf(tm, C)) ∈ R
m (8.5)
where tf(ti, C) counts the number of occurrences of the token ti in the context C.
The tokens of the entities in C are not taken into account at the calculation of φC(R),
however, punctuation and stops words are included. To improve the classification
performance, they extended the definition of φC to embed n-grams of (contiguous)
tokens up to n = 3. For each context (fore-between, between, or between-after), a n-
gram kernel method is obtained by substituting φC(R) into equation 8.4. The global
context kernel (see equation 8.6) is defined as the sum of the n-grams kernels that
work on the fore-between (KFB), between (KB) and between-after (KFBA) contexts,
respectively.
KGlobalContext(R1, R2) = KFB(R1, R2) +KB(R1, R2) +KBA(R1, R2) (8.6)
Figure 8.2 and 8.3 show some examples in which the global context kernel is
calculated with n-gram=1 and n-gram=2 respectively, to estimate the similarity
between relation instances.
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Figure 8.2: Global context kernel (n-gram=1).
Figure 8.3: Global context kernel (n-gram=2).
8.2.2. Local Context Kernel
The local context kernel is based on the hypothesis that the context information
of the candidates entities is especially useful in verifying if there is a relationship
between them. In particular, windows of limited size around the entities provide
useful clues to identify the roles of the entities within a relation. Thus, Giuliano
et al. [2006] use the information provided by the two local contexts of the candidate
interacting entities, called left and right local context respectively. They consider a
context window of W = ±2 tokens around the candidate entity, that is:
C = t
−w, . . . , t−1, t0, t1, . . . , t+w, (8.7)
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where t0 is the token of the candidate entity. The following features are proposed
to represent each local context:
Token: the token itself.
Lemma: the lemma of the token.
PoS : the PoS tag of the token.
Stem: The stem of the token.
Orthographic: This feature maps each token into equivalence classes that en-
code features such as capitalization, punctuation, numerals
Each example is basically represented as an instance of the original sentence with
the two candidate entities properly annotated, using the tag DRUG. The roles of the
candidates are labelled with the tags A (agent) and T (target). In our case, agent
is always the first argument and target the second argument. Any other entity and
tokens that are not entities are labelled O. In our approach, we use stem feature
instead of lemma, because MMTx does not provide lemmatization. To obtain the
stems, we use the Porter algorithm [Porter, 1980]. Figure 8.4 shows a sentence and
the representation of one of its relation intances. The local and right local contexts
for this relation instance are also shown.
Figure 8.4: Example of left and right local contexts (n-gram=2) in a relation in-
stance.
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The local context can be represented as a row vector, as follows:
φC(R) = (f1(C), f2(C), . . . , fm(C)) ∈ 0, 1
m (8.8)
where fi is a feature function that return 1 if it is active in the specified position
of the context window C, 0 otherwise (see figure 8.5). Kleft and Kright are defined
by substituting the embedding of the left and right local context into equation 8.4,
respectively. Then, the local context kernel can be defined as the sum of the left
context kernel and right context kernel, as follows:
KLocalContext(R1, R2) = Kleft(R1, R2) +Kright(R1, R2) (8.9)
Figure 8.5 shows the mapping function φ for the right local context of the relation
instance in figure 8.4. KLocalContext differs substantially from KGlobalContext as it
considers the ordering of the tokens and the features space is enriched with PoS
tags, lemmas, stems and orthographic features.
Figure 8.5: Mapping function φ for the right local context (window-size=2) of the
relation instance in figure 8.4.
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8.2.3. Shallow Linguistic Kernel
To integrate information from heterogeneous feature spaces (such as tokenization,
PoS tags, or entity tagging), both kernels must be normalized:
K(x1, x2) =
〈φ(x1), φ(x2)〉
‖ φ(x1) ‖‖ φ(x2) ‖
(8.10)
where φ(.) is the embedding vector and ‖ . ‖ is the 2-norm.
Finally, Giuliano et al. [2006] define a shallow linguistic kernel that is a linear
combination of the global and local kernels. It is defined as follows:
KShallowLinguistic(R1, R2) = KGlobalContext(R1, R2) +KLocalContext(R1, R2) (8.11)
Experiments were performed on the two biomedical data sets: the AImed and
LLL corpora. They adopted the evaluation methodology OAOD (one answer per
occurrence in the document) [Lavelli et al., 2004], that is, each individual occur-
rence of a protein interaction must be extracted from the document. Experiments
were performed using the correct named entities, that is, those manually annotated
in the corpora. The results obtained on the AIme corpus are: precision=60.0%,
recall=57.2%, and f-measure=59%. Better performance was achieved on the LLL
corpus, with a precision of 62.1%, a recall of 61.3%, and a f-measure of 61.7%.
8.3. Evaluation
Giuliano et al. [2006] have developed the java tool for relation extraction (jSRE)
to implement their shallow linguistic kernel. This tool has shown good performance
in both general and biological domains [Giuliano et al., 2006, 2007b]. Our objective
is to evaluate the shallow linguistic kernel in a domain different from the domains in
which it has already been used (news [Giuliano et al., 2007b,a] and PPIs [Giuliano
et al., 2006]). We conducted a set of experiments to study the results obtained in
the extraction of DDIs.
The layout of the section is split into two main parts. The first one describes
how we have generated examples from the DrugDDI corpus and built the datasets
for training and testing. The second part describes the performed experiments and
the obtained results.
8.3.1. Datasets
In this approach, DDI extraction is formulated as a supervised learning problem,
in particular, as a classification task. Therefore, a crucial task is to generate suitable
datasets to train and test a classifier from the DrugDDI corpus.
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The DrugDDI corpus consists of 579 files. The average number of sentence per
document is 10.3, and the average number of tokens per document is 211.5. The
corpus contains a total of 5,806 sentences with at least two drugs and a total of 3,160
drug-drug interactions. Since most of the existing approaches for relation extraction
usually assume that the argument entities of the relation occur in the same sentence,
we have only considered the interactions between drugs within the same sentence.
Although there may be relations between drugs in different sentences, they have not
been annotated in the DrugDDI corpus . The average number of interactions per
document is 5.46 and per sentence 0.54.
Figure 8.6: Real DDIs occurring in a sentence.
Figure 8.7: Examples generated from the sentence in figure 8.6.
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Figure 8.8: Labeling candidate drugs
The simplest way to generate examples to train a classifier for a specific relation R
is to enumerate all possible ordered pairs of entities in sentences. We have proceeded
in a similar way. Given a sentence S, as the own shown in figure 8.6, with at least
two drugs, we can define D as the set of drugs in S. The set of generated examples
for this sentence S, is defined as follows:
{(Di, Dj) : Di, DjǫD, 1 <= i, j <= N, i 6= j, i < j} (8.12)
The works presented in [Giuliano et al., 2006] and [Giuliano et al., 2007b] detect the
presence of a given relation and also identify the roles in the relation for each of the
entities. So each example is the copy of the original sentence S in which the candi-
dates are assigned distinctive attributes to specify their roles (AGENT,TARGET )
in the relation. In our case, although there are asymmetric interactions between
drugs, the roles of the interacting drugs have been neither included in the annota-
tion of the corpus, nor addressed in this thesis. Hence we enumerate the candidate
pairs without taking into account the drugs order, that is, (Di, Dj) and (Dj, Di) are
considered as one only candidate pair, that is,
(Di, Dj) = (Dj, Di) (8.13)
Since we do not take into account the order of the drugs in the sentence, each
example is the copy of the original sentence S in which the candidates are assigned
the tag DRUG, while the drugs not involved are assigned the tag OTHER (see figure
8.8). The set of possible candidate pairs is the set of 2-combinations of the whole
set of drugs in the sentence S, and thereby, the number of examples is
CN,2 =
(
N
2
)
(8.14)
where N is the number of drugs in S. If the interaction exits between the two
candidate drugs, then the example is labeled 1, otherwise, it is labeled 0. The
sentence shown in figure 8.6 contains four drugs (aspirin, probenecid, sulfinpyrazone
155
and phenylbutazone), and thereby, the total number of examples generated is C4,2 =(
4
2
)
= 6. Figure 8.7 shows the examples generated from this sentence. In each
example, the two drugs selected are considered as candidate interacting drugs, while
the other drugs are not considered as they do not participate in the interaction. It is
not necessary to generate examples for each ordered pair of drugs since this approach
considers the drug-drug interactions as symmetric relations.
Figure 8.9: Architecture for DDI extraction
Once we have generated the set of relation instances from the DrugDDI corpus,
we have split this set in order to build the datasets for training and testing the
different models. In this work, the extraction problem is reformulated as a binary
classification task. The relation extraction is performed in two distinct phases:
learning and classifying (see figure 8.9). First, one model must be learned for drug-
drug interactions from training dataset. This model is then applied in order to
identify the interactions occurring in the documents that form the testing dataset.
Positives Negatives total
3,160 (10.27%) 27,597 (89.72%) 30,757
Table 8.1: Total of positive and negative examples (relation instances) generated
from the DrugDDI corpus.
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Table 8.1 shows the total number of examples generated from the DrugDDI cor-
pus. In our corpus, sentences that contain at least two drugs are selected obtaining
3,775 sentences with 3,313 drugs. Possible pairs of drugs are 30,757, specifically,
3,160 are DDIs, and 27,597 are not. The corpus DrugDDI consists of 579 files, we
randomly choose 75% of them to build the training dataset, which will be used to
train and adapt the different models. The remaining 142 files are used in the final
evaluation of the best model. Table 8.2 shows the distribution of the documents,
sentences, drugs and DDIs in each dataset. So, the dataset for training and tuning
consists of 437 files and contains 4,578 sentences, 2,560 drugs and 2,421 DDIs. This
dataset will be used to build several models based on different configurations of the
jSRE tool. The final testing dataset consists of 142 files, containing 1,228 sentences,
753 drugs and 739 DDIs.
Set Documents Sentences Drugs DDI
Training 437 4,578 2,560 2,421
Final Test 142 1,228 753 739
Total 579 5,806 3,313 3,160
Table 8.2: Training and testing datasets.
Table 8.3 shows the distribution of the positive and negative examples in the
different datasets. Around 90% of instances in the training dataset are negative
examples, and only almost a 10% are positive examples. The distribution between
positive and negative examples is similar in the final testing dataset.
Set Documents Examples Positives Negatives
Training 437 25,209 2,433 (9,65%) 22,776 (90,35%)
Final Testing 142 (25%) 5,548 688 (12,40%) 4,860 (87,60%)
Total 579 30,757 3,121 (10,15%) 27,636 (89.85%)
Table 8.3: Distribution of the positive and negative examples in the training and
testing datasets.
8.3.2. Experimental results
Since one of our main objectives is to study the influence of the configuration
parameters of the jSRE tool (window size of the local context and n-gram of the
global context) on the final performance, we have designed a set of experiments in
which these parameters are varied.
We consider as baseline system, so called allDDIs, the case in which every relation
instance is classified as a DDI, that is, as a positive example. This baseline yields
the maximum recall, but a low precision. The baseline system is evaluated on final
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testing dataset achieving a baseline precision of 11% and a baseline f-measure of
19% (see table 8.4, row 1). We used 10-fold cross validation to train the classifier
on the training dataset. For each run, nine folds are used to train a model that is
evaluated on the other fold. The folds were built considering that examples from the
same sentence must belong to the same fold. We follow the evaluation methodology
OAOD [Lavelli et al., 2004], that is, each individual occurrence of a DDI must be
extracted from the document.
We set out various experiments varying the values of the configuration param-
eters concerning the local (window-size) and global contexts (n-grams) in order to
obtain the best performance. Giuliano et al. [2006] only considered n-grams up to
n=3 (global context) and only reported results with window size ±2 (local context).
Experiment P R F Time (ms.)
allDDIs 0.11 1 0.19 1,534
n-gram=1, window-size=1 0.51 0.78 0.62 3,915,762
n-gram=2, window-size=1 0.54 0.75 0.63 6,039,573
n-gram=3, window-size=1 0.57 0.72 0.64 8,353,649
n-gram=4, window-size=1 0.56 0.73 0.63 8,075,174
n-gram=5, window-size=1 0.56 0.72 0.63 7,930,885
n-gram=1, window-size=2 0.55 0.76 0.64 9,291,000
n-gram=2, window-size=2 0.55 0.73 0.63 6,976,556
n-gram=3, window-size=2 0.55 0.72 0.62 9,705,327
n-gram=4, window-size=2 0.53 0.76 0.63 9,286,145
n-gram=5, window-size=2 0.56 0.72 0.63 9,304,274
n-gram=1, window-size=3 0.52 0.77 0.62 5,971,677
n-gram=2, window-size=3 0.56 0.75 0.64 8,165,894
n-gram=3, window-size=3 0.55 0.75 0.64 10,224,599
n-gram=4, window-size=3 0.57 0.72 0.64 10,433,904
n-gram=5, window-size=3 0.57 0.73 0.64 14,945,000
n-gram=1, window-size=4 0.52 0.76 0.62 6,874,866
n-gram=2, window-size=4 0.55 0.72 0.62 9,022,820
n-gram=3, window-size=4 0.55 0.70 0.62 11,682,749
n-gram=4, window-size=4 0.57 0.71 0.63 11,742,036
n-gram=5, window-size=4 0.56 0.70 0.62 12,163,292
n-gram=1, window-size=5 0.52 0.80 0.63 8,201,097
n-gram=2, window-size=5 0.56 0.73 0.63 10,478,464
n-gram=3,window-size=5 0.57 0.70 0.63 12,078,133
n-gram=4, window-size=5 0.55 0.70 0.62 12,732,470
n-gram=5, window-size=5 0.57 0.69 0.63 12,578,524
Table 8.4: Experiment results based on different configurations of jSRE tool
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Experiment results (see table 8.4) show that the performance does not differ
significantly from one configuration to another. Precision ranges from 51% to 57%,
recall from 72% to 80%. The highest precision (57%) is achieved when n-gram is
equal to 3 and window-size is equal to 1 (72% recall). Other configurations also
achieve this precision, however, they yield lower recall than 72% and take much
more time to train its model. The highest recall is achieved when n-gram is equal
to 1 and window-size is equal to 5 (52% precision). Increasing the value of the
parameter n-gram does not influence the results since it is few probable that two
relation instances share long n-grams. Similarly, the choice of the parameter window-
size does not seem to affect the performance significantly. This is logic because this
parameter is designed to identify the roles of the entities within a relation, which are
not tackled in these experiments. Table 8.4 also shows the time needed to train each
model. While the increase of the configuration parameters does not seem to improve
the results, however results in a drastic increase of the training time. Among all
trained models, we choose one that minimizes the training time and maximizes the
precision (n-gram=3, window-size=1), because it avoids overloading end users with
too many false positives in the extraction of DDIs.
In addition, we have evaluated each kernel separately, in order, to analyze the
contributions of the global and local kernels to the overall shallow linguistic kernel.
Although, several global and local kernels were trained with different values of their
parameters (n-gram and window-size respectively), table 8.5 only presents the best
results corresponding to the best configurations. Results show that global context
is more useful than the local one in detecting DDIs. Giuliano et al. [2006] used the
local context kernel to identify the roles of the candidate entities within a relation.
Although in our approach the roles are not tackled, the results show that the local
context kernel also assists in the detection of DDIs since the combination of both
kernels achieves to improve the performance, especially the precision.
Kernel P R F Time (ms.)
Global Context (n-gram=3) 0.53 0.72 0.61 6,731,856
Local Context (window-size=2) 0.51 0.68 0.58 3,453,999
Shallow (n-gram=3, window-size=1) 0.57 0.72 0.64 8,353,649
Table 8.5: Comparative analysis of global, local and shallow kernels
Finally, the shallow kernel (trained with n-gram=3 and window-size=1) was
evaluated on the final testing dataset achieving a precision of 50%, a recall of 67%
and a f-measure of 57% (see table 8.6). It is an improvement of almost 40% with
regard to the baseline f-measure. The results are lower than those reported above
for its cross validation experiment (table 8.4, row 4). This may be due to the
final testing dataset can contain examples more complicated than those in the folds
generated from the training dataset. To validate this hypothesis, we have evaluated
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some of the above models on the final testing dataset. Every model shows lower
performance than in cross validation.
testing size TP FP FN P R F
allDDIs 7,017 747 6,270 0 0.11 1 0.19
n-gram=1, window-size=2 7,017 472 569 275 0.45 0.63 0.53
n-gram=2, window-size=3 7,017 518 547 229 0.49 0.69 0.57
n-gram=2, window-size=2 7,017 527 538 220 0.49 0.71 0.58
n-gram=3, window-size=1 7,017 503 509 244 0.50 0.67 0.57
n-gram=3, window-size=3 7,017 498 490 249 0.50 0.67 0.57
n-gram=4, window-size=3 7,017 497 497 250 0.50 0.67 0.57
Table 8.6: Final results obtained by the shallow kernels.
Learning curves are useful to show the results achieved by the learning process
for different training sizes. We now describe the process of construction of the
learning curves. We must estimate the f-mesure, precision and recall for different
training sizes. We have used the configuration of the jSRE that has shown the
best results in the previous experiments (window-size=1, n-gram=3). In order to
generate datasets of different sizes, the training dataset is split into 10 folds of
approximately the same size. Each fold consists of 10% of the total instances, that
is, each fold roughly contains 3,076 instances. We impose the following restriction:
relation instances of the same sentence must always be in the same fold. We can
merge the folds in order to generate new sets of different sizes. So, the first size is
3,076, and this is successively increased adding a new fold: the second one is 6,152,
the third one is 9,228, and so on until the total number of instances: 30,757. We
may randomly combine all folds in order to obtain all possible sets for each one of
the training sizes. For example, building a set using the 30% of instances (92,289)
requires to merge three different folds, and for this case, we may generate
(
10
3
)
= 120
different sets. For the training size 6,152, we may generate
(
10
2
)
= 45 different sets.
Training each model and evaluating on the final dataset, it a very time consuming
task. Therefore, we have decided to generate ten sets from all possible combinations
for each training size. Finally, a model is learned on each set and evaluated on the
final dataset. In order to obtain the results for a given size, we calculate the average
of the f-measure, precision and recall of the models that have been trained on the
ten sets of that size. Table 8.7 shows the performance obtained with each of the
training sizes.
Figure 8.10 shows the learning curves generated. We can see that increasing the
training size, the performance is hardly improved. The annotation of new sentences
do not seem to help for the improvement of the performance (from 40%). The dashed
lines represent the precision and f-measure obtained by the baseline experiment
(allDDIs). It is obvious that the baseline achieves a recall of 100%, but only a
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size Avg. P Avg. R Avg. F
3,075.7 (10%) 0,45 0,53 0,48
6,151.4 (20%) 0,47 0,6 0,53
9,227.1 (30%) 0,47 0,64 0,55
12,302.8 (40%) 0,48 0,66 0,56
15,378.5 (50%) 0,49 0,67 0,57
18,454.2 (60%) 0,49 0,68 0,57
21,529.9 (70%) 0,5 0,68 0,58
24,605.6 (80%) 0,49 0,68 0,57
27,681.3 (90%) 0,49 0,69 0,57
30,757 (100%) 0,48 0,7 0,57
Table 8.7: Average precision, recall and f-measure
precision equal to the percent of positive examples in the final test, that is, a 12%
of precision, and a f-measure of 22%.
Figure 8.10: Learning Curves.
As it was seen in the previous subsection, from all pair of drugs occurring in our
corpus (30,757), only 10% of them (3,160) are drugs that interact. That is, only a
10% of relation instances are DDIs (positive examples). For this reason, we want to
study the impact of our imbalanced dataset on the performance of the kernel-based
method. A common problem in most of the machine learning algorithms is their
inability to accurately learn from imbalanced data. The rules learnt by machine
learning algorithms to describe the minority classes are fewer and weaker than those
of the majority classes. This is due to minority classes are often underrepresented [He
and Garcia, 2009, Van Hulse and Khoshgoftaar, 2009]. There are different solutions
for imbalanced learning such as sampling, cost-sensitive, kernel and active learning
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methods. A detail description of these solutions can be found in [He and Garcia,
2009]. Regarding the sampling methods, they modify the imbalanced dataset by
some mechanisms in order to provide balanced distribution. The two most common
mechanisms are oversampling and undersampling. Basically, oversampling adds
copies of the examples from the minority classes, while undersampling consists of
removing examples from the majority classes. The main advantage is that these
mechanisms are simple to implement, however, they also present some drawbacks.
Undersampling involves a considerable information loss, in which discriminative
features to differentiate among classes may be discarded, adversely affecting the
classification performance [Van Hulse et al., 2009]. In this case, the ideal would be
to eliminate redundant examples and that are very close to those of the minority
classes. Regarding they oversampling technique, replicating existing minority class
examples may not add any actual information to the dataset. Moreover, adding
examples does not only lead to a significant increase in computational costs, but
also overfitting is very likely to occur [Seiffert et al., 2009]. We believe that the
computational time is crucial for clinical applications like the automatic extraction
of DDIs from texts. The models shown in table 8.4 already require high training
times. Therefore, we have decided to apply the undersampling technique in order
to reduce the computational costs and avoid the overfitting problem. Thus, we have
performed three different experiments with imbalanced data and balanced data,
which are described below:
1. Imbalanced : both training and testing dataset are unbalanced. This experi-
ment is the most nearest to the real situation. Our textual corpus has been
collected from a pharmacological database (DrugBank), specifically, from a
text field that describes DDIs for a given drug. It is foreseeable that this num-
ber will be very much less if we build a corpus from abstracts from Medline
(although we will build the corpus using keywords that express DDIs) since
many of these abstracts do not contain necessary information about DDIs.
2. TrainingBalanced: we used the undersampling mechanism to randomly remove
negative examples from the training dataset, while we maintained unbalanced
the testing dataset. After a model is obtained from the balanced training
dataset, then the trained model is applied to the unbalanced testing dataset.
Here, our objective is to analyze if the model learned from the balanced dataset
is useful with real imbalanced data. The drawback of this experiment is that
the size of training dataset is reduced notably, for equilibrating the number of
both types of examples. Our hypothesis is that if the amount of positive and
negative examples is the same in the training set, the model can distinguish
better the minority class (DDIs).
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3. (Balanced): we also applied the undersampling mechanism to randomly re-
duce both training dataset and testing dataset to obtain the same amount of
positive and negative examples in each dataset. In spite of this is an unreal
situation, we also tackled it in order to evaluate the performance of the kernels
in balanced training and testing data.
Each experiment is compared to the baseline allDDIs, in which all examples are
labeled as DDIs, that is, as 1. This baseline allows us to estimate the improvement
achieved in each experiment above described. Table 8.8 shows the results obtained
in each experiment. In the first experiment (Imbalanced), the baseline only achieves
a 11% of precision (it is obvious since the proportion of examples positives is a
11%). The learned model achieves a good performance with a 66% of f-measure.
This is an improvement of 55% respect to the baseline f-measure. The sencond
experiment, TrainingBalanced, obtains high recall (91%), however, the precision is
quite low (36%). Therefore, balancing training data helps to improve the recall but
the precision is severely degraded. We have also studied the increment in f-measure
obtained by each experiment with respect to the baseline f-measure. The increment
can defined as follows:
Inc(Fbaseline, FjSRE) =
FjSRE − Fbaseline
Fbaseline
(8.15)
Thus, the increment in f-measure with respect to the baseline f-measure (19%)
is lower in the TrainingBalanced experiment than in the Imbalanced experiment.
Therefore, we can conclude that balancing the training dataset does not show in-
creased performance. Regarding the last experiment (Balanced), its model achieves
a good performance. For this experiment, we can conclude that balancing positive
and negative examples by undersampling mechanism achieves a better results than
those obtained from the imbalanced data. However, the increase over the baseline
f-measure is higher in the above experiments performed on imbalanced dataset.
Experiment P R F1 Inc
allDDIs 0.50 1 0.67 –
Balanced 0.82 0.91 0.86 0.25
allDDIs 0.11 1 0.19 –
Imbalanced 0.55 0.82 0.66 2.47
TrainingBalanced 0.36 0.91 0.52 1.74
Table 8.8: Experiment results on imbalanced and balanced datasets.
Regarding the task of classification if a given example is an interaction or not,
table 8.9 shows the performance of the experiments for each class (1 DDI, 0 oth-
erwise). The Balanced experiment shows good and similar performance for both
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classes. The other two experiments, Imbalanced and TrainingBalanced, show good
performance in the classification of the negative examples. In the Imbalanced ex-
periment, this may be due to that the amount of negative examples is considerably
greater than the number of positive examples, providing strong clues to describe the
majority class (non-interactions). However, we must note that in the TrainingBal-
anced experiment, in which the number of negative examples was reduced to equal
the number of positive ones in the training dataset, its results for the non-interaction
class (that is, negative examples) are still considerably high. Therefore, we believe
that it is easier to determine a non-interaction than an interaction.
Experiment class P R F1
Balanced
0 0.91 0.82 0.86
1 0.82 0.91 0.86
Imbalanced
0 0.98 0.93 0.95
1 0.55 0.82 0.66
TrainingBalanced
0 0.99 0.82 0.90
1 0.36 0.91 0.52
Table 8.9: Experiment results on imbalanced and balanced datasets grouped by
class
8.4. Conclusions
Our major objective was to evaluate the performance of the shallow linguistic
kernel-method introduced in [Giuliano et al., 2006] to extract DDIs from biomedical
texts. Several experiments have been conducted on the DrugDDI corpus. In partic-
ular, we have varied the configuration parameters window-size (local context kernel)
and n-grams (global context kernel). Experiments show that the performance does
not differ significantly from one configuration to another. Increasing the value of
the parameter n-gram does not influence the results since it is few probable that two
relation instances share long n-grams. Similarly, the choice of the parameter window-
size does not seem to affect the performance significantly. This is logic since we do
not distinguish the roles of the interacting drugs, and this parameter is designed to
identify them. Among all learned models we decided to choose one that maximizes
the precision and the f-measure but minimizes the training time, (window-size=1,
n-gram=3). This model is tested on the final testing dataset achieving a precision
of 50%, a recall of 67% and a f-measure of 57%.
We are aware that the previous results are not directly comparable with those
obtained by our pattern-based approach (described in the previous chapter 7) since
it was evaluated on the whole DrugDDI corpus. In order to compare both ap-
164
proaches, the kernel-based approach has been tested on the whole DrugDDI corpus
using 10-fold cross validation. Table 8.10 compares the two approximations pro-
posed in this thesis for the extraction of DDIs. The Kernel-based approximation
has remarkably overcome the pattern matching method. The more significant im-
provement is achieved in terms of recall and f-measure. Recall increased up to 82%
and f-measure to 66%. This is an increase of almost 57% in recall rates, and almost
33% in f-measure. A minor improvement is also achieved for the precision, with an
increase of 6.31%. Therefore, we can conclude that machine learning-approach is
more efficient than the pattern-based approach to tackle the extraction of drug-drug
interactions from texts.
Approach P(%) R(%) Fβ = 1(%)
Pattern-based approach 48.7 25.7 33.6
Kernel-based approach 55 82 66
Table 8.10: Experiment results: patterns vs kernels.
We cannot compare this work with any other approach because we are the first
who have addressed the DDI extraction. Our experiments have been performed
on a specific corpus for our task, and different to the corpora used in Giuliano
et al. [2006]. Giuliano et al. [2006] performed several experiments on two different
biomedical corpora: AImed and LLL. Their experiments are performed using both
the correct named entities, that is, those manually annotated in the corpora. The
results obtained on the AImed corpus show a precision of 60.0%, a recall of 57.2%,
and f-measure of 59%. Better performance is achieved on the LLL corpus, with a
precision of 62.1%, a recall of 61.3%, and a f-measure of 61.7%. A possible explana-
tion of our results being lower than those, could be that our performance shows a
remarkable impact of automatic entity recognition on the relation extraction task.
It is predictable that if drug names were manually labeled in our corpus, our results
will significantly improve. On the other hand, the LLL corpus is smaller than the
DrugDDI corpus, however, its average number of interaction per sentence is higher
than that in the DrugDDI corpus (see table 8.11). We believe that a high density
of interactions could positively influence on the performance since sentences in the
LLL corpus are focused on the description of interactions, while sentences in our
DrugDDI corpus may be less discriminative.
The DrugDDI corpus shows a great imbalance distribution between positive and
negative examples because only 10% of relations instances are drug-drug interac-
tions. We have conducted thee experiments to study the influence of the imbal-
anced dataset on the performance of the kernel-method. Experiments evaluated on
imbalanced data show that balancing the training dataset does not show increased
performance. The experiment using balanced training and testing dataset achieves
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Corpora Dataset Sentences interactions Avg.
LLL
train 80 271 3.4
test 82 166 2
DrugDDI
train 4578 2421 0.5
test 1228 739 0.6
Table 8.11: Comparation between LLL and DrugDDI corpora.
better results than those obtained from the imbalanced dataset. However, the in-
crease over the baseline performance is higher in imbalanced dataset.
To conclude, we believe that the good performance achieved using the shallow
linguistic kernel provide a higher baseline, being possible to measure improvements
using other methods that use full syntactic or semantic information. We propose
several specific ideas for future work:
Evaluate each of the three contexts (before, between and after) separately,
assigning different weights to them. Here, our objective will be to study which
of the three contexts is the most discriminative for DDIs.
Evaluate the performance of the kernel-method when the drug names are man-
ually annotated.
Label the roles of drugs in the DrugDDI corpus in order to evaluate the con-
tribution of the local kernel in their detection.
Define a semantic kernel that uses semantic information such as semantic type
from UMLS or drug families obtained by the DrugNer module.
Design parse tree or dependency graph kernels for the extraction of DDIs.
Evaluate other solutions for imbalanced learning such as hybrid sampling or
cost-sensitive methods.
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Chapter 9
Conclusions
9.1. Conclusions and Future Work
A DDI occurs when one drug influences the level or activity of another drug.
DDIs are common adverse drug reactions (ADR), which can lead to significant
morbidity and mortality. In addition, DDIs are a direct cause of the increase of
health care costs because they account for 16.6% of adverse drug reactions causing
hospitalization [Pirmohamed et al., 2004].
There are several databases supporting health care professionals in the detec-
tion of DDIs, however they are rarely complete. A great deal of the most current
and valuable information on DDIs is unstructured and hidden in articles, scientific
journals, books and technical reports. Therefore, the medical literature is proba-
bly by far the most effective system for detection of DDIs [Aronson, 2007]. The
great amount of drug interaction databases and the deluge of published research
have overwhelmed most health care professionals because it is not possible to be
kept up-to-date of everything published about drug-drug interactions. Information
Extraction from unstructured data sources can be of great benefit providing an in-
teresting way to reduce the time spent by health care professionals on reviewing
the literature. Moreover, the development of tools for the automatic extraction of
drug-drug interactions is essential for improving and updating the drug knowledge
resources. The major goal of this thesis is to develop and improve IE techniques
applied to biomedical texts, in particular, in the scenario of DDIs. Next, we discuss
whether the objectives proposed in this thesis (see section 1.2) have been achieved.
Our first objective is the creation of an annotated corpus of DDIs. The review
presented in section 3.1 showed that most biomedical annotated corpora for relation
extraction are focused on the biological domain and there is no corpus for DDIs.
We have built the first annotated corpus of DDIs, the DrugDDI corpus, which has
allowed us to automatically evaluate the different approximations proposed in this
thesis to extract DDIs. To the best of our knowledge, the problem of producing
167
an annotated corpus for DDI extraction has not been explored in the depth and
extent reported in this chapter. Also the resulting corpus is the most semantically
rich annotated resource for pharmacological text processing built up to date. The
DrugDDI corpus consists of 579 documents from the DrugBank database and a to-
tal of 9,601 sentences. The documents were semantically and syntactically analyzed
by MMTx and annotated with linguistic information including sentence bound-
aries, tokenization, phrase boundaries and phrase semantic classification provided by
MMTx. MMTx integrates several biomedical knowledge resources contained within
the UMLS system, providing a broad coverage for a huge amount of biomedical
terms (objective 3). The corpus contains a total of 3,160 DDIs manually annotated
at sentence level with the assistance of an expert pharmacist. DrugDDI is larger
than other biomedical corpora, which never exceed 1,100 sentences and 2,662 rela-
tionships [Pyysalo et al., 2007]. We now outline directions for future improvements
of the DrugDDI corpus:
1. Increase the size of the corpus, using other textual sources such as the biblio-
graphics databases MedLine and EMBASE.
2. Annotate the interactions at document level for capturing those interactions
spanning several sentences.
3. Annotate related information on drug-drug interactions such as level of sever-
ity, mechanism of action, degree of certainty, drug dosages, time interval be-
tween administration of the drugs, etc. They are relevant features to charac-
terize the DDIs and assign them a real clinical significance.
4. From a syntactic point of view, the inclusion of full syntactic information
provided by biomedical parsers such as Genia dependency parser [Sagae, 2007]
or the one proposed in [Lease and Charniak, 2005] will be considered. In
addition, we will manually review the linguistic and semantic analysis provided
by the MMTx tool, dealing with the failures of MMTx. We will also annotate
negation and modality because they can significantly alter or even reverse the
meaning of the sentence.
5. Provide comprehensive annotation guidelines useful for other annotators to
cover aspects such as the annotation of interactions involving anaphoric and
cataphoric expressions or the treatment of uncertain interactions. This guide-
line is crucial in order to achieve high quality annotations.
6. Annotate the corpus by various pharmacists and measure the inter-annotator
agreement. This will allow us to test the quality of the annotation itself and
check if our guidelines are robust, consistent and easily identifiable.
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The availability of the DrugDDI corpus is an important contribution for the
development of other approaches for DDI extraction since it provides gold-standard
data for evaluation. We believe that this shared corpus should result in an increased
focus and rapid advances in the field. Thus, we hope to encourage many researchers
to make use of DrugDDI corpus for their research, and expect much feedback from
them that would be the most valuable source for further improvement of the corpus.
Our second objective pursued to study the main approaches for biomedical IE.
We have reviewed the main techniques used for named entity recognition, anaphora
resolution and relation extraction in the biomedical domain. Shortcomings of these
techniques in view of our work are identified and some solutions are proposed.
Detecting and classifying drug names occurring in biomedical texts have also
been carried out in this thesis (objectives 3 and 4). We have proposed a hybrid
method that combines the use of the MMTx tool and a set of affixes recommended
by the WHOINN Program to identify and classify drug names. MMTx is an effective
program for the automatic processing of the biomedical texts, however, it is not
able to provide complete and useful information about pharmacological substances.
The affixes allow to recognize drugs not detected by MMTx, and establish suitable
information such as their pharmacological families. Although evaluation reveals
that affixes alone are not feasible enough in detecting drugs they help to improve the
coverage. Combining MMTx and the affixes achieves a precision of 99.1% and a recall
of almost 100%. In our experiment, we assumed that the drug name recognition
provided by MMTx was correct, because our main objective was not to evaluate the
performance of MMTx, but to study if the affixes could help to identify new drugs
not detected by MMTx.
In future work, we are planning to provide a more realistic evaluation taking into
account the mistakes made by MMTx. It is foreseeable that the performance will
be negatively affected. Regarding the drug name classification task, the affixes are
able to correctly classify 74.9% of drugs occurring in the texts. The ATC system
provides a global standard for classifying medical substances and serves as a tool for
drug research, for this reason, we are planning to develop machine learning-based
techniques to predict the ATC class for unclassified drugs. Moreover, linking the
affixes with the groups of the ATC classification system is an important challenge
to be met in future work. Resolving drug acronyms, extending the set of affixes,
including additional clues for those affixes that are too short and ambiguous to
correctly detect drugs are some challenges for our future research to improve the
recall and the precision of drug name recognition and classification tasks.
We have also developed a pipeline prototype to provide a framework (objective
5), allowing to easily combine and evaluate several techniques for coping with the
different processes involved in the extraction of DDIs.
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The extraction of DDIs requires the resolution of anaphoric expressions in phar-
macological texts (objective 6). We have developed two different approaches to
address the problem of co-referring expressions in pharmacological literature. In
addition, we have built and annotated a corpus in order to analyze the phenomena
and evaluate both approaches. To the best of our knowledge, this is the first work
that addresses this issue. The first approach is based on a scoring system and ob-
tains results that are similar to those of other systems referred to in the biomedical
domain [Castano et al., 2002, Lin et al., 2004, Kim and Park, 2004a, Liang and
Lin, 2005]. It shares with these works the use of a set of linguistic features and a
semantic resource such as UMLS.
The second approach for anaphora resolution uses Centering Theory [Grosz et al.,
1995] in order to select the scope of the anaphoric expressions and assign the correct
antecedent. In contrast, a simpler heuristic that selects the closer nominal phrase
has been experimentally shown as a useful rule to solve relative pronouns and pos-
sessive nominal anaphoras. A key component of both approaches is the use of the
biomedical parser MMTx. Unfortunately, this tool only provides shallow syntactic
information, so it can be expected that full syntactic parsing improves the perfor-
mance of the linguistic rules-based method. The scoring-based approach achieves a
precision of 77% and a recall of 62%. The linguistic rules-based approach overcomes
the scoring approach, obtaining a precision of 84% and a recall of 70%. MMTx
makes several syntactic and semantic parsing failures [Divita et al., 2004], which
influence negatively on the performance of both approaches.
Neither of the proposed approaches for drug anaphora resolutions have been in-
tegrated in the extraction of DDIs. Thus, this objective is still an unsolved goal.
Future work will consider the overall contribution of the anaphora resolution ap-
proaches to the broader task of DDI extraction. To automatically evaluate the
overall contribution, it is necessary to annotate the DrugDDI corpus at document
level. Although sources providing information on interactions such as Medline ab-
stracts and DrugBank may share a common literary style, the distribution of in-
teractions is very different and it also deserves investigation. On the other hand,
semantic information about drug families provided by the DrugNer process can be
valuable for the improvement in the resolution of certain nominal anaphoras. Addi-
tional improvements include extending the coverage of the approach to other kinds
of biomedical entities, increasing of the size of the corpus in order to make more
reliable conclusions, and the application of machine learning techniques, which have
been successfully applied in other domains.
In this thesis, we have developed two different approximations for the extraction
of DDIs from biomedical texts. The first approximation proposes a hybrid approach
that combines shallow parsing and pattern matching to extract relations between
drugs from texts (objective 7). Appositions and coordinate structures are detected
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using shallow syntactic and semantic information provided by MMTx. Complex
and compound sentences are broken down into clauses from which relations are ex-
tracted by a pattern matching algorithm. The patterns were manually defined by our
pharmacist based on her professional experience and the observation of the training
corpus. The approach was evaluated on the DrugDDI corpus (annotated dataset)
showing a low performance (f-measure of 33.64%). Regarding the resolution of the
linguistic constructions, most of the errors are due to mistakes introduced in the
MMTx level and the difficulty of resolving nested clauses, so frequent in biomedical
texts. On the other hand, the variability of natural language expression makes it
difficult for this approach to accurately detect all semantic relations occurring in
text since sentences conveying the same relation may be composed lexically and
syntactically differently. Inversely, sentences which are lexically common may not
necessarily convey the same relation. Thus, our patterns are not enough to identify
many of the interactions.
We now point out potential future directions for research on the hybrid ap-
proach. The resolution of the different failures of MMTx hindering the successful
detection of the linguistic constructions will be addressed. We will also cope with
the kinds of appositions not addressed in this work. The improvement of the clause
splitting process using machine learning-based techniques as well as the definition
of new simplification rules to generate simple sentences from clauses also deserve
investigation.
We will carry out a more exhaustive treatment of negation and modality, since
these phenomena can significantly alter or even reverse the meaning of a sentence.
This approach firstly recognizes the coordinate structures, followed by the apposi-
tions, and finally, the clause splitting process is conducted. We will evaluate how the
order in which the different constructions are detected affects the performance of the
approach. In addition, we will manually annotate the corpus used for the evaluation
of the linguistic constructions. On the other hand, the utility of the other corpora
such as Genia-GR or Penn Treebank for the evaluation of the syntactic resolution
will be studied.
Finally, we will propose the use of the SPINDEL [de Pablo-Sa´nchez and Mart´ınez,
2009] system to semi-automatically acquire linguistic patterns for DDI extraction.
This system was developed by the Group of Advanced Databases (LABDA) 1 with
the aim of semi-automatic generation of valuable resources to build a named entity
recognition system for domains and languages with scarse resources. The system
bootstraps the acquisition of large dictionaries of entity types and pattern types
from a few seeds and a large unannotated corpora, providing good performance for
a weakly supervised method.
1http://basesdatos.uc3m.es/
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Our second approximation is based on the kernel-based approach presented by
Giuliano et al. [2006] (objective 8). The approach combines two kernel methods,
called global context and local context kernels, which integrate the information of
the whole sentence where the relation occurs and the context information of the
interacting entities, respectively. In particular, we have used their java tool for re-
lation extraction (jSRE), which has been applied to relation extraction with good
results in both general and biological domains. jSRE only needs shallow syntac-
tic information such as sentence splitting, tokenization, part-of-speech tagging and
lemmatization to build the structured representation of each relation instance.
Several experiments were performed on the DrugDDI corpus, which was split into
two sets: training dataset to learn models, and the final testing dataset to evaluate
the best models. In the experiments, we have varied the configuration parameters
of global (n-gram) and local kernels (window-size). Experiment results show that
the performance does not differ significantly from one configuration to another.
Therefore, we selected the model that maximized the results and minimized the
training time (n-gram=3, window-size=1). This model was evaluated on the final
testing dataset, achieving a precision of 51%, a recall of 67% and a f-measure of
58%. These results are not directly comparable with those obtained by our pattern-
based approach, since it was evaluated on the whole DrugDDI corpus. For this
reason, the kernel-based approach was evaluated on the whole corpus using 10-fold
cross validation, overcoming the pattern-based method remarkably (objective 9).
Precision was increased from 48,69% to 55%, recall from 25,70% to 82%, and f-
measure from 33,64 to 66%. The most significant improvement is achieved in terms
of recall and f-measure, with an increase of almost 57% in recall rates, and almost
33% in f-measure.
We cannot compare with any other approach because we are the first who have
addressed the DDI extraction problem. Although we have used the same evalua-
tion methodology (OAOD) adopted by Giuliano et al. [2006] (this work tackled the
extraction of PPIs), our experiments have been performed on a specific corpus for
our task. On the other hand, they used two biomedical corpora LLL and AIMed
in which proteins are manually annotated. Therefore, a possible explanation of our
results being lower than those obtained in their work, could be that our performance
shows a remarkable impact of automatic entity recognition on the relation extrac-
tion task. It is foreseeable that if drug names were manually labeled in our corpus,
our results will improve significantly.
The DrugDDI corpus exhibits highly imbalanced distribution (only the 10% of
the examples are DDIs). We have also studied the impact of the imbalanced dataset
on the performance of the kernel-based approach. We have performed three experi-
ments: Imbalanced in which training and testing datasets are imbalanced, Training-
Balanced in which only training dataset has been balanced, and Balanced in which
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both training and testing datasets have been balanced. Experiments show that bal-
ancing the training dataset does not show increased performance with respect to
using imbalanced training dataset and evaluating on imbalanced data. Regarding
the last experiment, although it shows better results than those obtained in the
previous experiments, we are aware that this experiment is far from representative
of the real situation, in which there is a high imbalance between classes.
In the near future, we plan to extend our work in several ways. First of all,
we will study other solutions for imbalanced learning such as oversampling or cost-
sensitive methods. We will also evaluate each of the three contexts (before, between
and after) separately in order to analyze which of the three contexts is the most
discriminative for DDI extraction. The roles of the interacting drugs will be labelled
in the corpus, and we will study the performance of the local kernel in their detection.
We believe that the good performance achieved using shallow linguistic information
provides a higher baseline, being possible to measure improvements obtained using
other methods such as full syntactic or semantic information. Thus, we will define
a semantic kernel considering semantic information from UMLS and other drug
knowledge sources such as ATC codes obtained from DrugBank or drug families
obtained by the DrugNer process. In addition, we are also discussing the possibility
to apply parse tree or dependency graph kernels.
On the other hand, we will also deal with the extraction of relevant information
on each interaction such as its mechanism, its relation to the doses of both drugs,
its time course, the factors that alter an individual’s susceptibility to it, its seri-
ousness and severity, and the probability of its occurrence. This is a very complex
challenge because it involves resolving temporal expressions, detecting events, recog-
nizing other biomedical entities and their relationships, integrating drug knowledge
information, among others. In addition, food-drug interactions, drug-disease inter-
actions, ADRs, drug-protein interactions (that is, drug targets) and many other
relationships in the pharmacological domain also deserve investigation.
To the best of our knowledge, this thesis has proposed the first integral solution
for the automatic extraction of DDI from biomedical texts. The other major contri-
bution of this thesis is the construction of the first corpus annotated for DDIs. We
hope that this corpus can encourage other researches to explore new solutions for
the extraction of DDIs. We have also developed a prototye integrating the different
developed techniques in this thesis to carry out our goal. We hope that our proposal
contributes to the development of useful tools to assist healthcare professionals in
the early detection of DDIs. However, we should point out that in an environment
as sensitive as health, it is important to take into account that automated solutions
can only facilitate routine tasks and serve as support, while the final decisions are
up to the experts. To finish, we believe that this thesis can become a starting point
for researching IE techniques applied to the pharmaceutical industry, for improving
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not only the patient safety, but also the drug discovery process by the identification
of drug targets in the biomedical literature, among many other contributions.
9.2. Publications
As a result of this work, several publications have been presented in workshops,
conferences and specific journals.
In A preliminary approach to recognize generic drug names by combining UMLS
resources and USAN naming conventions (BioNLP 2008) and Drug name recogni-
tion and classification in biomedical texts (Drug Discovery Today Journal), we have
presented two different approaches for drug name recognition. While in the first ap-
proach, we have collected a collection of MedLine abstracts analyzed by the GATE
architecture [Cunningham et al., 2002] and annotated with semantic types by query-
ing UMLS Methatesaurus, the second one is based on the use of the MMTx tool
to syntactically and semantically analyze a set of texts taken from the DrugBank
database. Both approaches apply the set of affixes recommended by the WHOINN
program to identify and classify drug names.
In The UC3M team at the Knowledge Base Population task (TAC 2009), we
have proposed a preliminary approach for knowledge base population, which will be
applied to integrate and consolidate registered drug names as well as non-registered
drugs. We have carried out drug anaphora resolution in Score-based approach for
Anaphora Resolution in Drug-Drug Interactions Documents (NLDB 2009), Resolv-
ing anaphoras for the extraction of drug-drug interactions in pharmacological doc-
uments (BMC BioInformatics). These aproaches are mainly based on the use of
linguistic and semantic information provided by the MMTx tool.
In UC3M: Classification of semantic relations between nominals using sequen-
tial minimal optimization (ACL-SEMEVAL 2007) and Detecting Semantic Rela-
tions Between Nominals Using Support Vector Machines and Linguistic-Based Rules
(OTM Workshops 2007)), we have developed several approaches based on machine
learning techniques to extract semantic relationships. In Una propuesta para el
etiquetado automa´tico de roles sema´nticos (SEPLN 2007), we have proposed an ap-
proach to annotate semantic roles and in Including deeper semantic information in
the Lexical Markup Framework: a proposal (IS-LTC 2006) we have presented a pro-
posal to integrate semantic information into the LMF framework, which is the ISO
standard for Natural Language Processing (NLP) lexicons and Machine Readable
Dictionaries (MRD).
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